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S I N G L E C R Y S T A L X - R A Y DIFFRACTION S T U D I E S ON S M A L L , MEDIUM & L A R G E M O L E C U L E S 
Susanna Butterworth 
Abstract 
Chapter 1. Production of crystals for diffraction analysis would be assisted by the devising of a set 
of rules which, given molecular formula, could predict crystal formation conditions. By studying 
trends in structural properties of a group of closely related simple molecules, deductions could be 
drawn which could then be applied more generally. Chalcone derivatives with minor substituent 
differences were recrystallised, X-ray diffraction data collected and the structures solved and 
refined. Additionally, NMR and UV studies were performed, investigating an observed dimerisation 
reaction. 
Chapter 2. Discovery of peptide hormones and neurotransmitters has stimulated the study of 
structure-activity relationships, although the structure of these molecules is often poorly defined. 
Proctolin, a linear pentapeptide, is a neurotransmitter in insects. Crystallisation was attempted, with 
the aim of deducing the active conformation structure, thereby assisting in design of small 
molecule analogues for use as non-cholinergic pesticides. No diffraction was observed from the 
crystals produced. 
Chapter 3. Glucosamine 6-phosphate synthase is an N-terminal nucleophile amidotransferase 
catalysing the first step in the hexosamine pathway, from which all amino-sugar containing 
macromolecules are derived. Structure determination of each of two subdomains was attempted. In 
one case, pseudo-symmetry appeared to obstruct stnjcture solution. The symmetry has 
subsequently been understood and the structure obtained. Crystals of the second domain are 
rotationally disordered. 
Chapters 4 and 5. Recent advances in macromolecular crystallographic techniques have facilitated 
the collection of an increasing number of high quality, atomic resolution data sets. Methods for 
refinement, previously limited to small moleculd structures, have increasing relevance for proteins. 
Atomic resolution refinements using these evolving protocols have been performed on two small 
proteins, rubredoxin from Desulfovibrio vulgaris and the protein G immunoglobulin-binding domain. 
Appropriate treatment of the solvent structure in a protein crystal and the benefit to be gained by 
using sharpened density maps during refinement were investigated. 
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General Introduction 
I began writing an account of my work during the last four years by drawing up a plan of 
the topics the thesis should cover. The unusually wide range of subject matter seemed to 
demand an introductory explanation of how the PhD had evolved, setting out my 
ambitions and goals at each stage, a summary of my achievements and experiences, 
and an explanation of why the direction of study changed and how my aims were 
modified over the course of time. 
The project, entitled "diffraction studies and NMR investigation of medium-sized 
molecules" was embarked upon in the framework of a C A S E award between Shell 
Research agrochemical division in Sittingbourne, Kent and the University of Durham 
Chemical Crystallography Department, commencing in October 1992. The goal of the 
Shell research program was the development of a new generation of non-cholinergic 
pesticides, the initial object being to obtain a structural model of the active conformation 
of an oligopeptide, proctolin, a substance with neuroregulatory activity in many species of 
insects and some other invertebrates as an input for modelling studies to suggest 
possible small molecular analogues. NMR studies on the material in progress at Shell had 
proved rather inconclusive, although I had little access to this information at that stage, so 
single crystal X-ray diffraction studies were required. Shell funded a supply of the material 
from Sigma Chemicals to the Chemical Crystallography Department in Durham. I 
attempted to obtain crystals. Realising that this was a different scale of problem from the 
recrystallisations of small molecules I had previously performed, I sought the advice of 
experts: Marek Brzozowski at York University and Steve Wood at Birkbeck College, 
London. 
Crystallisation attempts were undertaken without positive result until April 1993, when I 
accepted the generous offer of Steve Wood to spend some time under his supervision at 
Birkbeck learning about the practical techniques entailed in the crystallisation of peptides 
and larger molecules. In the following months at Birkbeck, some limited success was 
achieved, with the production of crystals from which no diffraction could be obsen/ed. 
In September 1993 the research project at Shell came to an end, with the take-over by a 
rival company and subsequent closure of the department In Sittlngbourne. Shell 
Research, while legally obliged to continue funding the C A S E award, had no further 
scientific Interest in the project. 
I returned to Durham and decided to continue work on a project which had originally been 
an Oxford Chemistry Part II project with David Watkin at the Chemical Crystallography 
Laboratory. This was a study of the properties of a set of closely related small organic 
compounds, chalcones, with the aim of deriving a relation behveen variation In formula 
and crystallisation behaviour and the nature of the crystal lattice. This work had been 
Initially successful but much remained to be done and I had regretted leaving It unfinished 
at the end of a year. At Durham, further recrystalllsatlon, data collection, structure 
solution, NMR and UV studies were performed on the chalcones, along with the re-
refinement of the previously obtained structures, In the light of my Increasing 
crystallographic knowledge. A body of results accumulated but I was still at loss to know 
how to Interpret them and derive relations between chemical formulae and lattice 
properties. Inspiration was required and it did not come. As the project stood. It did not 
constitute a PhD thesis. 
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In the spring of 1994 I attended the HERCULES School in Grenoble on the use of large 
facilities in solid state studies, for which I had applied while still working on proctolin. Here 
I learnt more about applications of synchrotron and neutron sources, especially in the 
field of biological macromolecular structures. The course provided new motivation and 
perspective and I realised I was getting stuck in a rut. 
Shortly aftenwards, I visited the EMBL synchrotron outstation at DESY, Hamburg. 
Discussions with Keith Wilson led to the suggestion that I might be able to spend a period 
working at the synchrotron, where there were projects available, given that I still had 18 
months funding. This proposal was agreed by Judith Howard in Durham and by the 
E P S R C and in June 1994 I arrived in Hamburg. 
At Hamburg I began working with Alex Teplyakov on the determination of the structure of 
two subdomains of an enzyme glucosamine 6-phosphate synthase. Crystals had already 
been obtained for both domains and initial data collection was underway. The project 
provided me with an introduction to the practical techniques of protein crystallography 
including crystallisation, synchrotron data collection, searching for heavy atom derivatives 
and molecular replacement. Unfortunately, progress soon became hindered by the 
appearance of crystal symmetry problems. The pseudo-symmetry of the crystals of one 
of the domains appeared to obstruct structure solution. My work on this domain was 
continued by Misha Usupov at Exeter University, who was eventually successful in 
gaining an understanding of the extremely subtle and complex nature of the crystal 
symmetry and so solving the structure. The crystals of the other domain were found to 
possess a kind of rotational disordered lattice. My attempts to somehow obtain crystals 
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with better symmetry were fruitless. No significant progress In tackling this problem has 
since been made. 
In January 1995 It was decided that, with only nine months remaining before the end of 
the third year of the PhD and no guarantee of imminent results, It would be advisable to 
do some work of a more analytical nature. For the next fifteen months I worked in 
collaboration with Victor Lamzin on the refinement of atomic resolution protein structures 
and the development of tools for the analysis and refinement of protein crystal structures. 
Thus, I Increased my knowledge of some more theoretical areas of crystallography and 
gained an Introduction to FORTRAN and C-Shell programming. And finally obtained 
some more tangible results. 
Looking at the overall thesis plan, It is possible to see a theme running through the series 
of projects covered. My initial experience In crystallisation concerned the essentially trivial 
solution and refinement of some small molecular structures with the far from trivial aim of 
developing a systematic method for the prediction of crystallisation conditions. I then went 
on to work on a larger molecule, a pentapeptide, thereby gaining first-hand experience of 
the problems and frustrations of the search for crystallisation conditions. In my next 
project, the molecules were considerably bigger, several hundred amino acids In length. 
In this case, crystallisation conditions had been found, the problem lay with the next step, 
structure solution, a different class of problem for a protein from that presented by 
running a default direct methods job on a twenty atom structure. My final objects of study 
were slightly smaller, with around sixty residues each. In the development of techniques 
for the treatment of atomic resolution protein data sets I was concerned with the progress 
of protein crystallography into the traditional territory of small molecular crystallographers 
12 
- almost (but not quite) completing the circle. Thus, the entire thesis could be seen as 
progress towards mapping out a continuum of structures, from molecules comprising a 
few atoms to those made up of hundreds of kilodaltons. 
13 
Abbreviations used In this thesis 
people & places 
DESY Deutsches Elektronen-SYnchrotron 
EMBL European Molecular Biology Laboratory 
EPSRC Engineering and Physical Sciences Research Council 
PDB Brookhaven Protein Data Bank (Bernstein et a/., 1 9 7 7 ) 
CSD Cambridge Structural Database (Allen et a/., 1 9 9 1 ) 
crystallographic terminology, especially conceming proteins 
A 1 Angstrom = 01 nm 
e diffraction angle 
X wavelength of radiation (commonly X-ray) (A) 
d resolution of diffracted intensity, Braggs law, d = X / 2sin 9 (A), 
s resolution expressed as 2sinG / X (A'^ ) 
F structure factor 
Fo / F c structure factor amplitude; obsen/ed / calculated 
E normalised (sharpened) structure factor 
H half-sharpened structure factor, F'*E'* (defined for the purposes of this thesis) 
etc calculated phase of a reflection 
R reliability index, Z I IFol - IFcl I / 2 IFol 
Rfree R factor evaluated from a subset of data independent of refinement (Brunger, 1 9 9 3 ) 
B isotropic thermal parameter, 8T^<U>^ (A^), where <u>^, root mean square displacement of 
atom 
p electron density, commonly expressed in e A'^ 
Vn, crystal volume per unit molecular weight (Matthews, 1 9 6 8 ) (A^ D"'') 
ksoi contrast parameter for modelling diffuse solvent, Zpsoi(r) / 5;pproiein(r) (Tronrud, 1 9 9 6 ) 
Bsoi average B factor for diffuse solvent (A^) (Tronrud, 1 9 9 6 ) 
rms(d) root-mean square (distance/deviation, commonly in A) 
H-bond hydrogen bond, ^^^^^ donor and acceptor atoms commonly 0,N,S 
possibly C 
NCS non-crystallographic symmetry 
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naturally occurring amino-acids 
Ala (A) alanine Leu(L) leucine 
Arg (R) arginine Lys (K) lysine 
Asn (N) asparagine Met (M) methionine 
Asp (D) aspartate Pro (P) proline 
Cys (C) cysteine Phe (F) phenylalanine 
Gly(G) glycine Ser (S) serine 
Glu (E) glutamate Thr(T) threonine 
Gin (Q) glutamine Trp (W) tryptophan 
His (H) histidine Tyr(Y) tyrosine 
lie (1) isoleucine Val (V) valine 
substances concerned with crystallisation 
PEG polyethylene glycol (precipitant) DMSO dimethyl sulphoxide 
TFA trifluoroacetic acid DMF dimethyl formamide 
DTT dithiothreitol (antioxidant) MPD methyl-pentanediol (additive) 
HEPES 2-[4-(2-hydroxyethyl)-1-piperazino]-ethanesulphonic acid (buffer) 
TRIS a,a,a-tris-(hydroxymethyl)-methylamine (buffer) 
EMTS mercury thiosalicylate 
substances concerned with biochemical processes 
ATP/ADP/AMP 
GTP 
UDP 
NADP* 
NADPH 
ig / igG 
Pi / PPi 
adenosine triphosphate / diphosphate / monophosphate 
guanosine triphosphate 
uridine diphosphate 
nicotinamide adenine dinucleotide phosphate oxidised 
nicotinamide adenine dinucleotide phosphate reduced 
immunoglobulin / immunoglobulin G 
inorganic orthophosphate / pyrophosphate 
other techniques 
HPLC high performance liquid chromatography 
NMR nuclear magnetic resonance 
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Chapter 1 : 
A systematic study of the crystal structures of phenyl 
acetophenones 
Background 
References to phenyl acetophenones, or chalcones, have occurred in the literature of 
various fields. An investigation into the polymorphism displayed by these compounds was 
reported by Weygand (1929). A study of relationships between structure and solid state 
reactivity of conjugated organic molecules, including chalcones, was carried out at the 
Weizmann Institute of Science. The effect of crystal packing on photopolymerisation 
reactions was investigated (Rabinovlch & Schmidt, 1970) and stereospecific syntheses, 
enabled by the crystallisation of non-chiral molecules into chiral spacegroups, were 
studied (Rabinovlch & Shakked, 1974). The pharmacological activity of several chalcones 
has been investigated, for example, the use of kukulkanins, which can be extracted from 
the bark of Mimosa tennuefolia, by Mexican Indians to heal burns (Dominguez et a/., 
1989). A recently reported study of chalcones was concerned with the relationship 
between the crystal structure, which Is non-centrosymmetric and the non-linear optical 
properties displayed by the material (Zhiengdong etal., 1992). 
Introduction 
Single X-ray crystal diffraction is the choice method for molecular structure determination 
for molecules of all sizes. The first hurdle to be overcome in such an analysis is the 
production of crystals of suitable quality for diffraction studies. Despite almost a century 
of experience, little is known about how and why a substance crystallises in a particular 
way from a specific set of conditions. The formulation of a set of rules which, given the 
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molecular formula, could be applied to predict conditions for the crystal formation of a 
substance would be extremely useful (Van der Sluis, 1989). One direction of approaching 
this goal is to study the crystal properties of a group of simple small molecules with very 
closely related structures. Deductions drawn from systematic trends traced within the 
group could then be generalised and applied across a wider field. 
The opportunity for a systematic study of the relationships between the molecular 
structure of a compound and its crystalline properties was offered by the synthesis of a 
series of twenty-five organic compounds with only minor differences in substituents on a 
common backbone: chalcone derivatives with varying numbers of oxy-methyl and 
methylene-dioxy substituents on the two aromatic rings, Table 1. A number of these 
chalcones were recrystallised under varying conditions, most commonly by the 
evaporation of a toluene or an ethanol solution, and X-ray diffraction data were collected 
on a total of seventeen different types of crystal. Details of these experiments are 
summarised in the Appendix at the end of the chapter. 
A survey of crystallisation conditions and the determination of twelve structures were 
carried out before the start of this PhD (Bahar, 1992). During this PhD, eleven of the 
structures were re-refined and the details of these refinements are presented, along with 
the four structures determined since, at Durham, in the Appendix. The chaicone XII 
crystals were extensively disordered, preventing determination of the spacegroup. No 
final conclusions were reached about this structure. Similar, problems were experienced 
with chalcone XV, following data collection on these crystals at Durham. Crystals of the 
remaining ten chalcone molecules could not be grown under the conditions successful for 
the first fifteen. 
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Table 1. Methoxy-chalcones synthesised 
12 13 14 15 16 
2- * . * - . 
MeO - - * - -
-* 
3 
MeO * - • - -
* - * - * 
* * 
4- * . * . 
MeO * - * -
- - * _ 
* * * 
5-
MeO -
MeO 
/ 
O 
C H r 
O 
* * * 
IV 
V 
VI 
VII 
VIII 
IX 
X 
XI 
XII 
XIII 
XIV 
XV 
XVI 
XXI 
XXil 
XXill 
XXIV 
XXV 
structures 
determined 
1^ 
a 
1 
0 
0 
0 
d 
1 
0 
0 
0 
1 
0 
i 
1 
1^  
c 
1 
XVII 1 ' 
XVIII 0 
XIX 1 ' 
XX 0 
1 
2 
0 
c 
2 
l ' 
structure determined at Oxford (Bahar, 92), re-refined at Durham 
" structure determined at Oxford (Bahar, 92), extensively disordered 
" structures of 2 polymorphs determined at Oxford (Bahar, 92), re-refined at Durham, 
d 
structure determined at Durham 
^ data collected at Durham, extensively disordered 
* monomer and dimer structures determined at Durham 
* methoxy group substituted at this position 
<-> methylene-dioxy group substituted at these 2 positions 
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Numbenng scheme for substitution positions on the chalcone molecule 
The first part of this chapter is a survey of the molecular conformations and packing 
motifs adopted in thirteen chalcone structures and the relationships between crystal 
properties and molecular formula. The final part comprises an account of the discovery 
and investigation of the dimerisation reaction of chalcone XXII. 
Molecular conformation 
The molecule possesses three approximately planar parts. The dihedral angle between 
ring 2 and plane 3 falls into one of two ranges: 0-35° and 85-90°, corresponding to the 
two conformational types, "cisoid" and "transoid", Figure 1. The dihedral angle ring 1 / 
plane 3 lies in the range 0-16°. These parts of the molecule are almost coplanar in all 
instances. 
The molecular conformation is determined by the balance of two sets of competing 
intramolecular forces: stabilisation due to n-n overlap across the three planar regions of 
the molecule and destabllisation due to steric repulsion between C(12) and C(16) 
substituents and 0(1) and H(8) and between C(2) and C(6) substituents and H(8) and 
H(7). 
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Figure 1, Molecular conformation 
a chalcone molecule has three planar moities 
cisoid conformation transoid conformation 
The stabilisation due to conjugation is maximised when the entire molecule is planar. 
However steric repulsion is also greatest in this conformation. Because of the position of 
the ketone oxygen, the repulsion experienced by ring 2 when coplanar with the central 
part is greater than that experienced by ring 1 and consequently the stabilising and 
repulsive forces between ring 2 and plane 3 are more closely balanced. When hydrogens 
are present at C(12) and C(16), ring 2 lies coplanar, but when methoxy groups are 
substituted, ring 2 becomes perpendicular to the rest of the molecule. Ring 1 remains 
coplanar with plane 3 even when methoxy groups are substituted at C(2) and C(6), the 
lowering in energy provided by the conjugation of ring 1 with the unsaturated ketone 
being the dominating stabilising force. 
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Packing characteristics - a survey of fourteen chalcone crystal structures 
Molecular conformation affects the nature of the packing within the crystal. Molecules in 
transoid conformation have a crossed shape, which limits their packing possibilities, 
preventing stacking in sheets or the interlocking herringbone pattern commonly seen in 
the structures of flat aromatic species. The flat cisoid conformation lacks these 
restrictions. Consequently the appearance of more unusual packing motifs and distinctive 
features, such as disorder and the incorporation of solvent, might be expected in the 
transoid molecule lattices. The crystal structures have been divided into small groups for 
description and comparison. 
Chalcones I, XVI & XXI (Table 9a) 
All three crystallise in space group Pbca and the unit cell dimensions for the three 
structures are roughly similar, viz., 7,14, 28A. 
In the chalcone I structure, sheets of molecules run perpendicular to the b axis. The ring 
1 phenyl groups of adjacent molecules form an interlocking herringbone pattern. Ring 2 
forms parallel stacks with approximately 40% overlap between adjacent rings, with an 
interplanar separation of 3.66 A. The division of the sheets into two regions, one of 
coplanar packed rings the other with adjacent rings aligned in a herringbone fashion, can 
be seen in the view down the a axis. Figure 2a. 
Chalcone XXI also forms rippled sheets with the plane perpendicular to the b axis. There 
are interactions between pairs of molecules, with the ketone of one molecule lying in 
proximity to the dioxy-methylene ring of its partner, Figure 2b. The sheet is divided into 
bands running parallel to the a axis, aromatic sectors occupied by phenyl groups and 
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Figure 2. Structures I, XVI and XXI 
a/ The packing diagram of the I structure, viewed down the a axis, shows the division of puckered 
sheets of molecules into n-n bonding and herringbone interlocking regions. 
b/ An illustration of the pairing of molecules in the XXI structure with close contacts formed 
between the methylene dioxy oxygens of one molecule with the ketonic oxygen of the other. 
c/ Packing diagram of the XVI structure, viewed down the b axis. There are no sheets in this 
structure. 
11 
polar sectors in which the oxygen atoms lie. The molecules are aligned in pairs within the 
sheet. According to Kitaigorodsky (1961), the packing of eight molecules in a unit cell in 
Pbca often implies that they are closely bound in pairs, as seen here. 
Chalcone XVI crystallises in the same space group as I and XXI, but the latter two 
structures have more features in common. In the I and XXI structures, molecules are 
arrayed in rippled sheets perpendicular to the short axis, Figure 2c. In the chalcone XVI 
structure the plane of the molecules is roughly parallel to the short axis of the unit cell, 
but the pattern of rippled sheets is absent and it is less easy to divide the lattice up into 
regions of different chemical environment. The aromatic rings lie parallel but do not 
overlap. 
Chalcones II, X & XI (Table 9b) 
Chalcones II and XI crystallise in non-centrosymmetric space groups, F2i2i2i and P2i 
respectively. The molecules are of similar shape, essentially planar with a twist about the 
long axis of the molecule, resulting in a chiral conformation. There are examples 
(Rabinovich & Shakked, 1974), in which the crystallisation of achiral chalcones in non-
centrosymmetric space groups in this fashion has allowed solid state asymmetric 
substitution on the olefinic bond. 
The modes of packing of chalcones II and XI are very similar, stacking parallel to the 
short a-axis. Figure 3a. There is no direct overlap between aromatic rings on adjacent 
molecules within the stacks. The planes of rings of molecules in neighbouring columns 
are tilted relative to one another. Chalcone X adopts an entirely different kind of lattice 
from the other two. Figure 3b. The molecules form planar sheets perpendicular to [1 1 0]. 
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Figure 3. Structures 11, X and XI 
a/ Packing diagram for the XI structure, viewed down the a axis, 
b/ Packing diagram for the X structure, viewed parallel to the molecular 
p lane, i l lustrat ing the associat ing of the molecules in pairs within sheets 
and the p lane-plane overlap of rings of molecules in neighbour ing sheets. 
2.+ 
Within sheets the molecules are associated in pairs. Plane-plane overlap of one of the 
rings occurs between molecules in adjacent sheets with an interplanar distance of 3.5 A. 
An extra methoxy group added to the meta position on ring 1 of chalcone II produces 
chalcone XI, which has a crystal structure with a similar packing arrangement to that of 
chalcone II. Conversely, if the methoxy group is added to the meta position on ring 2, 
chalcone X is produced, which adopts a markedly different packing motif. The reason for 
this difference is not obvious. 
Chalcones XXIV and XXV (Table 9c) 
Comparison of the two polymorphs of chalcone XXIV demonstrates the effect of n-n 
interactions in the crystal lattice of a small organic molecule. Both XXIV(A) and XXIV(B) 
structures are in space group P I. However, there are two molecules in the asymmetric 
unit of XXIV(A) giving Z=4, while there is a single molecule in the asymmetric unit of 
XXIV(B). 
The two independent molecules in the XXIV(A) lattice adopt notably different 
conformations, as can be seen from the differences in dihedral angles, Table 2. The two 
molecules have different functions in the structure. The planar molecule 1 is aligned in 
stacks running along [1 0 1], the molecular plane lying perpendicular to the stacking 
direction. There is an inversion centre between each pair of molecules in the stack and 
plane-plane overlap between the rings at each end, with an interplanar separation of 3.5 
A. Molecule 2 lies with its molecular plane perpendicular to [1 2 0]. There is no interplanar 
overlap between aromatic rings. From the packing diagram viewed down [1 0 1], Figure 
4a, it can be seen that molecule 2 acts as a space-filler between the molecule 1 stacks. 
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molecule 1 
molecule 2 
molecule 2 
molecule 1 
Figure 4. Structures XXIVA, XXIVB and XXV 
a/ Packing diagram for the XXIVA structure, viewed down [1 0 1], illustrating the different 
environments ot the two molecules. 
b/ The packing diagram of the XXV structure looking in the [1 -1 0] direction shows that the two 
molecules in the unit cell have different functions in this example as well. 
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Table 2. Dihedral angles for chalcones XXIV and XXV 
Molecule dihedral angle (°) dihedral angle (°) dihedral angle (°) 
plane 1/plane 3* plane 2/plane 3* plane 1/ plane 2* 
XXIV(A), mol 1 8 0 8 
XXIV(A), mol 2 6 26 32 
XXIV(B) 5 6 7 
XXV, mol 1 13 86 76 
XXV, mol 2 16 88 78 
* using notation of Figure 1 
The driving force behind crystallisation of the compound in the XXIV(A) form is the 
lowering in lattice energy afforded by n-n interactions along the molecule 1 stacks, with a 
second molecule Incorporated to fill spaces between the stacks, its conformation 
distorted to fit the shape of the cavity. 
The second polymorph, XXIV(B), has a lattice characterised by planar layers of 
molecules, with no overlap between rings of molecules in adjacent layers. The stacks of 
overlapping aromatic molecules in the XXIV(A) crystal structure and their absence in the 
XXIV(B) lattice can be directly related to the marked difference in colour between the two 
types of crystal: XIV(A) being bright yellow, while XXIV(B) is colourless. This contrast can 
be ascribed to the stabilising n-n interactions in the XXIV(A) lattice, which cause a shift to 
longer wavelength of the UV- chromophore. 
The chalcone XXV molecule has substituents at both ortho positions on ring 2 and adopts 
the transoid molecular conformation, as discussed above, while all the molecules so far 
discussed have cisoid conformation. Despite the difference in molecular conformation, 
the chalcone XXV crystal structure has several features in common with XXIV(A). 
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Chalcone XXV crystallises in P \, with two molecules in the asymmetric unit. Although 
the two molecules adopt similar conformations, their environments are different. Figure 
4b. Molecule 1 forms paired layers, which lie perpendicular to the c axis. Ring 1 of each 
molecule projects into the space between the layers, overlapping with ring 1 extended 
from the parallel layer, to form n-ii interacting stacks, which run through the lattice down 
[1,-1,0] with an interplanar separation of 3.58 A between the overlapping rings. Molecule 
2 acts as a space-filler in the lattice. 
It is possible that chalcone XXV could crystallise in a second polymorph with Z=2 and 
without 7i-7t interactions, but no evidence of this form exists. 
Chalcones XVII & XIX (Table 9d) 
Chalcones XVII & XIX both adopt a transoid conformation, since both ortho-positions on 
ring 2 are substituted. Members of the set that have the planar, cisoid conformation are 
likely to adopt modes of packing commonly seen among aromatic small organic 
molecules. Alignment of the molecule in a transoid conformation, in which ring 2 lies 
perpendicular to the plane of the rest of the molecule, leads to the formation of more 
uncharacteristic types of lattice. 
The chalcone XVII structure is unique among those of the methoxy chalcones so far 
investigated in being the only one of the set to incorporate solvent molecules within the 
lattice. The structure is less dense than the others and the space group, P 2/a, is unique 
in the group and less common generally. The crystallisation in a lattice with this space 
group can be related to the presence of the water molecules around the two-fold rotation 
axes. The stability of this structure can be attributed to the formation of H-bonds with the 
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carbonyl oxygen 0(1) acting as an acceptor and hydrogen atoms of the water molecules 
as donors. The lattice is divided into hydrophilic and hydrophobic regions. H-bonds 
traverse the polar zone, linking pairs of ketonic oxygen atoms via a water molecule. 
Figure 5a. 
Ring 1 stacks running parallel to the a axis make up apolar regions in the lattice with n-n 
interactions between neighbouring rings in the stack. Two types of overlap alternate 
along the stack, one between molecules related by an inversion centre, with an 
interplanar separation of 3.46 A, the other between molecules related by a rotation axis, 
with an Interplanar separation of 3.49 A. Ring 2, which has a dihedral angle of 78° with 
ring 1, forms a border between polar and apolar regions in the lattice. Figure 5b. 
The packing motif in the chalcone XIX structure bears some resemblance to that of 
chalcone XVII. The cross shaped molecules are aligned in pairs in a similar fashion to 
that seen in the chalcone XVII lattice. However, in the XIX lattice, the stacks of ring 1 only 
form n-n interactions between discrete pairs of overlapping rings, with an interplanar 
separation of 3.37 A. There is no polar solvent layer between the aromatic bands. 
Chalcone VI (Table 9e) 
The chalcone VI molecule is essentially planar and is packed in herringbone fashion, a 
feature common to several of the other cisoid chalcone structures investigated and which 
is commonly seen in the crystal structures of flat, aromatic molecules. 
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Figure 5. Stmctures XXVII and XIX 
a/ 2-fold related molecules in the XVII structure, their ketonic oxygens linked via a water molecule 
on the axis. 
b/ The packing in the XVII structure, illustrated by the view down the b axis. The lattice is divided 
into apolar regions, containing stacks of overlapping aromatic rings, and polar, H-bonding regions. 
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Chalcone XIV (Tad/e 9e) 
The chalcone XIV molecule adopts a twisted conformation in the crystal lattice. The 
molecules are associated in pairs around an inversion centre. Stacks of molecules run 
parallel to the a axis. There is no direct overlap between the aromatic rings of adjacent 
molecules in a stack. It is not clear whether crystal field forces in the lattice of chalcone 
XIV cause the twisted molecular conformation, or if this is a low-energy solution 
conformation which crystallises to give this particular mode of packing. 
Conclusions to packing survey 
The crystal structures possess a range of notable features. These include: 
• Crystallisation of a compound in two polymorphs: one form containing two molecules 
in the asymmetric unit, the other, only one molecule. 
• Stacks of overlapping aromatic rings in several of the structures, suggesting the 
occurrence of extensive n-n bonding. 
• Inclusion of waters of crystallisation in one example, allowing the formation of H-
bonded chains through the lattice. 
• Crystallisation of two structures in asymmetric space groups, although the molecules 
are inherently achiral, thus producing two enanteomorphic forms of crystal, which 
could not be differentiated in this case. 
• Disorder in two of the structures studied. 
Relationships were traced between crystallographic and molecular properties, notably 
that between the position of the methoxy substituents and the molecular conformation 
adopted in the crystal structure. However, the reason behind the specific arrangement of 
a particular molecule in a crystal lattice is not obvious. A prediction of the molecular 
conformation of members of this set, for which structures were not obtained, can be 
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made based on the positions of methoxy groups on tlie molecule. However, other 
features of the crystal lattice cannot be predicted reliably. 
Dimerisation of chalcone XXII 
Summary 
The investigation of chalcone XXII initially yielded the crystal structure of a dimer. 
Subsequently, crystals of the monomer were also obtained. In the monomer structure the 
molecules are aligned in an orientation which would allow photocatalysed dimerisation 
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with the stereospecific production of the stereoisomer of the dimer crystal. C NMR 
spectra provide evidence that only one stereoisomer has been formed. The path by which 
the formation of the dimer occurred remains uncertain. However the existence of the 
monomer crystal structure described gives a strong indication that it is a solid-state 
reaction. 
The original sample, with formula reported as in Figure 6 (1), was recrystallised by vapour 
diffusion, using toluene as the solvent and petroleum ether as the precipitant. The 
crystals grew in the form of small, monoclinic, pale yellow blocks. X-ray diffraction studies 
on these crystals showed that they were only weakly diffracting. Data were collected on a 
Siemens rotating anode. The structure was solved and refined, proving to be that of the 
dimer Figure 6 (2). 
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Figure 6. Chalcone XXII monomer and dimer structures 
MeO 
OMe O 
OMe O 
(1) monomer (2) dimer 
^^ C NMR spectroscopy was employed to probe the composition of the original sample, in 
the solid state and in acetone solution. This showed that the dimerisation reaction was 
stereospecific, resulting in formation of a single isomer of the dimer. 
Crystals grew in an acetonic solution of the original sample, at the bottom of an NMR 
tube. Unlike those previously obtained from toluene solution, the new crystals were large, 
bright yellow needles. X-ray diffraction data were collected on the second form of crystal 
using a Rigaku AF6S diffractometer. The structure was solved and refined, proving to be 
that of the monomer. 
Synthesis of fresh monomer was performed as described below. ^^ C NMR spectroscopy 
demonstrated that the sole product of the synthesis was the monomer. 
Crystals of chalcone XXII monomer were photographed on a Weissenberg camera, 
irradiated with light of X^350 nm for 90 minutes and then photographed again, in an 
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attempt to detect a solid state dimerisation reaction. An acetone solution of the freshly 
synthesised chalcone XXII monomer was irradiated with light A^380 nm for 40 minutes. 
The ^^ C NMR spectrum was then recorded to investigate whether dimerisation, or other 
reactions, are catalysed in the solution by ultra-violet light. No dimerisation or other 
chemical or structural change could be detected by these experiments, in either solution 
or crystalline state. 
Synthesis of chalcone XXII 
0.1 ml 2,4 dimethoxy acetophenone, Figure 7 (1) and 0.1 ml piperonal Figure 7 (2) were 
charged to a conical flask supported on a stirrer/hot plate. 200 ml of ethanol was added 
and the flask blanketed with nitrogen. After a few minutes stirring the reactants dissolved. 
Once the solution was clear, sodium hydroxide pellets (0.5 g) were added. The reaction 
mixture was then stirred under nitrogen until T.L.C. analysis indicated that the reaction 
has stopped. This took about six hours. After filtration, the crude product was 
recrystallised twice from ethanol. The pure product was then dried. 
Figure 7. Reactants in chalcone XXII synthesis 
OMe O 
Me 
(1) 
Me H 
(2) 
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Figure 8. Numbering scheme for XXII monomer and dimer 
120—o. 
140 
I 
240 220 
monomer 
dimer 
1BD O 120 
203*"^ 
204 
Crystal Structure Determination 
Crystals of the monomeric compound used in X-ray diffraction experiments grew from 
acetone solution in the form of large, bright yellow needles, Data were collected on a 
crystal of dimensions 0.9x0.5x0.4 mm. Crystals of the dimer, small, pale yellow, 
monoclinic blocks, were grown using vapour diffusion with toluene as the solvent and 
petroleum ether as the precipitant. 
For the monomer crystal, cell dimensions and intensity data were measured on a Rigaku 
AFC6S diffractometer. Data collection on the Rigaku proved the dimer crystal to be only 
weakly diffracting and larger crystals were not available, giving good reason to refine cell 
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parameters and collect intensity data using a Siemens rotating anode. Other details of 
the refinements are summarised in the Appendix and Table 9f. 
Discussion of crystal structures 
monomer crystal 
The unit cell has an extremely short, 3.91 A, a axis. Stacks of molecules, lying in the be 
plane, run along the short axis, Figure 9c. There is complete coplanar overlap between 
adjacent molecules in the stack. Figure 9d, thus double bonds of neighbouring molecules 
are in alignment for photo catalysed dimerisation, Figure 10, (Woodward & Hoffmann, 
1970), the distance between the planes formed by C(1), C(7), C(8), C(9) & 0(1) of 
neighbouring molecules being 3.74 A. Dimerisation from this configuration would result in 
stereospecific production of the isomer found in the dimer crystal structure. 
Photodimerisation often occurs in the solid state where double bonds on adjacent 
molecules are aligned in this manner, Figure 11. 
There is a number of short intermolecular C-H...0 distances, in the range 3.1-3.8 A, 
between molecules lying in a plane, Table 3. The presence of these links suggests that 
the lattice is held together by two principal types of intermolecular interaction, n-n bonding 
along stacks running parallel to (1, 0, 0) and C-H...0 bonding between neighbouring 
stacks. 
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Figure 9. The chalcone XXII monomer and dimer structures 
aJ The alignment of neighbouring molecules in the monomer lattice permits the occurrence of a 
solid-state dimerisation. 
b/ The dimer molecule does not possess mirror symmetry in the solid state. 
d The packing diagram for the monomer structure viewed down the c axis illustrates the close 
proximity of neighbouring molcuies in stacks along the a axis. 
61 The view of the XXII structure down the a axis depicts the anrangement of molecules in a sheet, 
and the short C-H --0 contacts within the sheet. 
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Table 3. Short C-H—0 intermolecular distances in the monomer crystal structure 
O(1)-C(140) 3.11 
0(3) - 0(120) 3.57 
0(4)-0(140) 3.76 
0(12)-0(120) 4.02 
0(14) - 0(43) 3.78 
Table 4. Interplanar angles in the monomer crystal structure 
angles between planes 
1 &3 8.4° 
2&3 37.9° 
1 &2 43.9° 
Figure 10. 
Intermolecular distances between C=C bonds in the XXII monomer structure 
ring 1 
ring 1 
- Jing 2 
* 3,93 A 
3.93 A '. ' ring 2 
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Figure 11. Dimerisation catalysed by UV radiation 
LUMO LUMO 
A. 
H' 
A 
H' 
A. 
A, 
H 
HOMO 
^ hv 
A - y 
H 
HOMO* 
dimer crystal 
The conformation and alignment of the molecules in the lattice bear no relation to those 
in the monomer structure, as illustrated in Figure 9a & b and by the values of dihedral 
angles. Table 5. This does not prove the reaction does not occur in the solid state. All 
that is certain is that the reaction occurred before the dimer was recrystallised from the 
acetone solution, in solution, or previously, in a solid phase. 
Planes in the XXII dimer 
MeO 
. 5 I 
OMe O 
OMe 
O 
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Table 5. Dihedral angles, XXII dimer 
angle between planes angle between planes 
1&2 93.4° 2&3 93.4° 
1&3 54.3° 2&4 49.1° 
1&4 44.3° 2&5 122.3° 
1&5 52.7° 3&4 65.3° 
4&5 84.3° 3&5 29.7° 
13 0 NMR studies on chalcone XXII 
Solution spectra were recorded on a Varian VXR 400-S spectrometer in De acetone 
solutions. Solid-state spectra were recorded on a Varian VXR 300 Solid-State 
spectrometer. Peak assignment for both monomer and dimer molecules were carried out 
using three solution spectra: 
1/ freshly synthesised monomer 
2/ original sample, composed of a mixture of monomer and dimer 
3/ original sample, following removal from solution of a proportion of the monomer by 
crystallisation. 
Peaks in the pure monomer spectrum were assigned with the aid of a predicted spectrum 
obtained from a ^^ C chemical shift calculation by SPECINFO (Daresbury). 
The assignment of dimer peaks in the mixed spectra could then be carried out, using 
three approaches: 
1/ subtraction of peaks assigned to the monomer using the pure monomer spectrum 
2/ comparison of the two dimer spectra - in the second spectrum, the dimer peaks 
become relatively more intense than the monomer peaks 
3/ use of a spectrum predicted for the dimer molecule by SPECINFO. 
The results of this peak assignment are listed in Table 6 
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Table 6. Assignment of peaks in ^^ C solution spectra 
m o n o m e r spectrum assignment prediction d i m e r spectrum assignment prediction 
(ppm) C(No.) (ppm) (ppm) C(No.) (ppm) 
189.82 9 190.0 198.01 9 191.6 
165.13,161.36 4 2* 164.4, 165.19,161.28 4. 2* 164.4,160.4 
162.8 
150.36, 149.34 13, 14* 147.8, 148.13,146.31 14,13* 147.5,147.3 
147.5 
141.68 7 143.6 
133.09 6 132.3 136.14 11 131.9 
130.83 11 129.2 133.13 6 128.3 
126.37 16 122.8 121.97, 121.33 1, 16* 126.9, 121.9 
125.50 8 119.8 
123.05 1 122.2 
109.25, 107.22, 5, 15, 12* 110.5, 109.33, 108.23, 12, 5,15* 111.2, 110.5, 109.1 
106.53 108.3, 106.46 
107.8 
102.57 43 101.1 101.51 43 101.1 
99.11 3 98.1 98.42 3 98.1 
56.18, 55.91 20, 40* 56.0, 55.4 55.84, 55.74 20, 40* 56.0, 55.4 
53.42,45.19 * 
8,7 
52.0, 44.9 
these assignments could not be made more specific and are interchangeable. 
Two solid-state spectra were obtained: one from the sample first received containing a 
mixture of monomer and dimer and one on a freshly synthesised pure monomer sample. 
Seventeen peaks were visible in the spectrum of the pure monomer which could be 
assigned by comparison to the solution spectrum of the pure monomer. 
The spectrum of the original sample is more complex. It contains monomer peaks, as 
seen in the spectrum of pure monomer, as well as dimer peaks, which are split due to the 
removal of the mirror-plane through the cyclo-butane ring in the solid-state and, in 
addition, a third carbonyl peak. All the other peaks in the spectrum can be assigned to 
either monomer or dimer. Assignments of solid-state spectra are set out in Tables 7 & 8. 
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Table 7. Assignments for Solid-State Spectrum of Pure Monomer 
Solution spectrum Assignment Solid-state spectrum 
(ppm) 0(no) (ppm) 
189.8 9 188.9(N) 
165.1, 161.4 4.2* 163.4(N), 157.4(N) 
150.4,149.3 13, 14* 149.6(N), 147.89(N) 
141.7 7 138.0(P) 
133.1 6 133.0(P) 
130.8 11 129.3(N) 
126.4 16 128.6(P) 
125.5 8 124.5(P) 
123.1 1 123.1 (N) 
109.3, 107.2, 106.5 5, 15, 12* 108.6(P), 103.2(P)" 
102.6 43 101.3(P) 
99.1 3 99.3(P) 
56.2, 55.9 20, 40* 57.0(P), 55.1 (P) 
(P) - Protonated carbon 
(N) - Non-Protonated carbon 
* these assignments could not be made more specific and are interchangeable. 
** only two out of three peaks visible 
Table 8. Assignment of Solid-State Spectrum of Mixed Monomer/Dimer Sample 
monomer peaks assignment dimer peaks assignment other peaks assignment 
(ppm) (monomer) (ppm) (dimer) (ppm) 
188.7 9 198(split) 9 190.7 carbonyl 
163.3,159.7 4,2* 165.0,159.7 4,2* 
149.4, 147.6 13, 14* 146.4 13, 14* 
137.8 7 
132.7 6 
129.1 11 
128.5 16 ** 
126.1 
1,6.11.16* 
124.4 8 
122.9 1 
108.5, 103.0** 5, 15, 12* 107.6, 5,15,12* 
105.9** 
101.2 43 
99.3 3 
57.0, 55.0 20, 40* 
49(split), 7.8* 
40(split) 
these assignments could not be made more specific and are interchangeable. 
* not all peaks visible 
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Conclusions from NMR experiments 
There are eighteen peaks in the spectrum of the freshly synthesised sample which can all 
be assigned to carbons in the monomer molecule. Therefore, this sample is pure 
monomer. The spectrum of material originally obtained contains thirty-six peaks, half of 
which are those assigned to the monomer. The other half can be assigned to the dimer 
molecule which crystallised from a solution of this material. There are no remaining 
peaks, therefore only one stereoisomer of the dimer is present. 
In the spectrum of the solution of monomer/dimer mixture, from which monomer had been 
removed via crystallisation, the relative intensity of the peaks attributed to the dimer is 
increased. This shows that monomer and dimer concentrations are not in equilibrium in 
solution. 
The spectrum of the monomer solution was unchanged after the solution was left for 
several months, showing that dimerisation does not occur in solution at room 
temperature. Irradiation with light, A^380 nm, for 90 minutes also failed to bring about a 
change in the spectrum. 
The solid-state spectrum of the freshly synthesised sample contains seventeen peaks, 
which can all be assigned to the monomer molecule with, the aid of solution spectra 
assignments. The spectrum of the originally obtained solid contains the monomer 
spectrum peaks. Other peaks can be assigned to the dimer, with the use of solution 
spectrum assignments, giving a ratio of roughly 50:50 for monomer:dimer concentration. 
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In solution, the dimer molecule possesses a mirror plane, which is broken in the solid, 
resulting in the splitting of the peaks. In addition, the mixed monomer/dimer spectrum 
contained a peak which can be assigned to a carbonyl carbon in a very similar 
environment to that of the monomer. There are no other peaks which cannot be assigned 
to either monomer or dimer. The most likely explanation for this third carbonyl peak is the 
presence of an additional polymorph, or pseudo-polymorph (containing solvent of 
crystallisation) of the monomer. It is likely that the shift of the carbonyl carbon would be 
the most sensitive to the difference in environment in the two crystal forms which would 
explain why the solid state spectrum contains no other additional peaks. 
Appendix: Details of structures and their data collection, structure solution and 
refinement 
Data were collected at Oxford on an Enraf-Nonius CAD4-F diffractometer, using Cu-Ka (k 
= 1.54180 A) radiation except for chalcones XII, XXI and XXV, which were collected using 
Mo-Ka {X = 0.7107 A) radiation. Data were collected at Durham on a Rigaku AFC6S 
diffractometer with a sealed tube source, except for the XXII dimer crystal, for which a 
Siemens rotating anode was employed, in all cases using Mo-Ka radiation. The data 
were corrected for Lorentz and polariation effects and absorption. 
Structure solution was acheived by direct methods using SHELX-86 (Sheldrick, 1985). 
The structures were refined at Oxford using the CRYSTALS package (Watkin et a/., 
1985). At Durham structures were refined or re-refined using SHELXTL-PLUS (Sheldrick, 
1985). Full matrix refinement against Fs was performed with all non-hydrogen atoms 
modelled anisotropically and hydrogen atom positions calculated using a riding model 
with C-H equal to 0.96 A and isotropic thermal parameter, u, to 0.08 A^. The final 
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refinements were performed using a weighting scheme implemented in SHELXTL, w 
1/(a2(F)+gF2), with g refined to values between 0.001 and 0.0001. 
Table 9. Data collection, refinement and structural parameters. 
a 1 XVI XXI 
Space group <- Pbca -> 
Z <- 8 -> 
Oell parameters(A) a= 11.705 a = 7.490 a = 11.172 
6 = 7.522 b= 16.782 /J = 7.806 
c= 32.222 c = 26.827 c= 28.586 
Unique data 2921 3445 1507 
Observed data 1775 1845 768 
Criterion for observed data 1 > 2a(l) 1 > 3a(l) 1 > 2a(l) 
R(Rw) (%) 4.44(5.82) 4.13(5.29) 3.99(3.90) 
b II X XI 
Space group P2i2i2i P 1 P21 
Z 4 2 2 
Oell parameters(A)), (°) a = 5.282 a = 8.798, a =107.64 a = 6.408 
b = 8.671 b = 8.911, p = 102.18 b= 10.498,.p = 90.34 
C = 30.670 c = 11.298,7=105.95 c= 11.472 
Unique data 2767 2927 1649 
Observed data 1829 2573 1429 
Oriterion for observed data <- 1 > 3a(l) 
R(Rw) {%) 5.11(6.09) 5.45(6.58) 3.24(4.09) 
c XXIV_A XXIV_B XXV 
Space group P 1 P 1 P 1 
Z 4 2 4 
Oell parameters(A), (°) a = 8.345, a = 64.39 a = 8.952, a = 69.25 a = 7.722, a = 85.82 
/7 =13.995, P = 83.46 t» = 9.696, p = 66.80 /? = 8.124, p = 85.06 
C= 14.692,7=85.10 C = 10.418,7= 68.82 c = 29.158,7 = : 66.26 
Unique data 5751 2927 3011 
Obsen/ed data 3478 2573 1811 
Oriterion for observed data <- 1 > 3a(l) 
R(Rw) (%) 4.09(5.38) 4.05(5.27) 4.41(5.43) 
d XVII XIX 
Space group P2/a P 1 
Z 4 2 
Oeil parameters(A). (°) a = 14.537 a = 8.037, a = 77.27 
6=9.400, p = 107.38 6 = 8.252, P = 88.14 
c= 14.894 c= 15.421,7 = : 66.40 
Unique data 3978 3567 
Observed data 3176 2531 
Oriterion for observed data 1 > 3a(l) 1 > 3a(l) 
R(Rw) (%) 5.27(6.42) 5.03(6.08) 
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e VI XIV 
Space group P2i/c P2i/n 
Z 4 4 
Cell parameters(A), (°) a = 13.546(4) a = 7.586(2) 
b = 8.052(4),p = 109.68(2) 6 =16.271 (2), p = 103.95(1) 
c= 15.097(4) c= 13.858(2) 
Unique data 2722 2919 
Observed data 1629 1746 
Criterion for observed data F > 4a(F) F > 4a(F) 
R(Rw) (%) 4.06(5.79) 4.37(5.72) 
f XXII(monomer) XXII(dimer) 
Structural formula ^18" l6°5 (^18^16°5)2 
M 312.31 624.62 
Crystal system Monoclinic Triclinic 
Space group F2i/c P 1 
z 4 2 
Cell parameters(A), (°) a = 3.927(1) a = 8.837(5), a = 89.90(1) 
6 = 15.790(3), p = 91.67(2) b= 12.729(8), p = 79.87(1) 
Cell volume(A )^ 
c= 24.013(3) c= 14.452(8), y: = 70.34(2) 
1488.4(6) 1504.1(6) 
Unique data 4354 5306 
Observed data 1581 3875 
Criterion for observed data F > 4a(F) F > 4a(F) 
R(Rw) (%) 5.34(3.91) 5.12(6.87) 
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Chapter 2: 
Crystallisation of proctolin, a pentapeptide Arg-Tyr-Leu-
Pro-Thr 
Introduction 
Peptides as neurotransmitters 
Proctolin, a linear pentapeptide, Arg-Tyr-Leu-Pro-Thr, was the first insect neuropeptide to 
be chemically characterised. It was isolated and identified in the American cockroach, 
Periplanta americana (Brown, 1975) and since found to occur in species of six orders of 
insects and some other invertebrates such as lobsters. The peptide was found to act as a 
neurotransmitter in the cockroach and has been shown to play a neuromodulatory role in 
several species (Konopifiska etal., 1992). 
Nerve impulses are transmitted along chains of nerve cells, neurons. An Impulse is 
passed from one cell to the next across the intervening synapse by the agency of a 
chemical neurotransmitter. These chemicals are released from vesicles in the pre-
synaptic membrane, diffuse across the synaptic cleft, which may be about 500 A in width, 
and couple with receptors in the post-synaptic membrane. Until the 1960's the amines 
acetylcholine, norepinephrine, and serotonin were the only well recognised transmitters. 
Then came the understanding that amino acids including y-amino butyric acid (GABA), 
glutamic acid, aspartic acid and glycine could also serve as neurotransmitters. Thus, it 
was thought that all neurotransmitters belonged to a group of small molecules with 
molecular weight around 200 Da. Peptide hormones, with chains comprising up to 40 
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amino acids, are now known to be involved in addition to these classical 
neurotransmitters (Snyder etal., 1980; Hokfelt etal., 1980). 
The functional significance of peptide neurotransmitters is not fully understood. In the 
mammalian central nervous system classical neurotransmitters were found to be present 
in only a small population of neurons. It appeared that cells lacking a classical 
neurotransmitter may produce a peptide. Peptide hormones have also been detected in 
neurons containing a small-molecule neurotransmitter, suggesting that the two species 
may have complementary roles. Some examples of pairs of classical and peptide 
neurotransmitters found in the mammalian central nervous system are listed in Table 1. 
This coexistence of two types of molecule may be a consequence of evolution. It is 
possible that peptides were important messengers in lower species, with more efficient, 
small molecule transmitters developing later (Hokfelt etal., 1987). 
The presence of peptides and classical neurotransmitters in the same neuron could have 
relevance to the understanding of certain disorders of the nervous system. The progress 
of Alzheimer's disease and senile dementia are accompanied by the degradation of 
cholinergic neurons responsible for higher brain functions, such as memory and learning. 
The peptide hormone galanin, coexisting with acetylcholine in these cells, may be 
implicated in this process (Hokfelt et a/., 1987). 
! f 
Investigation of insect neuropeptides shows that insects possess a hormone system 
similar to that of vertebrates, with parallels existing between families of neuropeptides 
with equivalent functions (Konopinska etal., 1992). Some examples are listed in Table 2. 
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Table 1. Mammalian classical and peptide neurotransmitter pairs. 
Classical transmitter Peptide Brain region Species 
dopamine neurotensin ventral mesencephalon rat 
acetylcholine enkephalin spinal cord ;rat 
acetylcholine galanin basal forebrain rat, monkey 
GABA somatostatin thalmus cat 
GABA somatostatin cortex, hippocampus rat, cat, monkey 
glycine neurotensin retina turtle 
Table 2. Vertebrate and invertebrate hormones with parallel functions. 
Invertebrate hormone Vertebrate hormone 
AKH^ family glucagon 
b 
myotropic hormones: proctolin, Lem-PK substance P 
leucosulfakinins gastrin, choiecystokinin 
c 
meianisation hormones: Bom-MRCH M S H " 
allatostatin somatostatin 
bombyxin-ll human insulin, adenocorticotropic mammal hormone 
^ AKH adipokinetic hormone 
" Lem-PK leukopyrokinin 
Bom-MRCH hormone from Bombyx mori (silkworm) 
MSH melanocyte-stimulating hormone 
X-ray crystallographic studies on oligopeptides 
The discovery of the significant roles played by small peptides as hormones and 
neurotransmitters has stimulated the study of the structure, activity and relationship 
between these properties for peptide hormones. Such investigations aim to learn about 
conformational changes as the molecule moves from solution to receptor and the effect 
of chemical modifications on structure and activity. In many cases the receptor site has 
not been located and the only source of information about the receptor is the study of 
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substrate structures and the conformational differences between active and inactive, 
agonistic and antagonistic analogues. 
Linear peptides of chain length 5 to 30 do not crystallise readily. As the chain length 
increases beyond 2 residues, the number of energetically favourable conformations a 
molecule may adopt in solution rapidly increases. However, these peptides are not long 
enough to fold into the stable secondary structure motifs seen in longer peptide chains. 
The difficulties encountered during X-ray crystallographic analysis of these materials are 
reflected by the small number of crystal structures for peptide molecules in the 1992 
release of the Cambridge Structural Database (Allen et al., 1991), Figure 1. Cyclisation 
reduces the conformational space accessible to a molecule, so, for a given chain length, 
the possibility of crystallisation is greater for a cyclic molecule than a linear one. 
Exceptions possessing some degree of secondary structure include artificial helical 
molecules, such as poly-leucines, natural helical molecules, such as glucagon (Sasaki et 
al., 1975) and species which are pseudo-cyclic due to disulphide linkages, such as 
deamino-oxytocin (Wood etal., 1986) and crambin (Teeter etal., 1993). 
Neither methods employed for the crystallisation of small molecules nor techniques used 
in protein crystallography are guaranteed to succeed in the production of crystals of oligo-
peptides. This fact is mirrored by the extremely variable nature of the peptide structures 
which have been elucidated. Some resemble the closely packed crystals of small 
molecules, while others have more protein crystal character, consisting of aggregates or 
layers of molecules separated by wide solvent channels. This point is illustrated by a 
comparison of four crystal structures of leucine and methionine enkephalin. Table 3 
(Murray-Rust, 1991). Enkephalins are endogenous pentapeptides which bind to opiate 
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receptors and have potent analgesic activity. The twelve independent molecules in these 
four structures exhibit two conformations, one extended, the other comprising a p-bend 
centred on Gly-Gly. Side-chain orientations are different in each molecule. 
Table 3. Comparison of Leu and Met enkephalin crystal structures 
crystallisation solvent space 
group 
cell: a.b.c.(A) a, p, y(') asymmetric unit 
Leu-enkephalin Tyr-Gly-Gly-Phe-Leu 
Aqueous Methanol 
(Smith & Griffin, 1978; 
Blundeli etal., 1979) 
A2 a = 31.937 b = 17.084 c = 24.861 
p = 95.54 
Z = 1 6 
4 nearly identical 
conformers with a Gly-
Gly p-bend, several 
water molecules 
Aqueous DMF 
(Karle etal., 1983; 
Camerman etal., 1983) 
P2i a = 18.720 b = 24.732 c = 20.311 
p = 115.86 
Z = 8 
4 extended conformers 
forming an antiparallel p-
sheet, 8 water and 8 
DMF molecules plus 
some disordered solvent. 
Ethanol 
(Griffin etal., 1986) 
P2i a = 11.549 b = 15.587 c = 16.673 
p = 92.19 
Z = 4 
dimers of molecules in 
extended conformation, 
related by a pseudo 2-
fold axis, 1 water 
molecule per dimer 
Met-enkephalin Tyr-Gly-Gly-Phe-Met 
1% aqueous pyridine + 
0.05% acetic acid 
(Griffin etal., 1986) 
P2i a = 11.607 b = 17.987 c = 16.519 
P = 91.24 
Z = 4 
similar to Leu-enkephalin 
from ethanol, but with 
10.6 water molecules per 
dimer. 
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occurrence 
100 
Figure 1. Polypeptides in tine CSD 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
• Linear • Cyclic number of amino acids 
About proctolin 
The long-term goal of this project was the development of a new generation of non-
cholinergic insecticides. The utilisation of peptide hormones as pesticides is unfeasible. 
The cost of industrial scale synthesis of these molecules would be prohibitive, but even if 
this were overcome, externally applied peptides would undergo degradation in the 
environment or the digestive tract of the target species. The development of small 
molecule analogues with chemistry tailored to allow their external application as well as 
an enhancement of agonistic activity is necessary. The aim of this project was to deduce 
the three-dimensional structure of the active conformation of proctolin to shed light on the 
nature of the interaction between proctolin and its receptor, providing input for molecular 
modelling calculations to assist in the design of small molecule proctolin analogues. 
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Structure-activity relationships for proctolin have been investigated. The activity of 
analogues in which one or more residues have been altered has been determined. The 
replacement of residues 3, 4 and 5 leads to inactivity. The analogues Lys-Tyr-Leu-Pro-
Thr and Arg-Arg-Leu-Pro-Thr do possess activity. Oxymethyl Tyr possesses enhanced 
activity and replacement of Tyr by a para-substituted phenylalanine does not lead to 
complete loss in activity. It has been concluded that a positively charged residue at (1) 
and a para-substituted aromatic ring at (2) play a crucial role. It has also been observed 
that the cyclic analogue displays enhanced agonistic activity. This could be because its 
rigidity makes it difficult to expel it from the receptor, although this does not necessarily 
imply that the structure of the cyclic form resembles the active conformation of the linear 
peptide (Temussi etal., 1989). 
Search for crystallisation conditions for proctolin 
undertaken at Birkbeck College Crystallography Department as part of this PhD 
Aim 
The physical and chemical nature of the material was explored, to provide indications of 
possible conditions for crystallisation. The intention was to develop and refine a 
crystallisation method, eventually producing crystals of X-ray diffraction quality. 
Repurification of old material and automated peptide synthesis were undertaken to 
supply sufficient peptide for this series of trials. 
IVIaterial 
Composition: 1 M proctolin + 3.5 M water + 0.5 M acetate 
Anhydrous molecular weight (free base): 648.8 
Molecular weight (with water and acetate): 746.3 
Appearance: white solids 
HPLC purity: 99% 
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Purification and analysis by HPLC 
The purification of peptides becomes simpler as the chain length decreases and the 
yields increase. The retrieval of material from old experiments for reuse is feasible for a 
five residue peptide. 
Rinsings of material from old experiments were pooled and the solvent removed using a 
vacuum centrifuge. An aqueous solution of the material, of concentration approximately 1 
mg/ml, was made up. Concentration was measured from the absorbance at 280 nm; 
absorption coefficient of 1 mg/ml solution at 280 nm = 1300 Niyr / Mmoiecuie (au"^) 
1 3 0 0 x 1 / 648 = 2 
Analysis of the material and separation of the peptide from the accumulated impurities 
was carried out by HPLC, Figure 2. Each HPLC run gave a large major peak, 
representing the elution of proctolin. The position of this peak varied between samples 
over a concentration range of 18.5 - 26.5 % B (as designated in Figure 2). Some samples 
also had minor peaks, eluted at higher B concentration. From this it can be concluded 
that the separation of proctolin from impurities may require more steps if it is to yield 
material of crystallisable quality. 
The 'proctolin' fractions were collected together, reduced to a volume of 1 ml on a rotary 
evaporator and then freeze-dried. This material differs from that supplied by Sigma, in 
that the counter-ion is tri-fluoro acetate, rather than acetate. The material showed 
significant differences in its behaviour in comparison to the original material. The change 
in counter-ion is one contributory factor, in addition to the generally high level of 
impurities. In conclusion, retrieval of material from old crystallisation experiments with a 
useful yield is probably not possible. 
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Figure 2, 
HPLC spectra of proctolin samples retrieved from old experiments, run on a Brownlee 018 300 A 
7.5 X 250 mm column, using a reversed phase program; solvent A: 0.1 % aqueous trifluoroacetic 
acid, solvent B: 0.1 % trifluoroacetic acid in 3:1 acetonitrileiwater, gradient: 0 -» 50 % 8 over 50 
minutes, flow rate: 2 ml/minute, detector: 280 nm absorbance. a: 1 division = 2 minutes, major 
peak at 21.25 % B, b: 1 division = 2 minutes, major peak at 15.5 % B, c: 1 division = 4 minutes, 
major peaks at 26.5 %, 37.5 % B - the second peak is due to the presence of a picrate complex. 
Jli a b s o r b a n c e , 
a r b i t a r y 
s c a l e 
4.0 nun 
10 30 mil-
LJ 
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Solid phase peptide synthesis 
Introduction 
The basis of this method is that the growing peptide chain remains attached to an 
insoluble support, consisting of beads of cross-linked polystyrene resin, from the first to 
the final step of the synthesis. Between each reactive step, the supporting resin and 
attached peptide are thoroughly washed, removing impurities and reaction by-products 
while keeping the loss of target peptide to a minimum. The dry beads have diameter 40 -
100 microns, swelling one-hundredfold on the addition of solvent, typically 
dichloromethane or dimethyl formamide. Macroscopically, the resin appears insoluble, 
while on a molecular level it is fully solvated, allowing reactants to approach the anchored 
peptide chain. 
The C-terminal amino-acid is attached to the resin by its a-carboxyl group and thus the 
peptide is assembled from C to N terminal, by consecutive coupling reactions in which 
amino-acids are added, one at a time, to the chain. Amino-acids are introduced into the 
reaction vessel with N terminal and side chains protected and C-terminal activated for the 
coupling reaction. Peptide bond formation is followed by the deprotection of the new N 
terminal. The activation, coupling and decoupling cycle is repeated for successive amino-
acid additions. Finally, the completed peptide chain is cleaved from the resin and the side 
chains are deprotected. The whole procedure is run by a program with parameters set 
before the commencement of the synthesis and it is completely automated. Thus, the 
time and skill required to synthesise a peptide in this manner are a small fraction of what 
is required for a solution phase synthesis. 
57 
In solid phase peptide synthesis, the N-terminal amine is typically protected by the 
carboxy-amide with either a Boc (t-butoxyloxycarbonyl) or F-moc (9-
fluorenylmethoxycarbonyl) group. The F-moc group is removed by base hydrolysis, using 
a weak base such as a secondary amine, commonly piperidine. Removal of Boc is 
accomplished by acid hydrolysis, using a weak acid, often tri-fluoro acetic acid. Side 
chain protecting groups must be stable under N-terminal deprotecting conditions, so 
complementary protection is required. If a synthesis employs F-moc protection for the N 
terminal, side chain protection should be acid labile and base stable. 
Activation of the attacking C terminal a-carboxyl group allows efficient peptide bond 
formation, without rearrangement. N,N'-dicyclohexylurea (DCC) is the activating agent 
commonly employed. The a-carboxyl of the amino acid attacks DCC, forming an O-
acylisourea. This derivative may be added directly to the reaction vessel. In excess of 
amino acid, the O-acylisourea is attacked again, giving the anhydride, an alternative 
activated species for introduction to the resin. In addition, HOBt is often added to the 
reaction vessel. HOBt attacks the O-acylisourea, forming an active ester, which 
undergoes highly efficient coupling with the free peptide N-terminal. 
Recently, activation using 2-(1 H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HBTU) has been employed. HBTU is dissolved in a solution of 
HOBt in DMF and the amino acid added, giving the HOBt active ester. The speed of this 
activation step significantly reduces the total synthesis time. 
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Automated solid-phase peptide synthesis of proctolin 
The synthesis of proctolin presents one potential problem. The proline residue is prone to 
attack by the unprotected N-terminal of the succeeding residue, in this case leucine, 
particularly when it is near the C-terminal of the chain and therefore close to the resin 
support. This attack causes rearrangement and removal of the peptide from the resin. 
Reduction of the time taken for steps in which the leucine N-terminal is free should help 
minimise this effect 
The synthesis employed 'Fastmoc' chemistry, with p-
hydroxymethylphenoxymethylpolystyrene (HMP) resin, HBTU.HOBt activation and F-moc 
protected amino acids: F-moc-Arg(Mtr), F-moc-Tyr(tBu), F-moc-Leu, F-moc-Pro and F-
moc-Thr(tBu). 
The initial step was the substitution of the N-protected threonine on to the resin. A Thr-
resin sample was removed from the reaction vessel for determination of the substitution 
efficiency. Any unsubstituted sites on the resin were then capped by reaction with 
benzylic anhydride. Activation, coupling and deprotection steps followed as the four 
remaining amino acids were successively added. Two coupling cycles were performed for 
both arginine and tyrosine, since these are known to have poorer coupling efficiencies. 
Following each coupling cycle, a small sample of the resin was removed for analysis of 
the coupling efficiency. 
Substitution determination 
The substitution in mmol/gram of an F-moc protected amino-acid on to the resin may be 
determined by complexation of the F-moc removed from a preweighed sample of the 
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substituted resin with piperidine. The concentration of the F-moc-piperidine complex is 
assayed by measurement of the 301 nm absorbance. 
The resin sample was dried, then weighed. 0.5 ml 20% piperidine in DMF was added. 
The solution was shaken for 15 minutes, then made up to a volume of 10 ml. Absorbance 
was measured. 
Sample mass: 1.3 mg 
Absorbance: 0.674 
Substitution (mmol/gram) = A301 x V(ml) / 7800 m(g) = 0.67 mmol/gram 
Total mass of resin: 278 mg 
Amino-acid substituted on the resin: 278x0 .67 = 0.186 mmol 
Quantitative Ninhydrin monitoring for determination of coupling efficiencies 
Ninhydrin monitoring measures the concentration of free amine in the resin sample 
withdrawn from the reaction vessel following a coupling step. The most recently added 
amino acid remains F-moc protected at this stage, so the concentration of free amine 
represents the proportion of vacant sites at which coupling failed. 
Samples were removed from the reaction vessel into preweighed tubes, to which 2-3 ml 
of methanol and 2-3 drops of acetic acid had been added. After the conclusion of the 
synthesis, the methanol was pipetted off, the resin was rinsed, then dried and the weight 
determined. A reagent mixture was added to each tube, including a control empty tube, 
as follows: 75 \i\ phenol in ethanol + 100|xl KCN in pyridine + 75 ^ll ninhydrin in ethanol. 5 
minutes incubation at 100° followed, then the volume was immediately made up to 5 ml 
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with 60% ethanol. The tubes were shaken to ensure thorough mixing. Absorbance at 570 
nm was measured, against a 60 % ethanol blank: 
Free amine concentration (nmol/g): 10® (A570 x dilution(ml) ) / (extinction coefficient x 
fTlsample (mg) ) 
dilution: 
extinction coefficient: 
mass resin before synthesis; 
substitution of first residue on to resin: 
results 
5 ml 
15 000 M"W^ 
0.278 g 
0.67 mmol / gram 
Table 4 
Table 4. Coupling efficiency of each stage of the synthesis 
residue coupling efficiency (%) predicted amount of peptide 
on resin (mmol) 
Thr 99.79 0.185 
Pro 99.85 0.184 
Leu 99.57 0.182 
Tyr 99.68 0.181 
Arg 99.58 0.180 
total 98.48 0.180 
Cleavage 
Cleavage of the peptide from the resin and simultaneous side chain deprotection were 
accomplished by acid hydrolysis, using trifluoroacetic acid. Acid hydrolysis of 0-t-Bu 
protecting groups produces t-butyl cations and t-butyl trifluoroacetate, which may attack 
the deprotected peptide. Cooling reduces the rate of these reactions, but also the 
cleavage and deprotection rates. A better solution is the introduction of scavengers to 
remove the cations. 1,2-ethane dithiol is an efficient scavenger for t-butyl trifluoroacetate. 
Addition of a second scavenger, such as anisole, phenol, ethyl methyl sulphide, 
thioanisole, 2-mercaptoethanol, thiophenol, tryptophan or methionine, is necessary for 
the complete suppression of the alkylating reactions. 
61 
The following cleavage reagent was prepared: 0.75 g crystalline phenol + 0.25 ml ethanol 
+ 0.5 ml water + 10 ml TFA. This was cooled in ice, then added to the dry peptide-resin in 
Eppendorf tubes, which were then sealed. The mixture was allowed to warm to room 
temperature and shaken at regular intervals over a three hour period. The solution was 
filtered from the resin through glass wool. The peptide was precipitated in excess diethyl 
ether. The precipitant was washed, dried and weighed. 
Yield 
The total yield of dry product, before purification, was 106.6 mg. 
Crystallisation 
Introduction : finding crystallising conditions for peptides 
This account summarises discussions witfi f^arek Brzozowski at York and Steve Wood at 
Birkbeck. 
When it comes to crystallisation, polypeptides may be divided into three groups. Small 
peptides, with 1 to 4 amino acids, medium, with 5 to around 30 and large, the remainder. 
Small peptides behave as small organic molecules and methods of crystallisation 
developed for organic molecules are applicable. Crystallisation from an evaporating 
solution is possible. It is best to make up the peptide solution, then allow around three 
days equilibration in a sealed vessel before evaporation commences. The interactions in 
solution are complex and the attainment of a minimum energy conformation may take 
time. Ethanol is a useful solvent, other possibilities include methanol, DMSO, dioxane and 
toluene. A mixture of solvents may improve results, for instance 2:1 Ethanol:DMSO. A 
polar / non-polar solvent mixture, such as 2:1 ethanol: cyclohexane may increase 
chances of crystallisation. It is possible that inclusion of both types of solvent within the 
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crystal could help stabilise the polar and apolar environments around different parts of 
the peptide molecule. 
Medium peptides, with their increasing number of accessible conformations and 
complexity of chemical properties, represent more of a challenge. Methods successful in 
crystallising smaller chains may be attempted. More precision in the reproduction of 
conditions and stricter purity of solutions are often required. Crystals are likely to be 
stable in a narrow range of conditions only. Long periods of equilibration followed by slow 
changes in the environment are needed and, on the appearance of crystals, rapid 
mounting and data collection are advisable. 
The search for crystallisation conditions initially entails a determination of the solubility of 
the material in water and organic solvents. Ways of manipulating this solubility must be 
explored. This is equivalent to mapping out the border between solution and precipitation 
in a multidimensional phase space. It involves experimenting with solvent mixtures. The 
effect of changing pH should be investigated. The presence of additives and change in 
temperature are other parameters that need to be considered. This approach is 
summarised in the flowchart. Figure 3. 
Charged groups present particular problems. One approach could be the crystallisation of 
material from which protecting groups were not removed following synthesis. However 
the resulting crystal structure might bear only a poor resemblance to the native form. 
Addition of a counter ion resulting in precipitation of a complex is a less extreme 
possibility, for example, flavine was co-crystallised with oxytocin. The counter ion may 
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stabilise a crystal lattice by acting as a bridge between regions of like charge in the 
peptide molecules. 
The division between medium and large peptides Is determined by the point at which the 
peptide chain has sufficient length to fold into globular structures containing stable 
secondary structural units. In the presence of favourable intramolecular interactions, such 
as disulphide linkages, the chain length required for the existence of secondary or tertiary 
structure is reduced. 
In protein crystals, loosely packed molecules are interspersed with solvent channels. The 
solvent content is typically around 50 %, see Chapter 5B. The crystals are often fragile 
and stable only under a solvent atmosphere. The protein molecule is a complex chemical 
system, thus the growth of crystals is mediated by a complex and precise interplay of 
external factors. The amount of material available for experiment may be small, a few 
tens of mgs, or less. Systematic methods for the crystallisation of proteins have been 
developed, utilising comparatively tiny quantities of material (Ducruix & Giege, 1992). 
Crystal growth by vapour diffusion from hanging drops is the usual method employed. 
Figure 4. A widely used procedure is the performance of an initial screening for 
precipitation inducing conditions using a set of 50 precipitant, buffer and salt 
combinations suggested by a factorial analysis (Ducruix & Giege, 1992; Jancarick & Kim, 
1991). Because a comparatively small amount of material is required to set up such a 
screening experiment, it is justifiable for a medium length peptide, although the chances 
of finding appropriate conditions are reduced. 
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Figure 3. The search for crystallisation conditions for a peptide of medium length 
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65 
Figure 4. hanging drop vapour diffusion method of crystallisation 
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Solubility tests 
Proctolin is extremely soluble in water, methanol, ethanol and iso-propanol, giving 40 
mg/ml or higher solution concentrations. Solubility across a range of pHs was tested, 
using a series of phosphate/citrate buffer solutions. The material was soluble at pHs 2.2 -
8.0 in water, 1:1 ethanohwater and ethanol. No precipitation occurred when the solutions 
were cooled to 4 °C. 
A 20 mg/ml aqueous solution was made up and drops of organic solvent; DMSO, DMF, 
dioxane, acetonltrile, butan-1-ol, acetone and ethyl acetate, were added. Precipitation 
was observed on addition of dioxane. The following organic solvents were added to 
alcoholic proctolin solutions; diethyl ether, dichloromethane, chloroform, toluene, hexane, 
cyclohexane and carbon tetrachloride. Precipitation from a 20 mg/ml ethanol solution was 
seen on addition of ether, chloroform, and dichloromethane, from a 20 mg/ml methanol 
solution on addition of ether and toluene. The greatest degree of precipitation was 
observed on addition of diethyl ether to an ethanol solution. 
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Complexation of the arginine residue could lead to precipitation. A saturated aqueous 
solution of picric acid was added to aqueous and alcoholic proctolin solutions buffered at 
pH 4. Precipitation was observed, to the greatest extent in a 1:1 ethanohwater solution. 
Evaporation of these solutions resulted in the growth of picrate crystals. Precipitation was 
also observed in a 10 mg/ml proctolin solution in 50% acetic acid. 
Crystallisation tests 
Concentrated solutions of proctolin were put into siliconised test tubes, sealed and left for 
several days. No encouraging results were obtained by this batch method. 
With indications of possible solvent/precipitant pairs from the solubility test results, vapour 
diffusion experiments were set up, using the apparatus shown in Figure 5. Ethanol and 
methanol solutions of proctolin were used, with diethyl ether, chloroform and 
dichloromethane as precipitants. Precipitation was observed after 1-2 days. The 
precipitate was mainly in the form of oily droplets. Tests using ether as precipitant 
contained some material which appeared more crystalline. 
Figure 5. Apparatus for crystallisation 
by 'batch' vapour diffusion 
precipitant 
sealed outer tube 
proctolin solution 
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The combination of an ethanol solution with ether as a precipitant was the most promising 
approach, from the trials up to this point. A recipe for crystallisation was developed as 
follows: 
Ether was added dropwise to a test tube containing a 40 mg/ml ethanolic solution of 
proctolin. Precipitation was observed to form and then redissolve. Addition of ether was 
continued until the point at which the precipitate remained. The tube was stoppered and 
placed in a water bath at 40° C for ten to fifteen minutes, after which time the precipitate 
had redissolved. The tube was allowed to cool slowly to room temperature, then placed in 
a cold room, at 4° C. 
Crystals grew in three to five days, forming clusters of extremely thin plates. It was 
possible to separate individual crystals from the clusters. The length and width of the 
largest were 0.35 mm x 0.10 mm but their thickness was too small to measure. A crystal 
was mounted in a capillary and X-ray photographs were taken. No diffraction was 
observed. 
Attempts were made to improve crystal quality by altering the concentrations of solvent 
and precipitant. The above recipe produced the best results. Ethanol and ethanol/ether 
solutions of proctolin were seeded with crystals obtained by the above method, but no 
improvement was observed. 
One crystallisation experiment was set up with essentially the conditions described 
above, but with increased size and greater control over the rate of change of 
temperature. 25 mgs of proctolin were dissolved in 0.625 ml of ethanol. The solution was 
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centrifuged to remove any solid contaminant, then pipetted into a large test tube. Ether 
was titrated into the solution until the point of stable precipitation was reached. The tube 
was sealed and heated in a water bath at 40° C for fifteen minutes, when the precipitate 
had redissolved. The tube was then placed inside a slow-cooling apparatus. Figure 6, 
which was sealed and left in the cold room, at 4° C, for three weeks. Crystals had grown 
of a very similar shape to those previously produced. The maximum length and width had 
increased considerably, to around 5 mm x 0.3 mm, but the crystals remained very thin. 
Figure 6. Slow cooling apparatus 
polystyrene box 
thread 
Insulation 
- sealed boiling tube 
water, initial temperature 40° C 
• proctolin solution 
vacuum flask 
Crystallisation was also attempted using the set of 50 conditions specified in the Hampton 
Research Crystal Screen (Jancarik & Kim, 1992) which are commonly used for initial trials 
in protein crystallography. A 20 mg/ml aqueous solution of proctolin was used. Two 
crystallisation methods were employed, sitting-drop vapour diffusion, using Linbro plates, 
and crystallisation under an oil film. Absolutely no precipitation was observed. 
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Conclusions 
The first problem encountered during the attempt to crystallise proctolin was its extreme 
solubility in aqueous and alcoholic solutions. Precipitation could only be induced from 
very concentrated solutions, therefore large amounts of material were required. Attempts 
to re-use old material and synthesise new did not succeed in producing material with the 
same properties as that supplied by Sigma. The newly synthesised proctolin requires ion 
exchange and further purification steps. Crystallisation was achieved, but the crystals 
were not suitable for diffraction studies. The extreme thinness made it difficult to harvest 
and mount the crystals from solution in the test tube in which they had grown. They were 
only stable under ethanol vapour and possibly the presence of ether is also required. No 
diffraction was observed, possibly due to mounting problems, or the meagre volume 
resulting from the small third dimension. 
A pentapeptide such as proctolin fluctuates in solution between many energetically 
similar conformations with low potential barriers between them. A unique bioactive 
conformation is adopted at the receptor site as a consequence of the peculiar 
environment. There is no obvious relationship between the bioactive and lowest energy 
solution conformations. Solution NMR studies provide information about conformations 
stabilised by an aqueous environment, while most active sites are known to be 
hydrophobic cavities. Crystallisation introduces yet another environment, the molecular 
conformation within a crystal being mediated largely by lattice forces. The presence of 
additives and counter ions in a crystal introduce further complexity. A single structure 
determination in solution or solid phase is thus of limited relevance when the goal is an 
understanding of the activity of the molecule. Putting together several pieces of structural 
information, coupled with modelling studies, may allow some speculations to be made. 
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Chapter 3 
Structural studies on glucosamine 6-phosphate synthase 
Abbreviations and definitions used in Chapter 3 
Rmerge S^Z^^ 1 <I (h)> - 1(h), 1 / Z^Z^^ 1(h), (%), 1(h),-. = Ah of N 
measurements of reflection h 
Rnative 1 <FpH (h) > - <Fp (h)> 1 / Z^ <Fp (h)> (%), Fp (h) = amplitude of 
reflection h in native, F P H (h) = amplitude of reflection h in 'derivative' 
Patterson synthesis P (x,y,z) = 1/V Z^Z^Z, IFhwl' COS2JC (hx + ky + Iz) 
isomorphous Patterson Patterson synthesis with coefficients (Ajso)^, Ajso = 1 FPH - Fp 1 
anomalous Patterson Patterson synthesis with coefficients (Aano)^. Aam = 1 FPH(+) - FPH(-) I 
kemp 2 V( < FpH - Fp >^ / < FPH(+) - FPH(-) >^) for acentric reflections 
G A T domain glutamine amide transfer domain of amidotransferase enzyme 
synthase / synthetase 
domain 
amidotransferase domain responsible for amination of a substrate. 
Synthetase, if a cofactor is involved, synthase othenwise 
Ntn amidotransferase amidotransferase subfamily defined by N terminal catalytic activity. 
Triad 
amidotransferase 
amidotransferase subfamily defined by catalytic triad in the G A T domain. 
G L M S glucosamine 6-phosphate synthase 
P U R F P R P P amidotransferase 
P R P P phosphoribosyl pyrophosphate 
D O N 6-diazo-5-oxonorleucine, an inhibitor of Ntn amidotransferases 
F M D P fumaroyi di-propionic acid methyl ester, inhibitor of Ntn 
amidotransferases 
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Introduction 
Glucosamine-6-phosphate is a member of the glutamine dependent amidotransferase 
class of enzymes. Glutamine constitutes a major source of nitrogen for biosynthetic 
processes. These enzymes are responsible for hydrolysis of glutamine and subsequent 
amination, as depicted in (1), of a range of substrates, including amino acids, 
nucleotides, sugars, coenzymes and antibiotics. The glutamine hydrolysis (2) and 
substrate amination (3) reactions occur at separate sites, on different domains known as 
glutamine amide transfer, GAT, and synthetase, if the reaction involves a cofactor, or 
synthase, where no cofactor is required. Although separated domains often exhibit limited 
activity, they function co-operatively, resulting in an efficient coupling of the two halves of 
the reaction. In some cases the two domains constitute distinct subunits, in others they 
are present on the same chain. The mechanism by which amide is passed between 
domains is unclear. There is evidence that the product of glutamine hydrolysis does not 
equilibrate with native ammonia. However, most amidotransferases can utilise free 
ammonia in the absence of glutamine. The glutaminase activity is dependent on an active 
site cysteine, since addition of an irreversibly binding glutamine analogue, such as 6-
diazo-5-oxonorleucine, DON, which complexes with the cysteine and mutation of the 
cysteine, both result in inactivity. 
Gin + R ^ R-NH3% Glu (1) 
Gin + OH" -> Glu" + 'NH3' (2) 
R + 'NH3' + H % R-NH3* (3) 
The enzymes can be divided into two subfamilies on the basis of conserved GAT 
domains, the synthase domains of each enzyme being generally unrelated. The members 
of one family are characterised by the possession of a Cys-His-Glu catalytic triad and are 
designated triad amidotransferases. The other type, distinguished by a catalytic N-
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terminal Cys, forms the N-terminal nucleophile, or Ntn subfamily. Examples of each are 
listed in Table 1. The Ntn subfamily are members of a wider group of Ntn 
amidohydrolases, including penicillin acylase (Brannigan et a/., 1995). Triad 
amidotransferases have a GAT domain of around 190 residues, which may or may not be 
a distinct subunit. The catalytic cysteine lies in the central conserved region of the chain, 
at around position 90. Ntn enzymes all have fused GAT and synthase domains, the GAT 
constituting the N-terminal domain and comprising 148-202 residues. The active cysteine 
is the N-terminal residue of the mature enzyme. 
Sixteen amidotransferases are known, four of which are members of the Ntn family, as 
listed in Table 1. The X-ray crystal structure of one of these, PRPP amidotransferase or 
PURF, has been determined (Smith et a/., 1994). The X-ray crystal structure of one 
member of the Triad amidotransferase family, GMP synthetase, has also been solved 
(Tesmer etal., 1996). 
Table 1. Examples of glutamine dependent amidotransferases 
enzyme pathway reaction catalysed class 
anthranilate Tryptophan Triad 
synthase chorismate + Gin anthranilate -i- pyruvate + Glu 
carbamoyl-P Arginine, UTP, HCO3 + 2ATP + Gin NHaCOzPOs^" + 2ADP + P/+ Glu Triad 
synthetase CTP 
CTP C T P Mg^* Triad 
synthetase UTP + ATP + Gin -> C T P + ADP + P/+ Glu 
GMP GMP XMP + ATP + H 2 O + Gin GMP + AMP + PPZ+Glu Triad 
synthetase 
asparagine Asparagine Mg^* Ntn 
synthetase Asp + ATP + Gin Asn + AMP + PP/Glu 
glucosamine 6-P Glucosamine 6-P fructose-6-P + Gin -> glucosamine 6-P + Glu Ntn 
synthase 
glutamate Giutamate a-ketoglutarate + NADPH + H* + Gin NADP* + 2Glu Ntn 
synthase 
glutamine PRPP AMP, GMP P R P P + H 2 O +Gin -» phosphribosylamine + P/+Glu Ntn 
amidotransferase 
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Glucosamine 6-phosphate synthase, GLMS, is an Ntn amidotransferase. It catalyses the 
first step in the hexosamine biosynthetic pathway (4). The product, glucosamine 6-
phosphate is the precursor of UDP-N-acetyl glucosamine from which all amino sugar 
containing macromolecules are derived in both prokaryotic and eukaryotic cells. The 
inhibition of this enzyme could consequently play a role in the treatment of bacterial and 
fungal infection, certain types of diabetes and some cancers. 
fructose-6-P + Gin -> glucosamine 6-P + Glu (4) 
Gin + H2O ^ Glu + 'NH3' 
GAT domain 
fructose-6-phosphate + 'NH3' -> glucosamine-6-phosphate 
synthase domain 
The mechanism of glutamine hydrolysis in Ntn amidotransferases has been subject to 
investigation. The importance of the terminal cysteine has been established. Nucleophilic 
attack by the thiol leads to formation of a covalent intermediate. Prior deprotonation of 
the cysteine by a base is necessary but the identity of this base was unclear. A sequence 
alignment between GAT domains of PURF, GLMS, asparagine synthetase and glutamate 
synthase, which have 45-50% identity, lead to the hypothesis of the existence of a 
catalytic Cys-Hls-Asp triad (Mel & Zaikin, 1989). In support of this theory, mutation of His 
101 in PURF resulted in loss of activity (Mei & Zaikin, 1989). However the crucial His was 
missing from the sequences of some active asparagine synthetases (Boehlein et a/., 
1994). Mutational analysis of the GAT domain of GLMS highlighted the necessity of the 
N-terminal cysteine but found that the mutation of each of the four histidine residues 
which are conserved in the Ntn family failed to decrease the hydrolysis rate (Badet-
Denisot & Badet, 1996). The structure of PURF at 3 A resolution (Smith et a/., 1994), 
showed neither histidine, nor any other suitable residue is in a position to abstract a 
76 
proton from the cysteine. It was proposed that the N terminal a-amino group could fulfil 
this role (Smith, 1995). 
Glucosamine 6-phosphate synthase is anomalous in its inability to utilise nascent 
ammonia in place of amide from glutamine for the amination of fructose-6-phosphate, 
•'i ••• 
which suggests that coupling between the domains of the substrate bound enzyme must 
be exceptionally tight, shielding the amide acceptor site on the synthase domain from the 
surroundings. 
Glutamine analogues, including DON, iodoacetamide and fumaroyl-di-propionic acid 
derivatives, notably the methyl ester, FMDP, alkylate the N-terminal cysteine resulting in 
loss of glutamine hydrolysis activity. In the presence of fructose-6-phosphate, addition of 
1 equivalent of DON is required for complete loss of activity, while, without fructose 6-
phosphate, 0.5 equivalents of DON are sufficient, indicating that there is negative co-
operativity between the two domains. These inhibitors have been found to possess 
antifungal/ antibacterial activity. 
The E. C O / / enzyme is a dimer of 67 kDa subunits. Each subunit comprises N-terminal 
GAT and C-terminal synthase domains, connected through a central hinge region which 
is uniquely cleaved by chymotrypsin at Tyr 240. A mixture of isolated GAT and synthase 
domains has no glucosamine-6-phosphate synthesising activity, however GAT domains 
bind glutamine and retain around 7% of their glutaminase activity. The isolated synthase 
domain binds 0.16 equivalents of fructose 6-phosphate, compared to 1 equivalent for the 
intact enzyme. 
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Figure 1. 
Inhibition of glucosamine 6-phosphate synthase by fumaroyi di-propionic acid derivatives 
temnlnal carboxyl 
& 
double bond 
necessary for inhibitory activity 
NH 
/ 
C O 2 " 
X = N H 2 F O D P 
X = OMe FMDP 
NH2 
Figure 2. Possible mechanisms proposed for formation of Cysl - FMDP complex 
Cys — s 
^NH-p-Ala 
nucleophilic attack: 
at a, of: less likely - thiols too unreactive 
at b, c. Michael addition - probable 
B : 
activates C y s 
for nucleophilic attack 
Overview 
Genes encoding the two separate domains of Glucosamine-6-phosphate synthase were 
cloned and the proteins were overexpressed and purified by Obmolova et a/. (1994). The 
determination of crystallisation conditions and initial collection of native data were also 
accomplished before the start of this PhD project, by Galya Obmolova and Alexei 
Teplyakov, although these steps are outlined below. The remainder of the work described 
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in the experimental sections which follow was performed as part of the PhD. The 
appendix on the structure of the GAT domain which concludes the chapter is the work of 
Michail Usupov and Alexei Teplyakov. It is added for general information, since the 
results are extremely interesting from both crystallographic and biological points of view 
and also as an indication of how far the work described in the experimental section was 
justified and where it was misguided. 
Experimental, GAT Domain 
Crystallisation and data collection 
Table 2. Native data collection and processing, GAT domain 
parameter value 
resolution (A) 1.8 
measured reflections 201 5 8 9 
In P 2 i 2 i 2 i : 
unique reflections 4 6 5 0 3 
Rmerge (%) 6.1 
completeness (%) 9 8 . 5 
In P 2 i : 
unique reflections 7 8 9 2 3 
Rmerge (%) 6 .2 
completeness (%) 8 6 . 6 
Crystals were obtained using hanging drop vapour diffusion. They were grown at 4 °C 
from a 1 M sodium acetate solution, with 20% PEG 4000 and 0.1 M cacodylate buffer at 
pH 6.5. 100 mM of the substrate, glutamine, was present in the crystallisation solution. 
Crystals grew in 2-4 weeks, reaching a size of 0.5 mm x 0.5 mm x 0.2 mm. Figure 3. The 
crystals diffracted to 1.8 A. The point group symmetry was determined as P222, with cell 
dimensions a= 70.4 k , b = 82.5 A and c = 86.1 A. This gives 2 molecules in the 
asymmetric unit with 48% solvent content. Systematic absences along all axes indicated 
the space group P2i2i2i. Data were collected on the X31 EMBL beamline, using a MAR 
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Research imaging plate detector. The data were processed using DENZO and 
SCALEPACK (Otwinowski & Minor, 1993). Statistics are listed in Table 2. 
Figure 3. GAT domain crystal shape 
The native Patterson map contained a strong peak, with height 35% of the origin peak, at 
(0.50,0.53,0). A self-rotation search found no significant peaks. This indicated that the 
two molecules in the asymmetric unit had essentially identical orientations and were 
related by a translation of approximately (0.5,0.5, 0). If this symmetry had been exact this 
would have been a C-centred lattice. The diffraction pattern contains a complex system 
of pseudo absences, as described and illustrated in Figure 4. This phenomenon is 
caused by the divergence from ideal symmetry along the b axis. 
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Figure 4. 
The sinusoidal pattern of mean intensity for h+k reflections with increasing k displayed by the 
form I data. 
<E> was plotted against k for h+k=2n (blue, continuous line) and h+k=2n+1 (red, dashed line) 
reflections. 
This pattern corresponds to pseudo-absence of h+k=2n+1 reflections for low k(0-4), h+k=2n for 
medium k(20-24) and h+k=2n+1 again for high k(40-44). The wavelength of this pattern is related 
to the difference between the pseudo-translation and the translation giving an exact, C-centred cell. 
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Multiple isomorphous replacement 
An extensive search for isomorphous heavy atom derivatives was performed. Data 
collections on prospective derivative crystals are summarised in Table 3. These crystals 
were reasonably robust, remaining intact under a variety of soaking conditions and often 
diffracting well, to 2.7 A resolution or better. In some cases, merging statistics with native 
data appeared promising. However, the only significant feature which could be seen on 
the isomorphous and anomalous Patterson maps was the peak at (0.5, 0.53, 0) resulting 
from the translation between the two molecules in the asymmetric unit. Thus, it proved 
impossible to locate any heavy atom sites and it remained unclear whether any of the 
crystals tested were actually derivatives. 
Table 3. The search for derivatives of GAT domain crystals 
compound concentration soak time resoiution Rmergg /higti resolution ^ native 
(Mm) (days) (A) (%) (%) 
mercury 
HgAc2 0.1 1 2.3 18.3 
HgAc2 0.5 3 2.25 5.9/16.8 15.1 
DTT/HgAc2 6/0.5 3hrs/1day 2.7 5.1 21.9 
DTT/HgAC2 6 / 0.45 3hrs/1day 2.6 9.3/20.0 20.8 
EMTS 0.5 1 2.25 7.0/18.7 10.4 
EMTS 2 2 2.15 3.2 / 7.0 9.9 
EMTS 2 1 2.7 3.3/10.2 21.3 
EMTS 1 1 2.4 **inonoclinic, P2i** 
transition metal 
K2PtCl4 2 2 2.35 27.3 
K2PtCN4 3 7 2.2 8.5 
Pt(NH3)2(N03)2 3 3 2.3 6.2/18.7 13.4 
Pt(NH3)4Cl2 1 21 2.6 6,3/15.8 16.7 
Pt(NH3)4Cl2 5 7 2.6 7.2/13.0 26.4 
K2PtBr6 1.5 3 2.7 8.8 / 40.0 36.5 
KalrCle 4 3 2.7 5.0/13.3 13.9 
lanthanide/ actinide 
Sm(N03)3 7 7 2.2 9.0 
SmCb 7 3 2.7 6.5 29.6 
UO2AC 2 3 2.25 10.0 
U02(02CH2)2 4 3 2.7 8.0/26.0 19.6 
EuCI 4.8 7 2.6 6.3/18.4 40.0 
La(N03)3 6 3 2.7 6.1 14.5 
ThAc 1.6 3 3 61./14.2 35.0 
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Molecular replacement 
PURF from Bacillus subtilis has a GAT domain which has 27% sequence identity with 
that of the E. coll GLMS GAT domain. Structure solution by molecular replacement was 
attempted, using the GAT domain from the structure of PURF at 3 A resolution (Smith et 
a/., 1994), PDB code 1GPH, as a search model. The model included all atoms of the first 
224 amino acids with unaltered B factors. The cross-rotation function with an integration 
radius of 18 A and the translation function were calculated in the resolution range 10-3 A 
using AMORE (Navaza, 1994). A clear rotation solution was found, with an peak height of 
18.6 a, compared to the next, 14.6 o. However the translation function gave many peaks, 
with similar peak heights. 
At this stage, the choice of space group was reconsidered. It was suggested that the 
correct space group could be P22^2^. The systematic absences along the a axis can be 
explained by the fact that the translation component of the intermolecular vector is almost 
exactly half the unit cell width. Molecular replacement, in this new space group yielded a 
unique translation solution, with correlation 21% and R factor 62.9%, other solutions 
having correlations not higher than 18.2%. This solution was fixed and the search for the 
second molecule followed. Two solutions were obtained with equal figures of merit, 
correlation 42.7%, R 56.1%. Both solutions were acceptable with respect to packing and 
close contacts within the unit cell. The two solutions were related by the vector (0, 0.053, 
0), the translation between the two peaks in the native Patterson map which arises from 
pseudo centring. Least-squares refinement with PROLSQ (Kpnnert & Hendrickson, 1980) 
was carried out using both solutions as starting models and data In the resolution range 
10 -1.95 A. The R factor dropped from 62.4% to 38.7% and Rfree from 62.3% to 53.1% in 
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both c a s e s , so the solutions were still indistinguishable. The density maps remained 
uninterpretable and no further progress in refinement was possible. 
Alteration of crystal symmetry 
The presence of a pseudo-symmetric translation in the unit cell with the consequent 
weakness of the pseudo-absent data and the large peak in the Patterson map resulted in 
a loss of information which hindered progress towards structure solution. Attempts were 
made to grow crystals with a different lattice, lacking the pseudo-symmetric translation. 
Alterations were made to the 'normal' crystallisation conditions, which were 0.8 - 1.2 M 
NaAc, 2 0 % P E G 4000, 0.1 M cacodylate buffer, pH 6.5. Options considered included 
changing the cation, the anion, the type of P E G or the pH and the addition of organic 
additives to the crystallisation solution. Crystals were grown under new conditions and 
their symmetry determined, with the results listed in Table 4. 
Table 4. The search for a new symmetry for G A T domain crystals 
crystallisation conditions (changes) lattice: a,b,c (A) comments 
P E G 8000 normal 
P E G 8000, 3% MPD primitive monoclinic: 53, 87, 56, p = 99° disordered 
P E G 8000, 3% MPD primitive monoclinic: 87, 71,168, p = 92° 
or centred monoclinic: 255, 63, 98, p = 95° 
disordered 
P E G 8000, 3% ethanol primitive monoclinic: 53, 87, 56, p = 
or centred orthorhombic: 69, 83, 87 
101° disordered 
P E G 8000, 3% ethanol primitive monoclinic: 53, 87, 56, p = 
or centred orthorhombic: 71, 83, 87 
99° disordered 
P E G 8000,1% cyclo-hexane normal 
P E G 6000 normal 
or primitive orthorhomic: 83, 87, 42 
disordered 
P E G 6000 3-octvl glyceride normal 
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The presence of ethanol and MPD during crystallisation evidently affected the lattice, but 
the crystals produced were disordered. Alteration of the crystal lattice by soaking crystals 
grown under normal conditions in concentrated salt solution (3.9 M NaAc), 5% ethanol, 
55% P E G 4000 and 60% MPD was also tried. Crystals were found to diffract following 
this treatment, although to a lower resolution limit, but no lattice changes were observed. 
Synthase Domain 
Crystallisation and data collection 
Crystals were grown by hanging-drop vapour diffusion, at 4 °C, from a solution containing 
27-31% sodium formate buffered by 0.1 M imidazole at pH7. 5 mM fructose-6-phosphate, 
the substrate, was present In the solution. Crystal growth in the absence of substrate is 
also possible. Hexagonal bipyramidal crystals grew in 2-8 weeks with dimensions 0.6 mm 
X 0.3 mm x 0.3 mm. These crystals diffracted to a limit of 2.2 A. The data indexed in 
space group P 6 i , or its enantiomer, P 6 5 , with a = b = 63.5 A and c = 334.5 A. Two 
molecules in the asymmetric unit give a solvent content of 49%. Data were collected on 
the X I I EMBL beamline to 2.6 A resolution and processed using DENZO and 
SCALEPACK. 108 620 measured reflections gave 23 992 unique data, with Rmerge 5.4%. 
The native data are summarised in Table 5. 
Structure solution attempts 
Structure solution by multiple isomorphous replacement was attempted and data were 
collected on potential derivative crystals as listed in Table 6 . Rmerge was high for all 
derivative datasets and the scaling of native and prospective derivative data proved 
impossible. The merging statistics for each pair of datasets are listed in Table 7. 
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The self rotation function for each dataset was calculated. Table 8. The equatorial angle, 
(]), which is equivalent to the angle of rotation about the 61 axis between the two 
molecules in the asymmetric unit, appears to vary widely between datasets. For a single 
dataset, Pt2 as defined in Table 6, the images were reprocessed in three sets of 20°, 
chronologically grouped. Rmerge for these subsets was lower than for the whole dataset 
and the self rotation function gave a different value for in each case. Table 9. From this 
variation in the rotation function, it appears that the alignment of the lattice varies 
between crystals and either with orientation or time or both, for a single crystal during 
data collection. The most obvious interpretation is that there is some type of rotational 
disorder in the lattice. 
If (|) = 0, the space group would be P6i22. The symmetry of these crystals may therefore 
be considered to be disordered P6i22. Progress in structure determination may be 
possible if this disorder could be removed, either by an induced lattice transformation, for 
instance by soaking or freezing of the crystals, or by a change in crystallisation 
conditions. The crystals are hexagonal bipyramidal, but some are symmetrical about a 
central mirror plane, while others are not. Figure 5. It was suggested that crystals with this 
symmetry may possess a P6i22 lattice, while the asymmetric ones were in P 6 1 . 
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Figure 5. Synthase domain crystal shapes 
symmetric - P6i22 ? asymmetric - P6^7 
Alteration of crystal symmetry 
New crystallisation conditions, resulting in crystals of altered symmetry, were sought. 
Crystals were found to grow in a range of conditions, including: 28% sodium formate 
precipitant, buffered by imidazole at a range of pHs, 7.0 - 8.0, and concentrations 0.1 -
0.15 M, or 0.1 M H E P E S at pH 7.0 - 8.0; 1 M sodium acetate, with 0.1 M TRIS buffer, at 
pH 8.5 and 10% P E G 4000, 35-40% ammonium sulphate, at pH 7.0; 38% ammonium 
sulphate with 0.1 M Imidazole at pH7.0; 35% sodium citrate with 0.1 M HEPES at pH7.0; 
35-40% lithium sulphate with 0.1 M H E P E S at pH 7.5. Generally, the crystals appeared to 
have the same form, and those tested possessed the old unit cell. The use of sodium 
citrate as precipitant resulted in hexagonal prisms. However the diffraction from these 
was too poor for the unit cell to be ascertained. 
Table 5. Native datasets collected, synthase domain 
dataset resolution (A) P6i a,c(A) N unique 
GS7 10-2.5 63.7 335.4 15 373 
GS8 18-2.6 63.6 335.0 22 619 
GS9_h 15-2.6 63.5 334.3 23 992 
GS9_/ 29 - 3.3 64.0 336.5 11 960 
GS10 25 - 2.6 64.2 337.8 22 644 
GS11 35 - 5.6 63.7 335.6 2 279 
87 
Table 6. 'Derivative' datasets collected, synthase domain 
dataset heavy atom 
compound 
cone 
(mM) 
soak 
time 
resolution 
(A) 
symmetry, cell 
/=6i a, c(A) 
Rmerge 
(high res) 
(%) 
complete 
(high res) 
(%) 
Nunique 
Pti RPy4Cl2 
.2H2O 
1.15 4 hrs 20 - 2.6 64.7 340.2 12.7 
(42) 
99.3 
(99.2) 
24 431 
Pt2 KaPtCU 1 1 day 20 - 2.6 64.2 340.7 10.0 
- (35) 
98.4 
(100) 
24 084 
Pt3 RPy4Cl2 
.2H2O 
1 4 hrs 35 - 5.6 63.6 334.1 6.6 
(10.5) 
89.0 
(84.1) 
2 089 
Hql ETMS 0.39 1 hr 20 - 2.6 cracked - - -
Table 7. Rmerge for pairs of synthase datasets 
GS7 GS8 GS9_ / GS9_h GS10 GS11 Pti Pt2 Pt3 
GS11 30.0 23.6 29.5 34.6 30.4 - 25.5 26.2 52.7 
G S I I a * 54.0 40.6 50.1 41.6 42.8 - 30.0 30.0 32.3 
Pti 40.0 29.6 41.1 34.7 36.4 - 11.9 37.8 
Pti a* 42.2 31.1 42.1 35.0 37.5 - 12.3 36.1 
Pt2 41.2 28.9 40.9 337 36.8 37.9 
Pt2a* 42.8 30.6 42.5 34.3 37.9 35.9 
Pt3 49.3 37.7 46.8 30.9 36.9 -
Pt3a* 17.6 20.0 42.1 20.2 13.5 -
* G s a = enantiomer of G S 
Table 8. Peaks in the self-rotation function for synthase data sets 
dataset peak height (b (°)* Q ( ° ) - K ( ° ) 
(% origin) 
GS7 1 83.8 -6.2 90 180 
2 33.9 0.0 90 180 
GS8 1 81.4 -14.1 90 180 
2 71.6 -3.0 90 180 
G S 9 J 1 71.7 -5.3 90 180 
2 69.2 0.0 90 180 
GS9_h 1 96.0 -0.7 90 180 
GS10 1 76.1 12.5 90 180 
GS11 1 84.8 -9.1 90 180 
2 79.0 0.0 90 180 
Pt1 1 97.2 -0.7 90 180 
Pt2 1 95.7 +0.5 90 180 
P t3 1 89.0 +5.9 90 180 
2 80.3 0.0 90 180 
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Rotation angles: 
n polar (90°) 
K around 2-fold rotation axis (180°) 
(p equatorial - around 61 axis 
* P 6 1 is a polar space group, so re-
indexing with the 61 axis in the opposite 
direction will cause (|) to change sign. 
The rotation function was calculated, as 
well as could be determined, for all data 
indexed the same way round, i.e. for the 
sets of data which gave the best 
merging statistics. 
Table 9. Results of processing dataset Pt2 in three subsets 
images 4'spindle axis Rnneroe (%) rotation function peak height <Kotation function 
range (°) (high resolution.) (% origin) n 
1-59 60 10.0 (35) 95.7 +0.5 
1-13 20 6.8 (18.6) 92.6 +5.2 
13-45 20 7.0 (28) 87.5 -4.5 
47-59 20 5.8 (27) 83.4 -10.9 
Appendix: Structure of the GAT domain 
(Summary of work by Usupov & Teplyakov) 
Solution and refinement 
During the screening for derivatives, data were collected on a single crystal which 
indexed in the monoclinic space group, P2i, with a = 53.5 k,b = 87.3 A, c = 56.6 A, p = 
98.9 °. In the monoclinic cell, form II, two molecules are related by a non-crystallographic 
2-fold axis. This new form has a similar packing motif to the orthorhombic cell, form I, but 
without the pseudo symmetric operators. Figure 6. 
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Figure 6. Relationship between GAT domain crystal forms I and II 
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70 
form I 
P2i2i2i cell, 
70x83x86 A 
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orthorhombic cell 
._ ! ;_ 
^-—1 
83 
If cell were face-centred, these 
operators would be added form II 
P2i cell, 
53 x87x56 A, |3 = 99° 
The monoclinic cell is a variant of 
the orthorhombic form, but without 
the pseudo-centric transformations 
Structure solution by molecular replacement was tried unsuccessfully, using the form II 
data with the PURF GAT domain as a search model, as described above for form I. An 
attempt was then made using the preliminarily refined molecular replacement solution in 
F22i2i as a search model. This yielded a solution for two molecules with correlation 
57.8% and R 46.5%. The solution was subjected to refinement at 23 - 2.4 A resolution 
using a maximum likelihood approach, REFMAC (Murshudov et a/., 1996), with the 
application of strict NCS restraints. 3% of the data were separated from the working data 
and used to evaluate Riree- Phase improvement, using the CCP4 program DM, resulted in 
a density map in which the deviations of the chain from the search model could be 
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traced, allowing manual corrections to be applied, using O (Jones at a/., 1991). This 
model refined to R 20.2% and Rfree 27.1%. 
The extension of the model to higher resolution and the investigation of complexes 
necessitated a solution of crystal form I. The data collection of form II was serendipitous 
and numerous crystallisation attempts had failed to procure another such crystal. 
Molecular replacement in P22•^2^ using the refined P2^ model as a search model resulted 
in two solutions which could not be refined, as had occurred previously. A solution was 
then searched for in all other primitive orthorhombic space groups, to no avail. The 
possibility of a lower symmetry was then considered. 
A unique solution was finally obtained in P2i, with the 2i axis along the 82 A cell edge. 
The solution had correlation 83% and R 34.3%, four crystallographically independent 
molecules; A, B, C, & D, with two pairs of molecules, A&C, B&D, related by the former 
•t 
pseudo-centring vector, and two pairs; A&B, C&D, related by the former orthorhombic 2-
fold along the c axis, Figure 7. The crystal lattice can be described as a superposition of 
two orthorhombic sublattices, shifted by 0.027£> along a common monoclinic 2, axis. 
Data were reprocessed in P2i, with statistics listed in Table 2. Due to the 
misapprehension that the symmetry was orthorhombic, only 90° of data had been 
collected and the completeness in the new monoclinic symmetry, was only 86%. 
PROLSQ refinement was performed at 10-1.8 A resolution without NCS restraints. 1% of 
the data were used for Rfree calculation. Water sites were added where peaks of height 
greater than 3.5 o in the difference map came within bonding distance, 3.5 A, of potential 
H-bonding partners. Their occupancies were set to 100% and not refined. 
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Figure 7. Relationship between monoclinic and orthorhombic symmetries of fonm I, 
and between the 4 independent molecules in the monoclinic cell 
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• C: related to A by (0.5,0.5,0) translation (NCS) 
• D: related to B by (0.5,0.5,0) translation (NCS) 
pairs of molecules: 
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fonm orthorhombic sublattices. 
there is a translation of 
(0, 0.03, 0) 
between the sublattices 
The final model had R 17.9%, Rfree 25.4% and 770 solvent sites, 238 residues modelled 
for A & C and 239 for B & D , out of 240 expected. A metal ion site was detected in the 
density. It is co-ordinated by five oxy-ligands, with distances in the range 2.2-2.6 A. The 
metal was modelled as Na"^ , since this cation was present in high concentration in the 
crystallisation medium. The substrate glutamine was also present in the solution and 
difference density for this molecule was observed and modelled. Substrate binding is 
discussed below. 
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An Inhibitor complex 
Data were collected on a crystal which had been soaked in a 50 mM solution of L-Glu-
hydroxamate. Figure 8, a competitive inhibitor of Gin binding and hydrolysis. The inhibitor 
binding was Identified in the difference map and the structure refined, using the model of 
the substrate complex. 
Figure 8. L-Glu hydroxamate, 
an inhibitor of Gin hydrolysis 
HO 
Description of the structure 
The four layer structure consists of a pair of p-sheets sandwiched between a-helical 
zones, Figure 9. The central strands of the p-sheet assembly are planar, but the end 
strands twist, so that opposite ends of the sheet lie perpendicular to one another. The C-
terminal strands, pi 4 and pi 5, can be considered as a single strand forming the closing 
link between the p-sheets. The secondary structural units are joined by short loop 
regions, 13 out of 18 of which contain Gly residues in conformations forbidden to other 
residues. These Gly residues are highly conserved in the Ntn family of 
amidotransferases. The region between the sheets is packed with hydrophobic residues. 
The majority of a-a and a-p interactions are also hydrophobic. The Na* binding site is 
formed from loops connecting a5 to p7 and P8 to P9. 
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P8 
B9 
Figure 9. 
Ribbon representation of the GAT domain of GLMS produced using MOLSGRIPT (Kraulis, 1991) 
Alpha-helices are depicted in green, beta-strands in red. A ball and stick representation of the 
product, Glu, lies in the active site. 
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Substrate binding site 
The catalytic residue, Cys1, is situated at the bottom of a deep pocket in the centre of the 
sheet structure. The substrate lies within this pocket. The binding pocket is comprised 
principally of the loop sections connecting P4 to P5 and P6 to a3. Numerous H bonds are 
formed between ligand and protein. The binding pocket is enclosed by the loop residues 
73-79, which interact with the a-COa" and a-NHa* of the molecule, the other end of which 
points towards the catalytic site at the bottom of the pocket. H-bonds are formed between 
the y-carboxyl group and Cys l N, Trp74 N and Gly99 N, which are all proton donors. This 
provides evidence that the ligand bound is the product, Glu, rather than Gin. In addition, 
the refinement of both y-carboxyl atoms as oxygens gives equal B values for the pair, 
while, if one is modelled as nitrogen, the nitrogen B factor drops by 5 A^. It is predicted 
that the amide group of Gin would lie less deep within the pocket, forming an H-bond to 
Trp74 O. The amide of the inhibitor L-Glu hydroxamate is indeed observed to interact in 
this manner. 
Comparison to PURF structure, the loop lid on the binding site 
The structures of the GAT domains of PURF (Smith et a/, 1994) and GLMS are very 
similar, the main structural difference being that the former lacks the C-terminal pair of p-
sheets. However, superposition of the 219 common CA atoms gives an rmsd of 2.15 A, 
due to the considerable deviation of almost all the loop regions between the two 
structures. Superposition of 70 CA atoms from p-sheet regions gives an rmsd of only 0.93 
A. 
The maximum deviation of up to 10 A occurs for the CA atoms of residues 74-83, the 
loop region joining p4 and P5, which forms a lid over the Gin binding site. In the PURF 
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structure, the binding site is empty and the lid loop in open conformation, with rather high 
B factors indicating considerable motion. In the GLMS structure, the occupied site is 
closed by the lid, which Is fixed in a much more rigid conformation. The open lid appears 
to provide the only access to the binding site. A gate mechanism, mediated by interaction 
with the synthase domain, is proposed for lid opening. In the PURF structure, the Gin 
binding site is shielded from the bulk solvent by the synthase domain and relative 
movement of the two domains is necessary for the opening of the site. In the structure of 
PURF complexed with the glutaminase inhibitor DON (Kim et a/., 1996), the loop also 
adopts the closed conformation. 
Mechanism for glutamine hydrolysis 
From the structure of the enzyme bound to the reaction product, a mechanism for 
glutamine hydrolysis can be deduced. Figure 10. 
1/ Deprotonation of the Cysl thiol is accomplished with the N-terminal a-amino group 
acting as a base catalyst, via a bridging water molecule. 
2/ Nucleophilic attack of the activated thiol on the amide carbon of Gin forms a 
tetrahedral intermediate, stabilised by H-bonding with Asn 98 ND and Gly 99 N. 
3/ The intermediate collapses, releasing ammonia and forming a y-glutamylthioester. 
4/ Deacylation results from the attack of a water molecule, activated by the N-terminal a-
amino group, in the same manner as in step 1, to form a second tetrahedral 
intermediate, stabilised as in step 2, followed by the collapse of this intermediate, 
releasing glutamate. 
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Figure 10. 
Proposed catalytic meclTanism of Gin hydrolysis by amidotransferases. 
Residue numb)ers are those of GLMS. 
Cys 1 
The thiol is activated for nucleophilic attack by the N-terminal a amino group. There are 
no other suitable basic groups neighbouring the active site, in either PURF or GLMS 
structures. There is no evidence for the involvement of a catalytic Cys His Asp triad of 
residues, as previously postulated. The evidence suggests that a mechanism of 
glutamine hydrolysis entailing single amino acid catalysis could be a common feature for 
the Ntn amidotransferase family of enzymes. 
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The mechanism assumes the prior repositioning of two key residues. The sidechain of 
Asn 98, which is hydrogen-bonded to Cys1 N in the GLMS structure should rotate 100° to 
form, with Gly 99, the oxyanion hole which stabilises tetrahedral reaction intermediates. 
The thiol of Cysl points outside the binding pocket in the GLMS structure. A rotation of 
180° around the CA - C bond and 120° around CA - CB moves It into the active position, 
ready for nucleophilic attack. This Is the conformation adopted In the PURF structure. 
This switch is Impossible with the lid loop In closed position, therefore, glutamine 
hydrolysis Is dependent on Cys1 adopting the active conformation prior to Gin binding 
and closure of the pocket. 
It has been shown that, for the Ntn family, Gin hydrolysis Is inhibited by the reaction 
product, Glu, in both the Isolated GAT domain and the complete enzyme In absence of 
the N acceptor substrate. This suggests that binding of the N acceptor to the synthase 
domain results In the co-operative activation of the GAT domain, with rotation of Cysl 
Into the attacking position. 
The unusual inhibition of the GLMS GAT domain by the product, Glu, can now be 
rationalised. In the Isolated domain, Cys1 Is free to adopt either active or Inactive 
conformation, at random. Gin In the crystallisation solution Is converted Into Glu by 
enzyme molecules In active conformation. Due to the unfavourable Interaction with the 
thiol in the active conformation, Glu complexes preferentially with enzyme In the Inactive 
conformation, trapping molecules In this alignment, since there is no release mechanism. 
The existance of a family of Ntn hydrolases has recently been recognised, members of 
which include penicillin acylase(PA), the proteasome(PROT) and aspartyl 
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glycosylaminase(AGA) (Brannigan et al., 1995). These enzymes are characterised by a 
common mechanism for hydrolysis, the intial step of which is the nucleophilic attack on 
the substrate carbonyl carbon by the side chain of the N-terminal residue, Cys for GAT, 
Ser for PA, Thr for PROT and AGA. This N-terminal side chain is activated by its own a-
amino group, via a bridging water molecule. 
The Ntn fold is a 4-layer a+p structure incorporating two antiparallel p-sheets, one flat the 
other twisted. Residues from the twisted sheet are incorporated in cavities in the flat 
sheet, thus the two sheets are packed very closely. The structural alignment of active 
sites of different Ntn hydrolases shows that elements of the catalytic centres are 
equivalent. Ser B1 OG, Ser B1 N, Ala B69 N and Asn B241 ND2 of PA may be 
superemposed on Cys1 SG, Cysl N, Gly103 N and Asn102 N of the PRPP GAT domain, 
with an rmsd 0.7 A. This common framework suggests that a common mechanism exists, 
involving intermediates with the same chirality. 
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Chapter 4: 
Anisotropic refinement of two small protein structures 
Introduction: Least-squares refinement 
The relationship of the parameters of an atomic model to the crystallographic diffraction 
pattern Is well understood. This allows a model to be refined to match experimental 
diffraction data with high fidelity, using the method of least-squares minimisation. 
Given a set of independent observations, yi , . . .ym, from which a set of parameters, Xi,...Xn. 
are to be determined, if the observations are linearly related to the parameters, equations 
(1) can be written. 
a i i X i + ....+ amXn = yi 
(1) 
amiXi + ....+ amnXn = y^ 
If m=n, there Is an exact solution, but no estimate of the errors on the parameters. If m > 
n, the equations are overdetermined and a best fit solution can be found by minimisation 
of the residual, dj for each observation, where 
di = l y i - a i i X i + ....+ ainXnl (2) 
This can be achieved by the minimisation of the sum of the squares of the residuals, (3) 
but only If all the observations are equally reliable, otherwise the residuals must be 
weighted, (4). 
m M = Z.^, di-^  (3) 
M = 2:.^^Widj^ Wi = 1/o ,^ o = standard nucertalnty of y (4) 
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M is minimum when the differential with respect to Xj Is zero (5). This gives the normal 
equation for each Xj , (6). 
S.^ , WiaiiaijX, Wiaij Xj +...+ E.^ ^ WiainayXn = S.^ ^ w, aijy (6) 
Least-squares refinement is relatively insensitive to gross errors and computationally 
economical. If the residuals obey a normal distribution and the ratio of observations to 
parameters Is large, the reliability of error estimation is good. 
A crystallographic least-squares refinement Involves minimisation of structure factor or 
Intensity residuals (7). In this case, the observations are not linearly dependent on the 
parameters that are to be fitted. As a result, iterative refinement steps are required. The 
solution of the normal equations Ignores higher than first order derivatives. Consequently, 
errors In the trial function must be small, othenwise the refinement will oscillate or diverge 
rapidly rather than converging. 
M = 2:j/ah'(IFh°''^l-IF.-"=l)^ (7) 
The solution of the normal equation Is achieved by expressing the problem In terms of 
matrices. A set of m observations, Y can be expressed as a function of a set of n 
parameters, x, with m > n. 
F(x) = Y (8) 
A trial model Is found, Yc. To get better estimates of Yc, Taylor expansion gives: 
Yc + (5F/5X) 5x= Yo (9) 
which can be rearranged: - • 
A6x = A Y (10) 
A^A5x = A^AY 
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N 5x = A^AY = r 
6x = N-^ r (11) 
where A(m,n) is a matrix, Aij = 5 F / d X j i , r is the residual vector n = S (5Ym/5Xi). (Yo - Yc)m, 
N(n,n) is the normal matrix A^A and 6x is the set of parameter shifts. The chief 
computational demands are for sufficient memory for storage of the V2n(n+1) terms of the 
symmetric normal matrix and time for y2nm(n+1) operations on this matrix. 
Data collected on small molecule crystals to atomic resolution (~1 A) give a large data to 
parameter ratio. There are a comparatively small number of atoms in the structure. Direct 
methods commonly provide an excellent starting model with co-ordinate errors not greater 
than 0.1 A. The relatively small number of parameters also means that y2n(n+1) is not a 
prohibitively large number for computational memory. Thus, full least-squares refinement 
of atomic co-ordinates and anisotropic thermal parameters is the routine procedure. 
As the number of model parameters, n, increases, the demand for computer time and 
memory for least-squares refinement increases by more than n .^ Thus, for 
macromolecules the supply of sufficient computational facilities is non-trivial. However, 
even if advances in computer technology were to render this factor insignificant some 
fundamental differences would remain. 
In a typical protein crystal, loosely packed molecules are interspersed with channels of 
solvent. The solvent regions contain diffuse density, the overall B factor of the structure is 
large and, especially at the protein solvent interface, atoms exhibit a high degree of 
thermal motion and disorder. Consequently, the high resolution data are weak and 
limited, leading to a low data to parameter ratio, with the refinement tending to become 
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under-determined. A further difficulty relates to the character of the starting models. 
Structure solution techniques for macromolecules often yield trial models with large 
errors, of around 0.5 A In co-ordinates, and the nature of the errors Inherent In a solution 
differs with the method by which it was derived. 
Although there Is a lack of high resolution information In the diffraction pattern, there 
exists a store of structural knowledge to help compensate. A library of stereochemical 
Information has been built up from sources Including amino acid and oligopeptide 
structures and spectroscopic measurements. This Information can be introduced Into a 
refinement by the application of restraints or constraints. 
A restraint restricts a model property to a realistic range of possibilities, weighted by the 
reciprocal variance of the property, whereas a constraint confines it to a specific value. If 
the weight on a restraint Is infinite, it becomes a constraint. In their application, both 
Increase the effective data to parameter ratio. In different ways. A constraint Is an exact 
mathematical condition leading to the elimination of one or more least-squares parameter 
because they can be expressed exactly In terms of other parameters. A restraint Is 
applied in the form of an additional weighted observation, with the discrepancy between 
model and ideal values to be minimised In the same way as the structure factor residuals 
(11). All observational terms contribute to a grand minimisation function (12). 
cp(x) = L1 /a^; (gJ ' ^ - ' -g^ ; °^^ f (11) 
0 = S9(x) (12) 
The storage space and time required for a refinement can be greatly restricted by 
considering only the diagonal terms of the normal matrix. This Is a very rough 
approximation since it ignores all correlation between parameters. Block diagonal 
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refinement involves the division of parameters into subsets, and contruction of a sparse 
matrix, with correlations within a subset accounted for, while those outside are ignored. 
This is a good compromise, especially if the blocks are different for each cycle of 
refinement. 
Modified matrix least squares 
full matrix refinement 
n=7 
diagonal matrix refinement blocked matrix refinement 
parameters split into blocks 
of 2, 2 and 3 
I J ™ , 
^^ ^^ ^^ ^^ ^^ ^^ ^ 
\ 
correlations between all no correlations between 
parameters accounted for. parameters accounted for. 
correlations between 
parameters (1,2), (3,4), 
(5,6,7) accounted for, 
but no others 
Conjugate gradient refinement is an approach which is often adopted as an acceptable 
compromise for macromolecular refinement. The method involves the storage of the 
parameter shifts between cycles. During each cycle, the direction vector of parameter 
shifts is modified by a factor derived from the direction vector for the previous cycle. The 
factor is larger when a parameter appears to creep in the same direction in successive 
cycles. This can be thought of as a method of approximating the second derivative of the 
function. It helps prevent the refinement becoming trapped in a false minimum and 
accelerates convergence while limiting time and memory consumed since the structure 
factor derivatives are computed only once, although the geometric information is updated 
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on every cycle. Convergence properties are less good than for full matrix least-squares 
refinement. An additional disadvantage of the conjugate gradient method Is that a reliable 
estimate of errors Is not obtained. 
PROLSQ (Hendrlckson, 1985, Konnert & Hendrlckson, 1980) Is a least-squares 
refinement package developed to deal with the problems posed by the refinement of 
protein crystal structures outlined above. Minimisation of structure factor residuals Is 
performed (7) using a conjugate gradient algorithm. Co-ordinates and individual Isotropic 
thermal parameters may be refined for each atom, although, for lower resolution data and 
In early stages of refinement, one overall B factor derived from the Wilson plot (Wilson, 
1942; Chapter 5A) can be fitted. A system of restraints Is Imposed during the refinement. 
The relative weight of observed data and restraints can be adjusted. The weight given to 
the restraints should be reduced at later stages in the refinement to allow maximum 
exploitation of the information In the diffraction data. 
The system of stereochemical restraints Implemented In PROLSQ is based on values In 
the Engh & Huber (1991) set. Restraints are applied to bonding distances and angles, to 
Impose the planarlty of groups and chlrallty at asymmetric centres. Non-bonding contacts 
shorter than given minimum values have a repulsive restraint Imposed. Selected torsion 
angles, sidechain rotamers and peptide bond torsions are restrained to the Ideal values to 
which model values correspond most closely. 
Restraints on atomic thermal parameters follow the rigid bond principle. The root mean 
square displacements of atoms within a protein structure are an order of magnitude larger 
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than the distortions observed in chemical bonds. This implies highly correlated atomic 
motion. B factors of bonded atoms are thus restrained to similar magnitudes. 
Restraints vary in strength of application. Bond distance restraints are strong, since the 
ideal bond distances are known to high accuracy for naturally occurring amino acids and 
the observed variances are small. The distributions of torsion angles are wider, so torsion 
angle restraints are softer. 
Non-crystallographic symmetry (NCS) can be exploited in the imposition of two types of 
restraints. NCS related objects are superimposed, allowing an average structure to be 
defined. Positional restraints on deviations from this average structure can then be 
applied, also restraints imposing similarity of equivalent temperature factors. These NCS 
restraints can confer stability at early stages in a refinement before being relaxed to allow 
genuine differences between the NCS related species to emerge. 
PROLSQ also imposes limits resisting excessive shifts in parameters in a single cycle. 
This can be a problem in badly defined parts of the structure and can cause instability in 
a refinement. 
Technological progress in X-ray crystallography in recent years includes the construction 
of high intensity X-ray sources such as dedicated and purpose built synchrotrons, the 
development of area detectors with rapid scanning and readout properties and cryogenic 
cooling techniques which allow crystals to be preserved at liquid nitrogen temperature 
during and between data collections. These achievements have facilitated the collection 
of an increasing number of high quality, atomic resolution data sets on protein crystals. 
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An atomic resolution data set has been defined by Sheldrick (1990) as one in which data 
extend to at least 1.2 A resolution, at least 50 % of the data in the outer shell possessing 
Intensities > 2a. There have also been vast expansions In the storage and operational 
capacity of computers. As a result of these advances, methods for both solution and 
refinement of crystal structures which were previously limited in application to small 
molecules have Increasing relevance in the field of high resolution protein 
crystallography. 
The SHELXL refinement package (Sheldrick & Schneider, 1996) was initially developed 
for small molecular refinement but Is now evolving to meet the demands of refinement of 
molecules of Increasing size. SHELXL refinement allows greater flexibility In the treatment 
of higher resolution protein structures where data quality makes this justifiable. 
SHELXL can be used for refinement with a choice of minimisation algorithms: conjugate 
gradient, blocked and full matrix refinement. At the end of the refinement, an error 
assessment can be made by running some final cycles using the full matrix. 
SHELXL refines against Intensity data rather than amplitudes. This Is especially 
advantageous for macromolecular data, particularly those with pseudosymmetry, since 
they include many weak reflections. During data collection, some weak reflections may be 
recorded with negative intensities. If the intensity data are then converted to structure 
factors, these weak reflections will be ascribed zero amplitudes. It is optimal to use all 
observations In refinement, with suitable weighting, rather than employ an Intensity cutoff. 
This Is achievable with the employment of F^  refinement. 
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In SHELXL atoms can be modelled with either individual isotropic thermal parameters or, 
if the data quality permits, with anisotropic thermal tensors. This more accurate modelling 
of static and dynamic displacements within a structure reduces the rms electron density in 
the ( F o - F c O c ) synthesis, allowing features such as solvent sites and alternate side chain 
conformations to become apparent above the background noise. The modelling of 
alternate conformations and partially occupied atoms, with the refinement of 
occupancies, is also facilitated within SHELXL. 
A large and flexible range of restraints are available which can be tightened when 
modelling diffuse regions of the structure and relaxed where they are not necessary. 
Geometrical restraints can be applied to interatomic distances, molecular planes and 
chiral centres. Chemically but not crystallographically equivalent distances can be 
restrained to be equal, which is useful where reliable dictionary values are not available. 
Two types of restraint are applied to anisotropic thermal parameters, a rigid bond restraint 
similar to that employed in PROLSQ can be applied to the component of the ellipsoid 
along the bond, while a weaker similarity restraint can be applied to transverse 
components. 
Anisotropically refined solvent atoms can be restrained so that the axes of the thermal 
ellipsoid remain approximately equal. This "isotropic" restraint helps prevent the atoms 
from becoming non-positive definite, the volume of the thermal ellipsoid refining to a 
negative value. This can easily happen because an ellipsoid is an inadequate model for 
the density of a typical solvent site. Besides smearing of the density due to thermal 
motion in a similar fashion to the libration of atoms at the ends of long side chains, such 
as Lys and Glu, the density at a 'solvent site' may result from the overlap of several 
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closely situated, partially occupied sites, these formations often having the appearance of 
a chain of beads. 
As the model becomes Increasingly sophisticated, it is Important to differentiate between 
modifications justified by observation and overfltting of the model. The Rfree test (Briinger, 
1 9 9 3 ) can be applied as an Indicator. A small percentage of reflections Is removed at 
random from the working data before any changes are made to the model. The 
refinement is therefore not biased by this subset of data. Rfree Is defined as the R factor 
( 1 4 ) evaluated using the omitted data. If the drop in Rfree on the introduction of a change, 
such as movement from isotropic to anisotropic modelling of thermal parameters. Is of the 
same magnitude as that in the R factor derived from the working data set, this is an 
independent verification of the protocol. However, the Rfree test Is Insensitive to 
adjustments made in the final stages of the refinement of an atomic resolution structure, 
such as the modelling of alternate solvent networks and no validation tool can 
compensate for lack of chemical knowledge and experience. Another problem with the 
evaluation of Rfree is that the absence of a percentage of data from the refinement is not 
optimal, since the electron density we are attempting to model Is a Fourier transform of 
the entire diffraction pattern. Missing reflections result in ripples In density maps, which 
can be misleadingly localised and lead to modelling errors. 
R = Z I I F o l - I F c l l / Z l F o l ( 1 4 ) 
A further fundamental difference between small molecule crystals and those of 
macromolecules requiring serious consideration during refinement lies In the solvent 
structure. The treatment of solvent is discussed in detail in Chapter 5 B . 
I l l 
Protocol used for protein G and rubredoxin refinements 
This chapter is concerned with the refinement of atomic resolution data sets for two small 
proteins, using essentially the same protocol. 
In both cases the initial model for the refinement was derived from an already existing 
isotropic model of the structure. 5% of the reflections were separated from the working 
data set prior to refinement for the evaluation of Rfree- The co-ordinates were randomised 
by rms 0.3 A and a number of cycles of isotropic refinement were performed in an 
attempt to remove the memory of these reflections from the model. Isotropic refinement 
using PROLSQ was followed by anisotropic refinement using SHELXL-93 (Sheldrick, 
1993). As already mentioned, the validity of the anisotropic model can be assessed by 
observing the change in Rfree following Its introduction. However, at atomic resolution the 
use of an anisotropic model is always justified (Dauter et a/., 1995). Hydrogen atom 
positions were not refined, but calculated using a riding model. During the course of 
refinement an Automated Refinement Procedure (ARP, Lamzin & Wilson, 1993) was 
employed, as explained below, for the construction and modification of the solvent 
network only, a procedure designated 'restrained ARP'. Thus, the solvent structure 
undenwent modification in real space in between rounds of least-squares refinement. 
Fourier maps were calculated using the CCP4 suite of programs including FFT (Ten 
Eyck, 1973). 
Stereochemical restraints applied during both PROLSQ and SHELXL-93 stages of the 
refinement were based on values from the Engh & Huber (1991) set. The restraints 
applied are listed in Table 1. 
112 
Table 1. Stereochemical Restraints applied during refinement 
restraints applied to: 
bonding distances 
1-2, 1-3, 1-4, H-bond/metal 
co-ordination 
PROLSQa 
0.02, 0.04", 0.05, 0.05 A 
SHELXL-93a 
0.03 (0.01 f , 0.03 (0.01 f , -, - A 
thermal parameters 
similarity main chain 1-2.1-3,side 
chain 1-2,1-3 
rigid bond restraint - component, 
along bond direction 
4, 5, 6,8A? 4A^ (0.05A^f 
0.8 A^ (0.01 A'^f 
planarity, chlral volume 0.02 A\ 0.15 A^ 0.2 A^, 0.2 A^ 
non-bonding contacts 
single torsion 
multiple torsion 
H-bondX..Y 
H-bondX-H..Y 
0.3 A, Dinc.= -0.3 
0.3 A, Dinc.= 0 
0.3 A, Dinc.= -0.2 
0.3 A, Dinc.= -0.9 
-
torsion angles 
planar (eg peptide il) 
staggered (eg aliphatic %) 
transverse (eg aromatic %) 
3° 
15° 
20° 
0.3 A'' 
solvent 
isotropic restraint: similarity thermal 
ellipsoid axes 
- 8 A' (0.1 A'f 
a of ideal distribution (not exactly for SHELX) 
b , 
0.03 A for protein G 
restraints applied to bond distances involving multiple conformations 
in terms of rms atomic displacement, <u>^ = B / 8JI^ 
distance of deviation from plane 
allowed separation = sum of Van der Waal's radii + Dine 
^ chiral volume restraint on peptide bond carbonyl carbon 
Real space refinement matches the expected and actual shape of density around an 
atom on the (3Fo-2Fc,ac) map and moves the atom to Improve its sphericity. This corrects 
the positioning of diffuse, possibly partially occupied, atoms which othenvise tend to drift 
towards the edges of the density. 
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Calculated structure factors were scaled prior to map calculation using a procedure which 
applies a correction accounting for the diffuse solvent scattering contribution, which is 
crucial for the fitting of data at 5 A and lower resolution. The modelling of diffuse solvent 
is considered in Chapter 5B. Another possible Improvement in this real space refinement, 
the use of sharpened density maps, is discussed in chapter 5A. 
Estimates of errors in bond distances, angles and refined occupancies were obtained by 
running a final cycle of SHELXL-93 least-squares refinement with a matrix of overlapping 
blocks of parameters, using the final model and the entire set of data. All restraints were 
removed and the refinement was prevented from crashing by setting the allowed shift on 
all parameters except the overall scale factor to zero. The accuracy of these estimates is 
limited, since correlations between parameters not refined in the same block remain 
unaccounted for. Ideally, the full least-squares matrix should be constructed. 
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Chapter 4A: 
Anisotropic refinement of the protein G IgG binding domain III 
introduction 
What is an Immunogiobulin? 
Immunoglobulins, or antibodies, are soluble proteins produced by plasma cells 
constituting the recognition element of the humoral immune response system. They are 
synthesised in response to the presence of a foreign substance, an antigen, which may 
be a protein, polysaccharide, nucleic acid, synthetic peptide or small molecule 
synthetically attached to a protein (hapten). Each antibody-producing cell has the 
capability of producing one sort of antibody only. 
Polyclonal antibodies to a specific molecule may be obtained by injecting the substance 
into an animal such as a rabbit. The rabbit will develop antibodies, which may be 
extracted in antiserum. The antibodies obtained will be heterogeneous, varying in affinity 
and specificity for the antigen, since they were produced by many populations of cells. 
The investigation of the structure and function of immunoglobulins was greatly advanced 
by the development of a method for production of homogenous monoclonal antibodies. A 
single antibody producing cell is fused with a myeloma tumour cell. This then divides 
rapidly, producing hybridoma cells, which all possess the ability to produce the same 
specific antibody. 
Immunoglobulin G is the principle class of antibody present in the blood plasma. The 
structure of IgG is schematically depicted in Figure 1. It has a moelcular mass of around 
150 kDa. When cleaved with papain, three 50 kDa domains are obtained. Two are 
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identical antigen-binding domains, Fab. The other, known as Fc, is responsible for 
effector functions, the processes by which the antigen-antibody complex is dismembered. 
The three domains fit together in a Y shape, with the Fc constituting the stem. Ig is made 
up of four polypeptide chains, two identical 25 kDa "lighf chains and two identical 50 kDa 
"heavy" chains. The C-terminal ends of the heavy chains constitute the Fc domain. Each 
Fab domain consists of a light chain and the N-terminal part of a heavy chain. The chains 
are held together by disulphide linkages. The antigen-binding site is a cleft located at the 
N-terminal end of the Fab domain, at the top of the T * . The link between the domains is 
flexible, allowing hinge-like movement of the two Fab segments, thus the distance 
between the antigen binding sites can be varied to optimise binding to antigens with 
multiple recognition sites, for example, viruses. 
Both heavy and light chains consist of a variable N-terminal region and a constant region. 
Within the variable regions are hypervariable segments which form the antigen-binding 
site. The Fab and Fc fragments both contain four globular subdomains arranged in a 
tetrahedral manner; Fab: VL, CL, VH & C H I and Fc: 2CH2 & 2CH3. Each subdomain adopts 
the structural motif known as the Immunoglobulin fold, consisting of a pair of p-sheets; 
three-stranded and four-stranded, back-to back, bridged by a.disulphide bond. 
Two types of light chain exist, K and X, with around 40% sequence identity in the CL 
subdomains. The heavy chain varies with the class of antibody. Some classes have 
larger Fc domains and exist as larger structures, with multiple copies of the (Fc 2Fab) 
unit. Membrane-bound immunoglobulins are also produced, which are embedded in the 
membrane via a hydrophobic extension to the Fc domain. 
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The specificity of the antibody for the antigen results from the fact that the binding site is 
composed of chain segments with sequences unique to each antibody. It is not caused 
by conformational changes following the invasion of antigens into the environment and 
novel antibodies are not synthesised in response to the presence of an antigen. The 
capacity to synthesise each type of antibody is inherent in the system. 
^HaN 
Figure 1. Schematic illustration of the structure of IgG 
^ h e a v y c h i 
region 
l i g h t c h a i n 
J C H 3 CH3 1 
C02 C02" 
l i g h t c h a i n 
disulphide bonds 
What is Protein G? 
Protein G is a large multi-domain cell surface protein of group G Streptococcus which 
binds to Immunoglobulin G. Many pathogens possess such proteins, which assist in the 
evasion of the host's immune response by binding to host antibodies, mimicking self 
markers commonly displayed by host cells (Boyle, 1990). Other examples are protein A 
from Staphylococcus aureus and protein L from Peptostreptococcus magnus. Ig binding 
proteins typically possess two or more Ig-binding domains, each comprising 50-60 
residues with close to 100% identity between them. These subdomains retain activity 
when individually expressed. 
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Figure 2 . Overall fold of protein G IgG binding domain. 
Beta strands are shown in green and the alpha helix in red. 
Drawn with Q U A N T A . 
11« 
The role of these Ig-binding proteins in enhancing microbial virulence makes them a 
target for the understanding and combating of infection. The common clinical symptom 
caused by group G Streptococcus is pharyngitis, but it can be responsible for more 
serious infections, such as septicaemia. The Ig-binding affinity of these proteins is high, 
comparable in strength to antibody-antigen binding and their specificity is low. Typically 
Igs of several species and classes are bound by the same protein. The nature of the 
protein-protein interactions is of interest. Affinity for Ig is unlikely to be affected by the 
binding of antigens, which has led to these molecules becoming crucial tools in the 
screening and purification of antibodies, proteins generally and other biomolecules in 
immunology and molecular biology. 
Protein G contains three IgG-binding domains. There is a high degree of sequence 
similarity between published sequences of protein G IgG-binding domains, suggesting 
that strict sequence conservation is necessary for the retention of binding ability. The 
secondary structure of protein G Ig-binding domains comprises a central a-heiix, packed 
against a four-stranded antiparallel p-sheet: - 1 , +3x, -1 topology, after the notation of 
Richardson (1981), Figure 2. The domains possess exceptional chemical and physical 
stability (Achari et a!., 1992). The B1 domain has a melting temperature of 87° C and is 
not denatured in 8 M urea. One factor contributing to this stability is that around 95% of 
the residues are incorporated in secondary structure, ensuring a large number of 
stabilising hydrogen bonds. A typical value for a domain of this size is 75% (Gronenborn 
eta!., 1991). The overall fold of the molecule enhances its stability, with the two ends of 
the chain making up the central strands of the p-sheet and a tightly packed, hydrophobic 
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core, coupled with a very hydrophilic exterior. This results in a large negative solvation-
free energy of folding, -55 ± 2 kcal mol'^ for 8 1 . 
Protein G binds to a wide range of mammalian IgGs, but not to other classes of Ig (Guss 
et a!., 1986). The binding domain utilises two almost completely non-overlapping sets of 
residues on its surface to recognise two separate sites on the Ig (Lian et a/., 1994), one 
on the Fc fragment, one on the Fab domain. The affinity of Protein G for IgG binding sites 
varies between IgG species. For human IgGs, interaction occurs preferentially to the Fc 
domain, while for mouse Igi, binding is with the Fab domain. 
Complex formation with the Fab domain of the antibody occurs through the antiparallel 
interaction of the second p-strand of the protein G domain with the last p-strand of the 
C H I subdomain, to form an extended p-sheet across the two domains. A minor binding 
site, comprising residues from the C-terminus of the a-helix and the first p-strand from 
C H I , packs against the p-p contact region, forming a hydrophobic interior to the 
interaction site. The crystal structure of Protein G domain III, complexed with a Fab 
fragment from mouse lgGi (Derrick & Wigley, 1994), gives insight into the manner in 
which high affinity, low specificity binding to Ig is achieved. NMR studies on a complex of 
domain II with a Fab fragment from mouse IgGi (Lian et a/., 1994) support the fact that 
this interaction persists in solution and is not an artefact of crystallisation. Protein G binds 
to the least variable part of the Fab domain. Out of a total of twelve hydrogen bonds, 
eight connect main chain atoms in CH1 , including the five involved in the p-p contact. In 
addition, the C H I residues with side chains involved in the interaction are highly 
conserved between different subclasses and species. 
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Binding to the Ig Fc domain occurs in a cleft between CH2 and CH3 subdomains. The 
binding site incorporates residues on the a-helix and the third p-strand of the protein G 
domain (Gronenborn & Clore, 1993). 
Protein A binds to mammalian IgG Fc fragments in a complementary fashion to Protein G 
(Guss etal., 1986). The two proteins exhibit competitive binding to Fc domains, indicating 
that the binding sites are close or overlapping (Lian et al., 1991). However, no significant 
homology has been found between protein A and G IgG-binding domains and the 
secondary structures are not alike. The protein A solution structure consists of three 
helices (Torigoe etal., 1990; Gouda etal., 1992), one of which is disrupted in the crystal 
structure of the protein A/ Fc complex (Deisenhofer, 1981). There is evidence that the 
protein G recognition of Fc principally involves the helix, in a similar fashion to the protein 
A - Fc interaction. It is possible to superimpose one of the two Fc interacting helices of 
protein A on to the G helix. This results in the alignment, with respect to Fc, of the third (3-
sheet of protein G in a similar position to that of the second interacting helix of protein A 
(Gronenborn & Clore, 1993). The manner in which these two different structures from 
bacterial proteins recognise the same site on a host Ig is a good example of convergent 
evolution. 
The protein L IgG binding domains adopt the same fold as the protein G chains. However 
no significant homology could be found (Kastern et al., 1992). Protein L binds to the Fab 
domains of all IgG classes. It interacts with the framework of the variable domain of K light 
chains and has low affinity for X chains. A hybrid molecule, protein LG, containing Ig-
binding domains from L and G, has been found to bind to a very wide range of Igs. 
(Kihiberg et al., 1992). Thus, proteins A and G possess similar functions but different 
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structures. Conversely, proteins L and G adopt similar structures while performing 
different functions. 
Summary 
Derrick & Wigley (1994) grew crystals of the third IgG binding domain (domain III) of 
protein G, collected X-ray diffraction data to a resolution of 1.1 A, obtained a structure 
solution, performed refinement and deposited the resulting co-ordinates in the PDB, code 
11GD. An outline of this study, which preceded the work performed as a part of this PhD, 
follows. In the present study, the data have been reprocessed and anisotropic refinement 
has been carried out, with the aim of assessing the additional information available from 
the anisotropic model. 
Previous experiment: (Derrick & Wigley, 1994) 
Protein and Crystallisation 
Expression and purification of domain III was carried out as described by Lian et a/. 
(1992). Crystals were grown by hanging-drop vapour diffusion, with a reservoir solution 
containing 10 mM sodium acetate buffer (pH 4.8), 0 .01% sodium azide and the 
precipitant, 24-26% PEG 4000. Crystals of dimensions up to 0.75 x 0.50 x 0.50 mm grew 
in one week. The crystal properties are summarised in Table 1. 
Table 1. Crystal properties, data processing statistics 
Crystal symmetry: Orthorhombic, P2^2^2^ Molecules per asymmetric unit; 1 
Cell dimensions (A) 
Vm(A 'da-^) 
Resolution (A) 
Rmerge (%) 
Nunique 
Completeness (%) 
Previous Refinement 
a= 34.9, b=40.4, c=42.2 
2.29 
25-1.1 
5.8 
23 530 
95.0 
New Refinement 
a= 34.78, b=40.28, c=42.19 
2.23 
10-1.1 
3.7 
24145 
97.9 
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Data Collection and Processing 
Data were collected at room temperature on the X31 beamline at the EMBL outstation 
using monochromatic radiation of 0.72 A wavelength and a Hendrix-Lentfer Image plate 
detector, the prototype MAR scanner. For the most effective solution and refinement of 
atomic resolution structures, data must be as complete as possible. The very low 
resolution data play a crucial role in refinement, e.g. (Dodson et al., 1996). In order to 
collect data over a wide range of resolutions on a MAR imaging plate at a synchrotron 
source, it is necessary to collect several data sets. 
To maximise the resolution which can be collected, crystal to detector distance must be 
short, a minimum of 80 mm is possible on beamlines at EMBL Hamburg. Due to the limits 
of its dynamic range, strong, low resolution reflections overload the detector when 
exposure time is sufficiently long to allow reliable measurement of weak, high resolution 
intensities. Therefore, data are collected in several runs with the crystal to detector 
distance increased and exposure time successively reduced between each one. Four 
data sets were collected (at distances 140, 190, 290 & 450 mm) with resolution ranges, 
1.8 -1 .1 A, 4.0 -1 .4 A, 10 - 2 A, 25.0 - 4.0 A, the low resolution limit for an image being 
determined by the radius of shadow cast by the beam stop at the centre of the image 
plate. The data were processed using the CCP4 (1979) suite of programs, giving 
statistics shown in Table 1. 
Structure Solution and Refinement 
Structure solution by molecular replacement, using structures obtained by NMR 
spectroscopy as search models, proved unsuccessful, so heavy-atom isomorphous 
replacement was required. Structure solution was achieved using data from a single lead 
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acetate derivative. An initial model was built using the interactive graphics program 
FRODO (Jones, 1978), comprising residues 2-13, 16-50 & 55-61, with numbering from 
the N-terminal Met, using the sequence described by Lian et a/. (1992). Following a few 
cycles of restrained least-squares refinement (Hendrickson & Konnert, 1980), 
construction of the remaining loops was possible, using a (2Fo-Fc) map. Alternate cycles 
of model rebuilding and least-squares refinement with phase extension followed. There 
was also a simulated annealing step using X-PLOR (Brunger efa/., 1990). Characteristics 
of the final (new) model are summarised in Table 2 in comparison with the 1IGD (old) 
model. 
Table 2. Comparison of new and previously refined models 
ojd new 
R ( % ) 19.3 9.4 
total water 120 130 
B protein, mean (A^) 11.9 12.6 
B water, mean (A^) 40.2 41.2 
rmsd, C A atoms(A) 0.054 
rmsd, all protein atoms (A) 0.423 
Anisotropic Refinement 
The work undertaken as part of this PhD commenced at this point. 
Data 
The data, collected as described above, were reprocessed using DENZO (Otwinowski & 
Minor, 1993). This was deemed to be necessary following initial test refinement runs, 
which suffered from problems including inexplicable program crashes, fluctuations in R 
factor and a high level of noise in density maps. Problems in scaling of the low resolution 
data were traced to merging errors in the medium resolution data set, (10-2 A) resulting 
from the fact that the beam-stop shadow was too large in this set of images and also off-
centred. This caused a select set of data to be unobserved. Once this problem was 
accounted for, the merging of the low resolution data improved. Reprocessing of the data 
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gave slightly different cell parameters (Table 1) with new data processing statistics. Errors 
in the very low resolution intensities remained large, so a resolution cutoff of 10 A was 
applied. Refinement was performed using a working set of 22944 data - 95% of the total. 
The remaining 5%, removed at random, were utilised in the calculation of Rfree, a cross-
validation method of assessing the progress of the refinement (Brunger, 1993). 
Model 
The starting point for the refinement was the previously determined isotropic model, PDB 
code 1IGD. Cell parameters were changed to the values obtained during the 
reprocessing of the data. All solvent atoms were removed. A random positional error with 
rms 0.3 A was introduced into the model to assist in the eradication of the memory of 
individual reflections from the model. 
Refinement 
Restrained least-squares refinement of atomic positions and thermal parameters was 
performed, in the initial stages using PROLSQ and then using SHELXL-93 (Sheldrick, 
1993). Stereochemical restraints to parameters taken from the Engh & Huber (1991) set 
were applied during both stages of the refinement, as explained in the introduction to this 
chapter. Hydrogen atom positions were not refined, but calculated using a riding model. 
ARP was employed for modification of the solvent structure in real space. Visualisation 
and manual rebuilding of the model were performed using FRODO. 
The course of the refinement is summarised in Table 3. The first stage consisted of 
PROLSQ refinement alone. This was a precaution to help remove memory in the model 
of the reflections in the Rfree data. Further isotropic refinement followed, during which 
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building of the solvent network was commenced. A cycle of ARP was run after each 
PROLSQ cycle, with ARP set to modify solvent atoms only. At first, the limits for addition 
and removal of solvent atoms were set to 20 per cycle, allowing the solvent network to be 
constructed. The numbers of atoms added and removed per cycle were then reduced to 
5, allowing more stable refinement of the existing solvent positions. When this refinement 
had converged and no more solvent was being added, it was judged time to start 
anisotropic refinement. 
Table 3. The course of refinement 
Cycles Stage R ( % ) ^R(%) Rfree-(%) ARfree(%) water sites n 
»» 
p 
•^ rms, F 
- randomisation of 35.9 - 37.3 - 0 
co-ordinates from 
previous 
refinement 
1-15 1 isotropic 
refinement, 
P R O L S Q 
26.6 -9.3 28.3 -9.0 0 0.557 0.093 
16-30 2 P R O L S Q + real 
space refinement 
& construction of 
solvent network, 
A R P 
17.5 -9.1 19.4 -8.9 118 0.562 0.090 
31-40 3 anisotropic 
refinement, 
S H E L X L - 9 3 , A R P 
10.1 -7.4 12.9 -6.5 119 0.500 0.049 
41-50 4a introduction of 4 
double 
conformations, 
occupancies of 3 
other residues 
refined 
9.5 -0.6 12.8 -0.1 121 0.493 0.047 
51-60 4b 8 double 
conformations & 
Lys 15 occupancy 
refined 
9.5 0 13.0 +0.2 123 0.495 0.047 
61-70 5 sharpened (3Fo-
2Fc) maps input to 
A R P ; (F^^E"-^) 
9.4 -0.1 12.5 -0.5 130 0.491 0.046 
71-80 6 100% data used 
(unsharpened 
maps) 
9.4 0 (9.5)* (-3.0r 131 0.504 0.047 
* the Rfree data set is no longer independent of the refinement at this stage 
* Prms F ~ °^ (3Fo-2Fc) map density 
## p^^ = rms of (Fo - Fc) map density 
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Before anisotropic refinement commenced, five cycles of SHELXL-93 were run on the 
isotropic model. The resulting model had R and Rfree 17.9% and 20.2%. This difference in 
R factors from the PROLSQ model principally results from the fact that SHELXL-93 
refines against F^ as opposed to F. Isotropic atoms remained isotropic for 1 cycle of 
refinement and were then refined anisotropically for 4 cycles. Atoms already anisotropic 
remain so throughout. After each round of SHELXL-93 refinement, ARP was run, adding 
and removing up to 5 atoms per cycle. R and Rfree dropped to 10.9% and 15.0% in two 
rounds of refinement, demonstrating the validity of the anisotropic model and the protocol 
in general. 
A prominent feature of a difference map, generated from a model with isotropic thermal 
parameters, is the presence of peaks close to atoms, especially in the more mobile parts 
of the structure, such as loop regions and at the ends of long side chains. Modelling of 
the anisotropy of the atoms reduces this difference density, lowering the rms density of 
the whole map and enabling parts of the structure which have been incorrectly or 
insufficiently modelled to become apparent from the remaining difference peaks. For this 
reason, manual fitting of the model to the density and the building of alternate 
conformations for disordered regions was left until several cycles of anisotropic 
refinement had been performed, to reduce the possibility of making incorrect alterations. 
The fit of the model to the (3Fo-2Fc, Oc) and (Fo-Fc, Oc) density syntheses was inspected 
using FRODO. The side chain of Lys 24 was adjusted. The pattern of water sites around 
Asn 13 suggested that ND2 and 0D1 should be interchanged. For four residues: Val 5, 
Glu 12, Val 26 & Glu 32, difference density clearly showed the presence of alternate 
conformations. Two alternative conformations of each side chain were modelled, with the 
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combined occupancy of each pair constrained to 1.0. For three residues: Met 1, Lys 15 
and Asp 40, difference density indicated some disorder and the correct side chain 
conformation was unclear. These residues were each modelled with a single side chain 
conformation and its occupancy was refined. Following further refinement, positions for 
second conformations of Met 1, Glu 20, Asn 40 and Asp 51 were modelled. 
When manual adjustments to the model were deemed complete, a further refinement 
was carried out with the same protocol except that the (3Fo-2Fe,ac) maps input to ARP 
were calculated using sharpened structure factors of the form (E°®F°^). This was an 
attempt to see if real space refinement using sharpened maps could improve the 
modelling of the solvent network, as explained in Chapter 5a. The working and Rfree data 
sets were then combined and refinement was performed using 100% of the data, now 
without sharpening of the maps input to ARP. Lastly, a cycle of blocked least-squares 
refinement was run to provide estimates of errors in the final model, as described in the 
introduction. The estimated co-ordinate errors for each atom type were strongly 
correlated to the B factors. The mean values for main-chain CA, N and O were 0.0183 A, 
0.0143 A and 0.0147 A respectively. 
Compar ison of anisotropic model with 1IGD 
Protein 
A comparison of overall geometry of new and 11GD models. Table 4, shows that mean 
bond distances are longer for 11GD, with a mean difference in main chain bond lengths of 
+0.7%. The former refinement was performed using a pre-Engh & Huber dictionary. A 
second possible cause for the difference in bond lengths is the exclusion of hydrogen 
atoms throughout the 1IGD refinement. In the absence of hydrogen atoms, the 
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unaccounted for electron density produces a tendency for bonds in the model to 
elongate. 
Figure 3 
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Table 4. Comparison of the geometry of the new and 11GD models 
New model target (A) 1IGD 
mean interatomic a interatomic mean interatomic a interatomic 
distance (A) distance (A) distance (A) distance (A) 
N-CA 1.448 0.015 1.458 1.468 0.011 
CA-C 1.515 0.014 1.525 1.527 0.011 
C - 0 1.226 0.010 1.231 1.244 0.009 
C-N 1.318 0.012 1.329 1.318 0.009 
N-C 2.430 0.025 2.462 2.440 0.039 
CA-0 2.383 0.021 2.401 2.400 0.021 
O-N 2.232 0.016 2.250 2.262 0.015 
C-CA 2.424 0.022 2.435 2.429 0.015 
CA-N 2.414 0.020 2.425 2.417 0.026 
mean £2 (°) a[Q] (°) target (°) mean Q (°) a[n] (°) 
177.3 5.8 180.0 178.9 2.9 
The distributions of distances for 1IGD are sharper than for the new refinement, Table 4. 
The distribution of the peptide torsion angle, Q., Figure 3, is narrower, more peaked and 
centred closer to 180° in the former. This is a sign that, during the old refinement, too 
much weight was placed on geometric restraints. This forced the adoption of idealised 
stereochemistry, overriding information present in the X-ray data, thereby leading to loss 
of information in the model. 
The furthest outliers to the new model Q distribution are the angles before and after Trp 
48, 195° and 162°. Figure 4 is an illustration of the possible consequences of the 
application of an over strong planarity restraint to this section of chain. Trp 48 is in the 
centre of the P3 strand, the surrounding chain Interacting with P2 of the neighbouring 
molecule, 048 and N20 are H-bonded, and with p4 of the same molecule, via H-bonds 
N49-058 and O47-N60. The bulky side-chain sits in a hydrophobic cleft between the p-
sheet and the C-terminal end of the a-helix. Val 59 CB points towards the Trp ring and is 
separated from it by around 3.8 A. A difference peak 2.5 o in height lies between the Val 
CB and the Trp ring, at around 1.7 A from the ring, in an othenwise very clean area of 
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Trp 48 O 
Tro 48 N 
Figure 4: 
The peptide torsions before and after Trp 48 were distorted from 165 and 192 
to the 'ideal' value of 180 degrees. The geometry around these bonds was then 
re-regularised. 
The green ball-and-stick model shows the original atomic positions. The distorted 
model is shown in red. 
The fit of both models to the 3Fo - 2Fc density map is shown. 
density.This suggests that there may be an alternate conformation of Trp 48, in which the 
ring is rotated by 180°,allowing one C G of an alternate conformation of Val 59 to lie in the 
density observed between the two residues. 
While the mean B factor for solvent atoms in the new model is almost identical to the old 
value (see Figure 10), that for protein atoms increased by an average of +0.8 A^ per 
residue. Figure 5. This can be explained by the fact that refinement without application of 
a diffuse solvent correction, as in the case of 1IGD, results in a global underestimation of 
B factors, see Chapter 5B. There are nine residues for which the new refinement 
produced a lower mean B factor: Val 5, lie 12, Lys 15, Glu 29, Glu 32, Lys 33, Glu 37, 
Asn 40 and Asp 45. 
The change in map correlation (1) by residue, shown in Figure 6, exhibits the same trend 
as the change in B factors, with residues 5,12,15, 29, 32, 37, 40 and 45 all experiencing 
an improvement of over 10 % in their real space fit. 
Correlation correlation coefficient, k= (<xy> - <xxy>) / (V(<xV-<x>^)V(<y^>-<y>^)) (1) 
All these residues fitted poorly into the density in the initial stages of the refinement. Two 
alternate conformations were modelled for the side chains of Val 5, lie 12, Glu 32 and 
Asn 40. The density for Lys 15 CD, C E and NZ was weak and the occupancy of a single 
conformation was refined to a value of 60%. The density for Glu 29 and Lys 33 was also 
weak, but density for all atoms could be seen after refinement. Modelling of alternate side 
chains was attempted for Glu 37 and Asp 45, but was unsuccessful. Continued 
refinement greatly improved their fit and difference density around them was removed. It 
is likely that several of these residues were the victims of the noisy solvent interface, 
which resulted from incomplete modelling of the solvent in the early stages of refinement. 
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Figure 5. 
Comparison of the new and 11GD models by residue. 
The dashed line shows the change in equivalent isotropic B factor: 
<B(new)> - <B(1IGD)> 
The continuous line depicts the rmsd between the CA atoms of the two models: 
100 (rmsd (CA)) 
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Figure 6. 
Map correlation of the (3Fo-2Fc) map to the Fc map for the new and 11GD models 
a/ for main chain atoms 
b/ for side chain atoms (excludes Gly) 
k(new)(continuous line)and k(old) (dashed line) are plotted against residue number, 
where k is the correlation to the map per residue. 
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In the crystal structure of the protein G-Fab complex (Derrick & Wigley, 1994) an 
antiparallel alignment of the second p-strand from protein G domain III, residues 15-22, 
with the 7th and last p-strand of the CH1 domain, extends the 4-stranded p-sheet from 
domain III into CH1. The end of the domain III a-helix and the 1st p-strand of CH I come 
together to form a secondary binding zone, which lies on top of the join between the two 
p-sheets, creating a hydrophobic binding region. NMR studies on a protein G domain II -
Fab complex (Lian etal., 1994) show that the regions of the protein G domain involved in 
IgG binding in solution correspond to the binding residues in the crystal, so this alignment 
of the molecules is not merely an artefact of crystallisation. When protein G IgG binding 
domains are crystallised in the absence of IgG, a similar p-p interaction is commonly 
observed (Derrick & Wigley, 1994; Gallagher et al., 1994): the antiparallel alignment of 
the second p-strand of one molecule with the third strand of the next, resulting in 
continuous ribbons of p-sheet extending through the structure. 
Intermolecular contacts in the crystal have been examined, with particular attention to the 
p-p interaction region. Figure 7. Four main-chain hydrogen-bonding interactions were 
observed between P2 and P3, as listed in Table 5. In the new model, the placing of the 
Thr 16 side chain in a different rotamer, coupled with the modelling of two conformations 
for Asp 51 has lead to a new contact being established between OG 16 and 0D1 51. The 
B factors of the main chain atoms involved in H bonding increased slightly, while those of 
the side chain atoms decreased. The lengths of already established contacts decreased 
by an average of 3.5% of the new mean distance, 2.83 A. Other intermolecular hydrogen 
bonds were formed by very exposed residues, the N and C tennini, N Z of Lys 9 and Lys 
24 and the side chains of Glu 20, Asp 27, Gin 37 and Asp 41. The new refinement has 
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resulted in Improved modelling of these residues in diffuse density, as described above, 
allowing these contacts to be more clearly revealed. 
Table 5. Comparison of intermolecular H-bonding in new and 11GD models 
(1) (1) (2) (2) 
dnew (A) doid (A) Bnew - Bold (A ) Bnew • Bold ( A ) 
B-6 H-bonding contacts - main chain atoms 
0 16 -0.3 N52 +1.4 2.95(1) 3.02 
N 18 +1.6 O 5 0 +1.5 2.94(1) 3.01 
0 1 8 +1.2 N50 +1.5 2.88(1) 2.95 
N20 +1.0 0 48 +1.0 2.86(1) 2.92 
new side chain p-p H-bonding contact 
OG 16 -10.2 GDI 51 -4.2 3.16(3) >4.5 
other intenvolecular H-bonds 
N 1 -0.9 0G1 60 +1.5 2.94(1) 3.00 
N 1 -0.9 0 22 +1.8 2.94(1) 3.02 
NZ9 +5.3 OD1*27 +1.5 2.84(2) 2.74 
NZ9 +5.3 0 E 2 29 +4.0 2.70(4) 2.89 
NZ24 -1.5 NE2 37 -3.5 3.27(4) 4.45 
NZ 24 -1.5 OD2 41 .0.8 2.82(4) 3.21 
NE2 37 -3.5 OD2 41 -0.8 2.82(3) 3.00 
0 E 2 a 2 0 " +2.2 OD1*27 +1.5 2.96(1) 2.56 
0E2b 20** 0 OD1*27 +1.5 2.51(7) 2.56 
* 0D2 27 in 11GD ** 0 E 2 20 single site in 11GD 
WHATCHECK highlights the fact that the Asn 13 side chain in 11GD should be rotated, as 
in the new model. Five unsatisfied potential hydrogen bonding atoms buried in the protein 
are listed for each model. Three of these listed only for the old model are Lys9 NZ, 
Lys15N and Glu 61 OE2. Asn13 ND2 features in both lists, although its position has 
changed. This residue is in an unusual environment, at the start of the intermolecular p-p 
binding region. Asp 27 N, also in both lists and Thr 30 N, in the list for the new model 
only, face each other in the tight loop at the start of the a helix. The other atoms in the list 
for the new model are Ala 53 N, which lies in the centre of the p-turn linking p strands 3 
and 4 and Tyr 38 OH, which has one nearby water site. 
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Figure 7. Intermolecular H-bonding. 
a/ The five beta-beta H-bonds are shown as dashed lines. 
b/ 3Fo - 2Fc electron density for this region. 
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Solvent 
The improvement in solvent modelling can be seen from a comparison of the distributions 
of map correlation(1) for 1IGD and new solvent sites. Figure 8. In the new model, 50% of 
the solvent sites have a correlation of 0.9 -1.0, with 18 % better than 0.95. In 1IGD, only 
16 % have a correlation of over 0.9 and none greater than 0.95. Conversely, the old 
model contains 28 % sites with worse than 0.75 correlation, with 8 worse than 0.5, while 
the new model has 15 % sites with values less than 0.75, two of these below 0.5. 65 % of 
the solvent sites in the new model are within 1 A of one in the 11GD model. Figure 9. All 
new model sites with low B factors, < 36 A^, are within 0.5 A of a site in the 1IGD model, 
the range of separation increasing with B factor, as illustrated by Figure 10. 
From the distribution of solvent B factors. Figure 11, it can be seen that the number of 
sites with low B factors, 5-30 A^, is slightly reduced. More sites were added with B in the 
range 30-60 A^, while the number with very high B factors, over 60 A^, was reduced. The 
distribution of [(distance of solvent from protein)*B], Figure 12, shows a similar increase in 
sites in the intermediate range, 75-225 A^, while the number with extreme values 
declines. There are 2, possibly 3 peaks in the mid-range of the distribution, at 90 A^, 140 
A^ and 220 A^. These peaks are more pronounced in the distribution for the new model. 
This suggests that during refinement the solvent in the model becomes arranged in a 
series of shells around the protein. The removal of peaks with low B factors close to the 
protein is a consequence of improved modelling of the diffuse regions of the protein and 
the general reduction in noise at the protein-solvent interface following the introduction of 
a diffuse solvent correction. The removal of peaks with very high B factors remote from 
the protein could be due to the reduction in noise and also to more discriminating 
modelling of the solvent. 
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Figure 8. Map correlation of solvent sites 
Histogram of correlation, k, of (3Fo-2Fc) map to Fc map for solvent sites in the 
anisotropic model (continuous line) and 1IGD (dashed line). 
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Figure 9. Separation of solvent sites 
The histogram of the separation of solvent sites In the new model from those in 11GD. 
The distance from each new solvent site to the closest site in 11GD was evaluated and 
the distances were sorted into bins of width 0.5 Angstrom 
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Figure 10. Separat ion distance between solvent sites in the 2 models against sqrt. B. 
The separation of each new water position from the closest 11GD solvent site was plotted 
againstthe square root of the new site B factor. Only equivalent water sites, defined as 
those with separat ion less than 1 Angstrom, are shown. 
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Figure 11. 
New and 11GD solvent structure are compared. Distributions of solvent site B factor are plotted 
for the new model (continuous line) and 1IGD (dashed line). 
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Figure 12. 
Distributions of d(sp) * B(s) for the new model(continuous line) and 11GD(dashed line) illustrate 
the arrangement of the solvent structure, where d(sp) is the separation of a solvent site from its 
closest protein atom and B(s), the solvent site B factor. The existence of a series of solvent shells, 
each possessing a characteristic B factor range, will result in a series of peaks in the distribution. 
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Chapter 4B: 
Anisotropic refinement of rubredoxin from Desulfovlbrlo vulgaris 
Background 
Rubredoxin is a small bacterial non-haem iron-containing protein, around 50 amino acids 
in length. Figure 1. The iron atom is complexed to four cysteine sulphur atoms in an 
approximately tetrahedral geometry. The protein has been isolated from sulphate-
reducing and some aerobic bacteria, however the aerobic rubredoxin is a larger molecule 
of around 80 residues. Its precise function is not known, but it is thought to participate in 
a redox chain. Electron transfer interactions with cytochrome Ca have been reported (Bell 
et a/., 1978). Extensive structural studies have been carried out on rubredoxins from 
several species. Table 1 lists crystal structures which have been determined. 
Table 1. Rubredoxin crystal structures 
source best 
resol. (A) 
bestR 
(%) 
residues H2O symmetry/cell references 
Clostridium 1.1 9.0 54 110 R3: Watenpaugh etal., 1973 
pasteurianum 64.0, 64.0, 32.5 A Watenpaugh et a/., 1979 
ox, F e Dauter etal., 1996 
Clostridium 1.2 10.7 54 87 R3 Dauter etal., 1996 
pasteurianum 64.1,64.1,33.1 A 
ox, Zn 
Desulfovibrio 1.0 14.7 52 102 P2, Pierrot etal., 1976 
vulgaris (1.5) (9.8) 19.9, 41.4, 24.4 A Adman etal., 1991 
108.3° Dauter a/., 1992 
Sheldrickefa/., 1993 
Desulfovibrio 1.4 14.0 53 117 P2i Pierrot etal., 1976 
gigas 19.7, 41.7, 24.4 A Frey etal., 1987 
109.4° 
Desulfovibrio 1.5 9.3 45 121 PI Sieker etal., 1986 
desulfuricans 24.9, 17.8, 19.7 A 
101,83.3, 104.5° 
Stenkamp etal., 1990 
Pyrococcus 1.8 17.8 53 61 P2i2i2i Day etal., 1992 
furiousus ox 34.6, 35.5, 44.4 A 
Pyrococcus 1.8 19.3 53 37 P2i2i2, Day etal., 1992 
furiousus red 34.6, 35.5,.44.4 A 
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su lphate binding site 
Figure 1. Overall fold of rubredoxin , showing the Fe (Cys)4 cluster 
and the sulphate binding site. Depicted using QUANTA. 
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The redox potential of rubredoxin varies from -60 to +6 mV between species (Moura et 
a!., 1979). Structural studies have attempted to correlate changes in sequence and 
activity and explain how structure is conserved with changes in sequence. Rubredoxin 
forms crystals which are often of exceptional quality. This has resulted in the protein 
becoming the subject of much work aiming towards the development of methods in 
protein crystallography, including pioneering work on refinement of protein structures by 
least-squares minimisation (Watenpaugh et a/., 1973) and the application of small 
molecule structure solution methods to protein data (Sheldrick etal., 1993). 
Aims 
Rubredoxin from Desulfovibrio vulgaris is a member of a set of proteins, for all of which 
X-ray diffraction data had been collected at EMBL Hamburg, which were being used as 
test structures during the ongoing development of refinement and evaluation techniques 
in protein crystallography. The refinement of the structure relied heavily on the automated 
methods under development. A comparison was made between the anisotropic model at 
0.92 A and the completely independent, 1.0 A resolution, isotropic model published by 
Dauter et a/., (1992). This allowed the assessment of advantages to be gained by the 
adoption of new refinement protocols and the identification of areas for future 
development of techniques. 
Experimental 
The refinement of Rubredoxin was undertaken as part of this PhD. The crystallisation, 
data collection and refinement to give the starting model in the present study were 
performed previously. 
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Crystailisation and Data Collection 
Dark red prismatic crystals were grown as described by Adman et a/., (1977) from a 0.5 -
1.0% protein solution, buffered by 0.1 M sodium citrate at pH 4, with 2 M ammonium 
sulphate precipitant. Crystal properties are listed in Table 2. Data were collected as 
outlined by Sheldrick et a/., (1993) on the X31 beamline, with a wavelength of 0.70 A. 
The detector was a MAR research imaging plate scanner. Data processing statistics are 
summarised in Table 2. 
Table 2. Crystal properties and data processing statistics 
Crystal symmetry; h/lonoclinic, P2i 
Molecules per asymmetric unit 1 
Cell dimensions (A) a= 19.99, b=41.51, 0=24.40 
|J = 107.60° 
V,n(A'da-V 1.74 
Resolution (A) 20 - 0.92 
Rmerqe (%) 3.7 
Nuniqve (Frcidels separate) 48 291 
Nunique (Frcidcls merged) 26 108 
Completeness (%) 98.9 
Initial Model and Data 
The starting model for this refinement was derived from an unpublished, intermediate 
model obtained by George Sheidrick. This model had been refined anisotropically using 
SHELXL-93 (Sheldrick, 1993) to an R factor of 7.44 %. The model comprised 52 
residues, one Fe atom, a sulphate ion and 117 water sites. The sulphate ion, with an 
associated water, had 68% occupancy, while another water, with 32 % occupancy, also 
lies at the sulphur atom position. The remaining water sites numbered 63 fully occupied, 
13 pairs with 50:50 occupancy and 26 single sites with half occupancy, making a total of 
90 water molecules in the asymmetric unit. 6 residues: Lys 2, Glu 12, Pro 15, Asp 2 1 , Lys 
25 and Ser 29 had two alternate side chain conformations, with all hydrogen atoms 
included. 
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To obtain the starting model for the new refinement, the sulphate ion and all water 
molecules were removed, as well as the minor conformations of disordered residues, the 
major conformation occupancy being reset to 100 %. Co-ordinates of the remaining 
atoms were randomised by rms 0.3 A to reduce model bias from reflections now to be 
used for the evaluation of Rfree- The data consisted of a total of 48291 unique reflections, 
26108 with Freidel pairs merged, in the resolution range 20-0.92 A. Freidel pairs were 
held separately in the reflection file, but merged before refinement and map calculation. 
5% of the reflections, 1327, were removed from the working dataset and used for the 
calculation of Rfree, the refinement being independent of these data. The commencing 
stages of the refinement were against Fs, while in following stages intensities were used. 
Refinement strategy 
Restrained least-squares refinement of atomic positions and thermal parameters was 
performed. The initial stages consisted of isotropic refinement, against Fs, using 
PROLSQ. When the isotropic model had converged satisfactorily, anisotropic refinement 
against intensities using SHELXL-93 followed. Stereochemical restraints using ideal 
values taken from the Engh & Huber (1991) set were applied during both the PROLSQ 
and SHELXL-93 stages of the refinement, as explained in the introduction to this chapter. 
Hydrogen atom positions were not refined, but calculated using a riding model. The 
Automated Refinement Procedure (ARP, Lamzin & Wilson, 1993) was used continuously 
during the refinement for construction and improvement of the solvent network. 
The scheme of refinement is summarised in Table 3. Initially, ten cycles of PROLSQ were 
run on the randomised model, partly as a further precaution to remove any remaining 
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memory of the Rfree data. The density for the sulphate ion was then clearly apparent in the 
(3Fo-2Fc) and difference maps, so it was built into the model to be refined without 
restraints. Following five more cycles of PROLSQ, the construction of the solvent network 
commenced. A cycle of ARP was run after each PROLSQ cycle, with ARP set to modify 
solvent only, adding and removing up to ten atoms per cycle, within a range of 2.2-3.3 A 
from existing atoms. Solvent atoms which came closer than 0.5 A to one another were 
merged. The refinement converged with R 14.9 %, Rfree 18.3 % and 99 water sites. 
Table 3. Scheme of refinement 
Cycle R (%) AR Rfree (%) A R/ree water 
sites 
0 
•^rms, F 
m 
0 
r rms, AF 
randomisation of co-ordinates 
from previous refinement 
33.7 - 34.6 - 0 
1-10 isotropic refinement, PROLSQ 21.1 -12.6 21.8 -12.8 0 0.823 0.163 
11-15 introduction of sulphate ion 20.3 -0.8 21.7 -0.1 0 0.818 0.157 
16-30 PROLSQ & construction of 
solvent network with ARP 
14.9 -5.4 18.3 -3.4 99 0.745 0.097 
isotropic refinement, SHELXL-
93 
15.9 +1.0 99 
31-40 anisotropic refinement, 
SHELXL-93, ARP 
8.5 -7.4 11.5 -6.8 91 0.695 0.076 
41 -50 6 double conformation side 
chains and 2 conformations for 
45-48, with occupancy 70:30 % 
8.1 -0.4 10.7 -0.8 83 0.682 0.072 
51-60 sulphate/glycol modelled in the 
sulphate site, sulphate and 
major split chain conformation 
refined together 
7.9 -0.2 11.0 +0.3 85.7* 0.683 0.071 
61-70 refinement against 100 % data 7.9 0 (8.4)** (-2.6)" 85.7* 0.699 0.071 
* Prms F = rms of (3Fo-2Fc) map density * the 0.7 is a water bound to the sulphate 
## p ^ = rms of (Fo - Fc) map density ** these data are no longer independent 
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Before anisotropic refinement, five cycles of SHELXL-93 were run on the isotropic model. 
The R factor rose to 15.9 %, due to the application of a different set of restraints, as 
explained in the introduction to this chapter. This rise in R factor is a commonly observed 
phenomenon. Anisotropic refinement proceeded with ten rounds, each consisting of five 
cycles of SHELX-93 refinement followed by a cycle of ARP. The R factor dropped to 
8.5% and Rfree to 11.5%. Following these ten rounds of anisotropic refinement, the fit of 
the model into the (3Fo-2Fc) and difference maps was examined using FRODO (Jones, 
1978). Difference density showed the positions for second conformations of 6 residues: 
Met 1, Glu 12 , Pro 15, Asp 21, Lys 25 and Ser 29. Two alternative conformations for 
each side chain were modelled. H atoms bound to partially occupied C, N and O atoms 
were not included in the model. Geometric restraints on the residues with multiple 
conformations were tightened. The occupancies of the alternate conformations were 
refined, with the sum of occupancies for each residue set to 100 %. Following further 
refinement, a third position for Ser 29 OG became apparent. Three conformations were 
then modelled, with the occupancies set to 75%, 2 0 % and 5%. 
At this stage, most of the difference density was clustered in one region of the map, the 
cavity containing the sulphate ion, and the surrounding section of chain, residues 45-48. 
Inspection of the difference density around these residues clearly indicated the position 
of a second main chain conformation. The largest difference peak, X I , was situated 1.58 
A from 01 of the sulphate. The sulphate itself, which had been refined from the 
beginning with no restraints, was evidently imperfectly modelled. Although the geometry 
was tetrahedral, the bond lengths were abnormally short for sulphate and the density for 
0 2 and 0 4 was very weak, see Figure 2a. The search for an appropriate way to treat this 
problem comprised several steps. 
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First, alternative main chain and side chain conformations for residues Pro 45, Lys 46, 
Ser 47 and Glu 48 were modelled. Restraints were set allowing independent movement 
of the two alternate chain conformations, with distance restraints between the two 
conformations completely removed, since stronger restraints were found to pull the minor 
conformation back on to the major. The occupancies of the two parts were fixed at 70% 
and 30%. These changes were introduced to the model following the first ten rounds of 
anisotropic refinement, after cycle 40. Ten rounds of refinement were run on the model 
with the alternate chain conformation, then a further ten, with the occupancies of the 
alternate chain conformations and the sulphate now refined, but independently of each 
other. The major chain occupancy refined to 73% and the sulphate to 66%. Ten further 
rounds of refinement followed, in which the occupancy of an oxygen at X I was also 
refined. The occupancies of chain, sulphate and X I were then 75%, 62% and 25%. 
From cycle 50, the occupancies were refined separately for the chain, X I , the sulphate S, 
sulphate 0 1 and 0 3 , sulphate 0 2 and 0 4 and two nearby water sites OWO 1 and OWO 
2. The resulting occupancies are shown in Figure 2b. Next, four atoms, modelled as 
oxygen, were placed in the sulphate site, in the absence of sulphate. OWO 2 is clearly 
bound to the sulphate 0 1 , so it was assigned the same occupancy as the sulphate and 
renamed 0 5 . The relative occupancies of the four-atom fragment and sulphate were then 
refined. The result of this step is shown in Figure 2c. 
The geometry of the four-atom fragment was consistent with that of glycol, although the 
crystal had not been exposed to glycol at any stage. It was suggested that the four atoms 
visible were part of a citrate ion, the remainder of which was completely disordered. The 
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four atoms were modelled as glycol, with appropriate restraints applied. The sulphate 
bond lengths were restrained to be equal and the geometry, tetrahedral. The 
occupancies of the split chain and sulphate/glycol were refined independently to 70% / 
30%. Finally, the occupancies of the split chain and sulphate/glycol were refined as one 
variable, from cycle 50. After ten rounds of refinement, the sulphate and major chain 
conformation occupancy was 67(1)%. The final sulphate and glycol conformations are 
shown in Figure 2d. 
Figure 2, stages in modelling of the disordered sulphate ion 
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The ambiguity has not been completely removed, but much more information has 
become apparent. In the final model, the mean separation of pairs of main-chain atoms in 
the split section were 0.46 A, 0.59 A, 0.53 A and 0.31 A fon residues 45, 46, 47, and 48 
respectively. The sulphate ion is present for 67 % of the time. When the sulphate is 
absent, the protein chain around the site shifts by around 0.5 A to adopt an alternative 
conformation, thus complexing more effectively with the species now occupying the 
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cavity, with Ser 47 OG, N46 and N47 positioned to interact and also Lys 46 NZ, although 
the second conformation of the lysine side chain is not certain. 
•I •' 
The largest difference peaks which remained, following the alterations described above, 
were all in the solvent region. This reveals the inadequacy in the solvent model, 
consisting of 85 fully occupied water sites. If the relative volumes of the protein and the 
unit cell it occupies are considered, it can be estimated that there is sufficient space for 
approximately 94 waters. Observation of the density in the solvent region reveals 'dumb 
beir and 'chain-of-beads' type features, with distances between neighbouring peaks in 
the 1.0 - 2.4 A range. The solvent structure evidently consists of alternate networks of 
partially occupied sites. Therefore, although the number of waters modelled is 
appropriate, a model with more sites, some with partial occupancies, would be better. 
Preliminary attempts were made to assign half occupancies to pairs of sites, with 
difference peaks greater than 4a, separated by less than H-bonding distance, but no 
change in R or Rfree was observed and the atoms tended to drift out of the density during 
subsequent refinement. More stringent modelling criteria are evidently required. 
The working and Rfree datasets were combined and ten rounds of refinement were run 
against all the reflections. This precaution was taken because random absences in a 
dataset cause ripples in density maps and such spurious density may result in incorrect 
modelling of the structure. In this case, refinement with the extra 5% of data made no 
significant difference. Errors in the final model were estimated by running a cycle of 
overlapping blocked refinement, as explained in the introduction. As for protein G, these 
errors had a strong correlation with the atomic B factors. Mean co-ordinate errors 
estimated were 0.0152 A, 0.0121 A and 0.0129 A for main-chain atoms, CA, N and O. 
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Comparison with an isotropic modei of the rubredoxin structure 
The 1.0 A resolution structure of rubredoxin from Desulfovibrio vulgaris (Dauter et al, 
1992), PDB code 8RXN, obtained by an independent refinement of a different data set, 
provides an instructive comparison to the new model. The resolution range of the present 
dataset is greater, with more high and low resolution reflections included. However, the 
principle difference is that the present structure is modelled with anisotropic thermal 
parameters for all non-hydrogen atoms, while the 8RXN structure is an isotropic model. 
Differences between the models are summarised in Table 4. 
Table 4. Comparison between 1.0 A isotropic (8RXN) and 0.92 A anisotropic models 
8RXN New Refinement 
Cell dimensions (A) 
Nunique 
Completeness (%) 
Rmerqe (%) 
Resolution (A) 
R(%) 
a= 19.97, b=41.45, 0=24.41 
p = 108.3° 
18 532 
90.5 
5.8 
12.8-1.0 
14.7 
a= 19.99, b=41.51,0=24.20 
p = 107.6° 
26 108 
98.9 
3.7 
20.0 - 0.92 
7.9 
total water sites 102 85.7 
B protein, mean (A )^ 
B residue, mean (A ) 
B SO4, mean (A )^ 
B Fe (A )^ 
B H2O, mean (A )^ 
10.0 
10.7 
16.3 
5.1 
38.8 
9.1 
9.6 
14.5 
4.9 
32.1 
rmsd, CA (A) 
rmsd, protein (A) 
mean H2O sep. (A) 
0.058 
0.149 
0.523 
Unit Ceil 
The 8RXN model was refined using a cell derived from the indexing of synchrotron data. 
These measurements possess an inherent uncertainty resulting from the uncertainty in 
the measurement of the X-ray wavelength. For data measured at Hamburg in the era of 
the collection of the rubredoxin and protein G data sets which this chapter is concerned 
with (pre mid-1995) there may be an error of up to 0.5% in cell dimensions. Since this 
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time, more stringent procedures have been introduced, entailing regular calibration of the 
X-ray wavelength and crystal to detector distance by measurement of silicon powder 
diffraction rings. This has reduced the inherent error in cell dimensions from synchrotron 
measurements to around 0.1 %, which is sufficiently small to have no significant effect on 
the accuracy of bond distances in a structure. The present structure was refined using 
the cell obtained from diffractometer measurements (Adman et al., 1977). This is not an 
infallible practice, since there are examples of significant variation in crystal cell 
dimensions, even between crystals grown in a single drop. 
A systematic deviation in the 8RXN model bond lengths was noted. Overestimation of cell 
dimensions was one suggested explanation, it could also be related to the use of a 
different (pre Engh & Huber) dictionary for the application for geometric restraints. Exactly 
the same phenomenon was observed in the comparison of isotropic and anisotropic 
refinements of protein G (Chapter 4a). 
Protein 
A comparison of the overall geometry of new and 8RXN models. Table 5, shows that 
average bond distances in the 8RXN model are longer, as mentioned above. The width 
of the distributions of bond lengths was also greater for 8RXN, indicating that different 
restraints were applied during the refinement. The distribution of the peptide bond torsion 
angle, is much more sharply peaked for 8RXN and centred at 180°, while the new 
model has a much wider range of f2 values and a slightly lower mean value. Figure 3. 
The deviation from planarity for peptide bonds is a phenomenon observed in high 
resolution protein structures, in the absence of over-strong planarity restraints. 
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Table 5. A comparison of overall geometry of new and 8RXN models 
New model target (A) 8RXN 
mean interatomic a interatomic mean interatomic a interatomic 
distance (A) distance (A) distance (A) distance (A) 
N-CA 1.455 0.014 1.458 1.464 0.027 
CA-C 1.516 0.016 1.525 1.520 0.035 
C-0 1.228 0.012 1.231 1.231 0.034 
C-N 1.324 0.013 1.329 1.325 0.030 
N-C 2.458 0.034 2.462 2.458 0.039 
CA-0 2.387 0.018 2.401 2.391 0.034 
0-N 2.233 0.016 2.250 2.244 0.021 
C-CA 2.429 0.015 2.435 2.429 0.030 
CA-N 2.427 0.022 2.425 2.421 0.027 
mean Q (°) aim n target (°) mean Q (°) a[Q] (°) 
179.7 5.1 180.0 179.9 3.1 
Figure 3 
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The rmsd between the models is 0.149 A for all protein atoms and 0 . 0 5 8 A for CA atoms. 
The rmsd was calculated with the nomenclature of atoms adjusted to be identical for the 
two structures, vyith changes to Tyr 4, Asp 2 1 , Phe 3 0 and Asp 3 1 . The largest rmsd's are 
seen for residues in regions of diffuse density. Met 1, Glu 1 2 , Glu 17 , Asp 2 1 , Asp 3 1 , 
Glu 5 0 and Ala 5 2 all have rmsd greater than 0 .2 A, Lys 3 and Pro 15 , greater than 0.1 A, 
Figure 4. The B factors of protein atoms in the new model are, on average, 1 A^ smaller, 
while much larger differences exist for residues in regions of diffuse density. Figure 4a. 
The residues with the largest reductions in B factor between old and new models, in 
descending order, are Lys 2 , Ala 5 2 , Glu 1 7 , Glu 1 2 , Asp 3 1 , Met 1, Asp 21 and Pro 15 . 
The N-terminus in the new model has an additional formate group. There is density in the 
(3Fo-2Fc) map for this group, however there is some residual negative density in the (Fo-
Fc) map. During the 8 R X N refinement, broad, low atomic peaks were seen, indicating 
disorder, but this was not modelled. Two conformations for the side chain have been 
modelled in this refinement, the major conformation being very similar to that in the old 
model. The B factors are around 2 A smaller. Lys 2 and Lys 3 were also noted to be 
disordered in the previous study and CD, CE and NZ of Lys 2 were assigned zero 
occupancies. All atoms were included in the new model, however the density for the Lys 
2 side chain remains extremely weak and there is negative difference density at the Lys 3 
side chain position. 
The side chains of Glu 1 2 , Pro 15 and Asp 21 were all modelled with two alternate 
conformations in both cases. In the 1 A structure, the occupancies were set to 50 :50 , 
while for the new model, the major conformation occupancy refined to 6 0 ( 2 ) % , 6 7 ( 3 ) % 
1 6 0 
and 58(2)%. The conformations of residues 15 and 21 are very similar, witli tlie 
refinement of occupancy and anisotropic modelling of atoms resulting in reduction in B 
factors. Neither of the Glu 12 side chain conformations is conserved between the models. 
The new conformations appear to fit into the density better and the atoms have B factors 
on average 3 lower. 
During the 8RXN refinement, peaks in the difference synthesis suggested the existence 
of more than one conformation for several other residues, but the density was not 
sufficiently well defined to allow their modelling. Some of this difference density could 
result from the uncompensated-for anisotropy of the atoms and possibly some from the 
insufficient treatment of diffuse solvent, see below. The new refinement includes two 
conformations for Lys 25 and three for Ser 29 which were not previously modelled, 
although the second conformation of Ser 29 was present as a water site. 
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Figure 4. Comparison of tiie final model with 8RXN. 
(a) The differences between the 2 models are plotted against residue number; 
[B(residue,o!d)-B(residue,new)] (continuous line), 100[rmsd CA atoms] (dashes) 
30 40 50 
residue number 
(b) The rms distances between equivalent atoms in the 2 models are plotted against residue 
number; 100[rmsd(CA)] (continuous line), 100[rmsd(all atoms)] (dashes) 
40 50 
residue number 
Table 6. Comparison of [Fe(Cys)4] cluster geometry 
bond lengths (A) 8RXN new model bond angles (°) 8RXN new model 
Fe-Se 2.30 2.295 (3) Se-Fe-Sg 115 114.5 (1) 
Fe-Sgg 2.30 2.295 (3) S3g-Fe-S42 112 111.7 (1) 
Fe-Sg 2.27 2.258 (2) S6-Fe-S39 111 110.8 (1) 
Fe-S42 2.27 2.254 (2) S9-Fe-S42 109 110.1 (1) 
S6-Fe-S42 106 105.5 (1) 
Sg-Fe-Sag 105 104.4 (1) 
torsion angles (°) 
Fe-Se-CB-CA 180 -173.1 (3) Fe-Se-CB 101 102.2(2) 
Fe-S39-CB-CA 180 -175.3(4) Fe-Sag-CB 99 100.3(2) 
Fe-Sg-CB-CA 270 -88.9 (5) Fe-Sg-CB 110 109.8(2) 
Fe-S42-CB-CA 270 -94.7 (5) Fe-S42-CB 110 108.7(2) 
bond lengths (A) 8RXN new model 8RXN new model 
Fe-Ne 5.13 5.15(1) Se-Na 3.54 3.56 (1) 
Fe-Ng 3.77 3.80 (1) Se-Ng 3.55 3.57 (1) 
Fe-Nii 4.69 4.77 (1) Sg-Nii 3.42 3.47(1) 
Fe-N4i 5.10 5.10(1) S3g-N4i 3.57 3.57 (1) 
Fe-N42 3.87 3.89 (1) S3g-N42 3.62 3.64 (1) 
Fe-N44 4.84 4.83 (1) S42-N44 3.50 3.49 (1) 
bond angles (°) 
Se-Ns-CA 98.8 98.6 (3) CB-Se-Ne 106.1 106.5 (2) 
Se-Ng-CA 122.0 121.9(3) CB-Se-Ng 101.7 100.5 (2) 
Sg-Nii-CA 111.1 109.5(4) CB-S9-N11 113.8 114.8 (2) 
S3g-N4i-CA 104.7 103.8(4) CB-S3g-N4i 106.4 106.3 (2) 
S3g-N42-CA 120.7 118.2(4) CB-S39-N42 95.4 95.0 (2) 
S42-N44-CA 105.6 105.5(4) CB-S42-N44 114.2 115.5 (3) 
Fe (C^s)4 cluster conformation 
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\ / 
S42 CA 
Fe 
CB 
CA 
CB 
local 2-fold axis ^ A 
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Figure 6. The sulphate binding site. The major chain conformation 
and sulphate are shown in red, the minor chain conformation, in 
green. The (3Fo - 2Fc) electron density is plotted. Using QUANTA. 
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Glu 17 and Asp 31 have diffuse side chain density in old and new structures, however 
anisotropic modelling has improved the fit to the density for both residues. Residues Asp 
32 and 33, as well as the C-terminal Ala 52, are also shifted from their positions in the old 
model, resulting in a better fit to the density. 
The [Fe(Cys)4 ] cluster. Figure 5, adopts close to perfect Ca symmetry, with pairs of 
sulphur atoms: Se & 839, Sg & S42 related by the local 2-fold axis. The symmetry extends 
to include two sets of three nitrogen atoms; N8, N9, N i l and N41, N42 & N44, which 
surround the cluster, forming N-H--S bonds. A comparison of the two models. Table 6, 
shows no significant differences and the rmsd of FeS4 between the two structures is 0.03 
A. 
The major chain conformation for residues 45-48 in the new model was similar to that of 
the 1 A model. The B factors per residue are also similar. However, the old and new 
position and geometry of the sulphate ion. Figure 6, are different. Table 7. 
Table 7. Comparison of SO4 ^ ' geometry 
bond lengths (A) 8RXN new model bond angles (°) 8RXN new model 
S-O1 (S-O3)* 1.55 1.44(2) O1-S-O3 113 111 (1) 
S-O3 (S-O1) * 1.46 1.40(2) O2-S-O4 111 107 (2) 
S-O2 1.51 1.43(2) O1-S-O2 (O3-S-O2)* 109 107(1) 
S-O4 1.54 1.44(2) O 3 - S - O 4 {Oi-S-04)* 109 111 (1) 
B factors (A )^ O1-S-O4 (O3-S-O4)* 104 105(1) 
S 12 11 O2-S-O3 (O2-S-O1)* 108 114(1) 
O1 (O3 ) * 13 11 
O3 (O1) * 11 11 
O2 22 19 * O 3 (8RXN) = O1 (new) 
O 4 23 20 
The rms deviations between old and new models are 0.087 A, 0.098 A, 0.137 A, 0.173 A, 
0.284 A, for 8, 0 1 , 0 3 , 0 2 & 0 4 respectively. In the old model, the 8 -0 bond lengths 
averaged 1.52 A, in the new, only 1.43 A, a lower than expected value for sulphate. In 
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the new model, the S-01 bond was the longest, prior to application of restraints and 
modelling of a partially occupied glycol molecule, while in the old model it was the bond 
equivalent to S-03. A puzzling difference in B factors between ( 0 1 , 0 3 , S) and (02, 04) 
exists in both models and the peak seen in the difference map at 1.6 A from 0 1 , prior to 
the modelling of glycol in the new refinement. Figure 2a, is also observed in the other 
model. On balance, the evidence suggests that different treatment of the sulphate during 
the two refinements, rather than differences in the environment of the molecule in the 
crystal, has given rise to the differences in the models. 
The structure validation program WHATCHECK (Vriend & Sander, 1993) searches for 
potential hydrogen bonding atoms buried inside the protein, which are not participating in 
hydrogen bonds. Virtually all protein atoms in the structure were classed as buried, due to 
the close packing of the crystal. The list of unsatisfied hydrogen bond donors and 
acceptors was the same for both models, with the exception of Lys 2 NZ, which is not 
present in 8RXN. The density around the Lys 2 side chain remains too diffuse for the 
modelling to be completed. The other atoms listed are Lys 46 N and Lys 25 NZ, which are 
both disordered and pointing, from opposite directions, into the sulphate binding site. 
Solvent 
The 8RXN model contains 102 water sites, compared to 85 in the new model, all fully 
occupied. The mean separation of a site in the new model from one in the old is 0.52 A 
and over 90 % of new sites are within 1.0 A of an old site. Figure 7a. Solvent B factors 
are, on average, 4 A^ lower in the new model. Dauter et al. (1992) noted a surprising 
deficiency of water sites with low B factors, only 12 with B < 20 A^. The new model 
contains 13 such sites. The distribution of solvent B factors. Figure 7b, is more sharply 
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peaked for the new model, with 32 % of sites with mid-range B factors, 30-40 A ,^ 
compared to 23.5 %. Overall, the number of sites with medium and low B factors is 
similar for both models, while the number with high values, > 40 A^, is larger in the old 
model, which has 45 such sites compared to 29. 
By considering the relative molecular and asymmetric unit volumes, it can be estimated 
that there is space for approximately 94 water molecules in the asymmetric unit. There 
are actually more than 94 water sites, since many are partially occupied. The 8RXN 
model contains more of these disordered water sites, with full occupancies assigned. An 
attempt was made during that refinement to model solvent with partial occupancies, 
assigned on the basis of their B factors, but this achieved no reduction in R factor, so it 
was abandoned. In this refinement, the disordered solvent network was not modelled and 
this resulted in most of the remaining difference density peaks being located in the 
solvent region, as described above. 
During this refinement, density maps were calculated using data which had been scaled 
to account for the contribution of diffuse solvent to the low resolution scattering, below 
about 4 A. This effect is not as large for rubredoxin as for most protein structures, since 
the tight crystal packing leaves little room for a diffuse solvent region. This is reflected by 
the Vm for the structure, 1.74 A^Da"^ (Matthews,1968). For protein crystals Vm values lie in 
the range 1.65 to 3.35 A^Da'\ most frequently between 2.1 and 2.4 A^Da V Thus, 
rubredoxin lies at the lower limit of the distribution. The effect of application of a diffuse 
solvent correction to data prior to map construction is to reduce the noise in the density at 
the protein-solvent interface. This is one factor contributing to the reduction in number of 
solvent sites found during the new refinement compared to the old. 
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Figure 7. Comparison of the solvent structure of the final model with 8RXN 
(a) distributions of solvent B factors for the new model (white) and 8RXN (grey). 
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(b) The distance of each solvent site in the new model from the closest solvent site in 8RXN was 
evaluated. The distribution of these separations is plotted, with frequencies given as percentages 
of the total solvent in the new model. 
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WHATCHECK tabulates pairs of atoms separated by an unusually short distance. 38 of 
these 'bumps' were listed for 8RXN, 25 between water sites, 13 between solvent and 
protein atoms. The new model had 6 water/water bumps, 6 water/protein and 1 
protein/protein. The large number of bumps for 8RXN results from the large number of 
water sites, with 100% occupancy assigned, added to weak density. The bumps in the 
new model were inspected using FRODO. The closely separated water sites included a 
chain of three and three pairs of sites which would be better modelled with partial 
occupancies. The solvent sites approaching protein too closely were in regions of diffuse 
density around the Lys 3, Glu 12 and Glu 17 side chains. The pair of protein atoms listed 
is Pro 26 C and Lys 25 O, separated by 2.77 A. This appears to be a genuinely short 
distance, brought about by a tight bend in the chain centred around Pro 26. 
Anisotropic refinement made improvements in the modelling possible. During the 8RXN 
refinement, residual peaks caused by anisotropic thermal motion were observed in the 
difference map. This was most clearly illustrated by the doughnut-shaped features lying 
round the atoms of the [Fe(Cys)4] cluster. The modelling of this anisotropy in the present 
refinement greatly reduced the noise in the difference map, increasing the visibility of 
features in weak density regions. The effect of this was seen in the improved positioning 
of several weakly scattering residues such as Asp 3 1 , Asp 32 and Asp 33 and, most 
notably, by the appearance of difference peaks on the main chain for residues 45-48, 
which indicated the position of a minor chain conformation. The modelling of atoms 
anisotropically, coupled with the ability to refine occupancy, allowed multiple 
conformations to be modelled more effectively, thus more multiple conformations could 
be built into the model, for example, two conformations for Met 1, and they refined to give 
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a better fit to the density, as can be seen by a comparison of old and new models for Asp 
2 1 . 
Other questions which need to be addressed include whether the increased resolution 
range of the data in the new refinement has lead to any obvious improvement. The 
contribution of the extra data is not obvious, since the 13 - 1 A range was sufficient for a 
high resolution refinement. The effect of introducing anisotropy to the model is much 
larger and probably masks any changes caused by the presence of extra data. However, 
if the 1 A model were to be modelled anisotropically, the effect of the additional data 
would probably become more noticeable and the R factor would be higher for the 1 A 
than the 0.92 A resolution structure. 
Another question is whether it is possible to distinguish between divergence in the 
models arising from the distinct refinement protocols and differences actually present in 
the crystal structures. This was mentioned in relation to the modelling of the sulphate site. 
Genuine differences are small and therefore masked by the much larger effects resulting 
from the specific treatment of the models. To be certain of this point, it would be 
necessary to refine the two structures with an identical approach, but in isolation from one 
another, so the features observed for one model do not give clues about how to model 
the other. 
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Chapter 5: 
Aspects of the refinement of atomic resolution protein structures 
A: Sharpening as a tool in protein crystal structure refinement 
Summary 
Due to the fall-off of scattering intensity with increasing e, high resolution data are 
generally weak. Structure factors can be normalised to remove their resolution 
dependence, so the high resolution terms make a more significant contribution to electron 
density maps, resulting in sharper atomic peaks. Since the high resolution intensities are 
inherently weak measurements, they have relatively large associated errors, thus their 
upweighting leads to a concurrent magnification of the associated errors and the 
appearance of spurious peaks in the density map. An optimal degree of sharpening of 
the data leads to maps in which atomic peaks are sharp and well defined, while the noise 
contribution is minimal. The desirable degree of sharpening varies with characteristics of 
the structure including the resolution of the data, overall B factor and associated errors. 
This study involved an estimation of the most informative level of sharpening for maps of 
varying resolution and quality through an evaluation of the properties of the electron 
density distributions. Refinement runs were performed to test these deductions. It was 
concluded that a degree of sharpening applied to maps during refinement was indeed 
beneficial at all resolutions at which atoms can be distinguished in the density. The 
optimal amount of sharpening was found to vary between 100% for the preliminary 
stages of a refinement at atomic resolution to around 50% in'the later stages. 
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Introduction 
Structure Factors, F 's & E ' s 
A structure factor is the result of the diffraction, in a specific direction which satisfies the 
Bragg conditions, from all parts of the electron density within the unit cell of a crystal 
structure. For the calculation of model structure factors this is approximated by the sum of 
the scattering from all the atoms within the unit cell, as expressed in equation (1). The 
structure factor possesses phase and amplitude. For calculated structure factors, the 
phase relates to the atomic position relative to the cell origin and the amplitude to the 
nature of the electron distribution around the atom. 
F(h)=2:^,Jjexp[27i/(hXj)] (1) 
The atomic scattering factor is resolution dependent. Due to the finite size of the electron 
charge cloud around an atom, the path difference between waves diffracted from 
different parts increases with the diffraction angle, resulting in destructive interference. 
Figure 1. 
Figure 1. 
Schematic illustration explaining the cause of fall-off in diffraction intensity with 
increasing resolution for spherical atoms of a finite size. 
SPHERICAL 
ATOM 
For a small diffraction angle, Oi, For a large diffraction angle, 0,, 
there is a small path difference, there is a large path difference, 
di between diffracted waves d2 between diffracted waves 
The scattering factor of an atom in a real crystal (2) declines even more rapidly with 
increasing scattering angle, due to the spreading of the atomic electron density by static 
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and dynamic effects. The scattering factor for a point atom (3) is without resolution 
dependent terms. 
fj = fojexp[-Bs2] (2) 
where s = smQ/X and B = 8K^U^, U^ = mean squared amplitude of atomic vibration, 
at the limit of (2), when 6 = 0, fj = fo,j(e =0) = Zj, Z = atomic number 
f point atom = Zj (3) 
For a cell containing equal atoms, (1) becomes F = f ZX, with X = exp[ 27t/(hx)] and the 
relation between the structure factors for a real and a point atom can be obtained by 
combining (2) and (3) to give (4). For structures containing j different atoms, the 
approximation (5) can then be made. The normalised structure factor, E(h) obtained from 
F(h), (6) (Karle & Hauptmann, 1956), has all the resolution dependent terms cancelled 
out, so can be thought of as the scattering factor for a point atom. 
Fpoin./Freai = Z/ foexp[-Bs ' ] (4) 
Fpoint = Freal ( IZ i ) / (exp [ -Bs ' ] (E fo , j ) ) (5) 
E{h) = f{h)/{<F'>y" (6) 
A normalisation factor may be determined, assuming randomly distributed atoms, from 
the gradient of the Wilson plot (Wilson, 1942). The ideal intensity of a reflection is given 
by (7), where ff and fj are atomic scattering factors. If reflections are divided into small 
ranges of resolution and the mean intensity is calculated, the exponential terms will tend 
to zero, leaving a simple relation (8). The ideal intensity differs from the real intensity by 
two factors, a scaling factor independent of resolution, k, and a thermal factor. Thus, the 
ratio of ideal to real intensity is a function of these two factors. With the resolution 
dependent temperature factor expressed as exp [-2Bs^] this leads to (9). The plot 
ln[<lhki>/2ifi^ ] versus s^ has gradient -2B and intercept In k. 
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Ihw = L . fi fj exp[ 271/ ( h(Xi - Xj) + k(yi - yj) + l(Zi - Zj)) ] (7) 
rearranged Ihw = X fi^ + £ . ^  .Efi fj exp[ 27t/ ( h(Xi - Xj) + k(yi - yj) + l(Zi - Zj)) ] 
<lhki>=Xfi^ (8) 
ln[<lhki>/Z,f i^] = l n k - 2 B s ^ (9) 
This derivation a s s u m e s that the structure is composed of a collection of uniformly 
distributed atoms whose thermal motion may be described by an overall B factor. The first 
assumption is very approximate for a protein crystal (Blessing & Langs, 1988, 1996). At 
low resolution, the structure is divided into higher density protein regions, interspersed 
with lower density solvent regions, with solvent occupying between 2 5 % and 65% of the 
volume (Matthews, 1968). At medium resolution the regular secondary structural features, 
typically adopted by around 75% of the molecule, are observed. Bonding and non-
bonding distances fall into a narrow range. The result is that the Wilson plot will possess 
a ser ies of characteristic fluctuations. Realistic estimates of B and k may be obtained 
from the plot for data excluding the lower resolution range at which these fluctuations are 
particularly significant. 
The description of thermal motion by an overall B factor is improved if anisotropy is 
accounted for using a matrix, Uij. Use of the mean B factor for scaling would be 
appropriate if the B factor distribution for a structure were Gauss ian , the mean and mode 
values for a Gauss ian distribution both being equivalent. In fact the distribution is skewed, 
with a sharp cutoff for low values and a long tail for high values. A s a result, the mean B 
value is larger than the peak value and it may be better to use the latter (Blessing & 
Langs, 1996). 
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The K-curve method of estimating E values (Karle & Hauptmann, 1953; Blessing & 
Langs, 1988) entails the division of the data into resolution bins. A scale factor, K is 
calculated for each bin (10). The values of K are plotted against s and smoothing is 
applied. The function K = / ( s ) so obtained gives the scaling factors. This method 
accounts for the deviation of the structure from a uniform distribution of atoms. 
K(s) = < 5 : f j ^ ( s ) / I F l S s (10) 
Ehki = KFhk, (11) 
Electron Density Maps 
The electron density map in real space and the diffraction data in reciprocal space are 
related by a Fourier transform (12). To generate an electron density map, both magnitude 
and phase of the structure factors are required. Phases are calculated by the inverse 
Fourier transform from the atomic model. Observed and/or calculated amplitudes are 
input. During a crystal structure refinement, fitting of calculated to observed data in 
reciprocal space is typically alternated with fitting of the model structure into electron 
density maps in real space, by either automated analysis of the density or manual 
inspection using computer graphics. The quality of these maps is therefore crucial to the 
success of the refinement. 
p(x,y,z) = ( 1 / V) St IFhkil exp[-27r/(hx + ky + Iz - a'^w)] (12) 
where a' = aJ2n, the phase angle in cycles 
The contribution of high resolution data to the Fo synthesis is decreased by the reduction 
in magnitude of structure factors as the diffraction angle increases. E values are not 
resolution dependent, so E maps are more strongly influenced by the high resolution 
terms. Comparison of E and F maps shows that the former have sharper, better defined 
atomic peaks. Thus E-values are 'sharpened' structure factors. Since weak reflections 
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have large errors associated with their measurement, upweighting of low intensity high 
angle data also magnifies errors, resulting in a higher noise level in the sharpened map. 
However combining E and F, giving 'semi-sharpened' structure factors, allows the 
advantages of sharpening to be exploited while the drawbacks are minimised. 
Experimental 
Models 
This study involved four crystal structures, Table 1. The data were collected using 
synchrotron radiation at EMBL. The models were refined using similar protocols with 
details described elsewhere. The resolution of the data covers the range over which the 
sharpening of maps might be expected to be beneficial, from atomic to around 2 A. 
Table 1 . Crystal Structures 
Structure Spacegroup Resolution (A) Wilson Plot B factor (A^) Reference 
Rubredoxin P2i 20.0 - 0.92 15 Dauter etal., 1992 
Protein G P2i2 i2 i 1 0 . 0 - 1 . 1 0 20 Derrick & Wigley, 1994 
Eglin c P43 1 0 . 0 - 2 . 0 0 37 Betze! etal.. 1993 
Transthyretin P2 i2 i2 1 0 . 0 - 1 . 9 0 44 Damas etal., 1996 
Maps 
(Xo-XcOc) and (3Xo-2Xc,o(c) maps, where X = (F ' E'^"'^) and X < 1 , with varying sharpness 
and resolution limits, were computed, using FFT (Ten Eyck, 1 9 7 3 ) , ECALC and other 
programs from the C C P 4 ( 1 9 9 4 ) suite. Following the application of resolution cuts to the 
data, 2 0 cycles of restrained least-squares refinement were run using the C C P 4 version 
of PROLSQ (Konnert & Hendrickson, 1 9 8 0 ) to help remove the memory of the high 
resolution data from the model. 
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Both observed and calculated structure factors were then independently normalised to 
give E-values. Calculation of E-values necessitates the division of the data into a 
sufficient number of bins with an adequate number of reflections in each bin, so care is 
required in setting bin widths for data sets to which successively large high resolution 
cutoffs have been applied. This is particularly important for structures with a small 
asymmetric unit, such as rubredoxin, protein G and eglin c, due to the relatively small 
number of low resolution reflections. Prior to the calculation of semi-sharpened maps, a 
scale factor of (ZF^/ZE^)^'^ was applied to the E-values, so that maps calculated with 
different degrees of sharpness would be comparable. Such scaling gives rise to a 
comparable rms density for maps of varying sharpness at a given resolution. 
A further problem with the scaling of low resolution data, especially those originating from 
a synchrotron, can arise due to strong reflections overloading the detector and thus being 
wrongly measured. The only solution is to be observant during data collection and to 
collect a high resolution data set in three or four runs, as explained in Chapter 4B. 
Nominal and Effective Resolution of the Data 
An electron density map of a protein crystal structure consists of a collection of blurred 
peaks, corresponding to the electron density around atoms. The amount of detail which 
can be visualised in a density map is determined by the resolution of the data. However, 
the nominal resolution is not the only deciding factor. The peaks are broadened by 
thermal motion and static disorder. Thus, the quality of a map generated from data 
artificially cut to a certain resolution will be different to that of one from data collected 
from crystals which only diffracted to that resolution. 
1 7 9 
The first ideas about atom resolvability in electron density maps obtained from X-ray 
diffraction were formulated for the theoretical case of a point atom. The Rayleigh criterion 
states that for a simple lens with axial illumination a pair of two-dimensional images may 
be resolved when the maximum of one image is superimposed upon the first minimum of 
the other, a separation of 0.61 X (James, 1948). For the case of three-dimensional point 
atoms, this corresponds to the superposition of the maximum of one image peak on to 
the first zero of the other, which occurs at an interpeak distance of 0.715 dmin (James, 
1948). Stenkamp & Jensen (1984) proposed that the distance should be that at which the 
maximum of the first peak is superimposed with the first minimum of the second, which is 
equal to 0.917 dmin. They added that for atoms with B > 0 the image peaks would be 
broadened, and the local minimum between two peaks at a given separation would 
therefore become shallower. 
Swanson (1988) considered the case for real atoms, with B > 0. The effective resolution, 
Deff is determined, at low resolution, by the high resolution limit and at atomic resolution, 
1.2 - 0.8 A there is a limiting constant value of Den, reflecting the nature of the atomic 
peaks. At intermediate resolution, both factors play a part. The intermediate range, 1 - 2 
A, corresponds to that of high resolution protein crystallography. The changing visibility of 
atoms across this resolution range is a key issue in high resolution protein 
crystallography. In this range lies the point at which anisotropic refinement of a structure 
becomes beneficial (Dauter et al., 1995) and the resolution at which structure solution by 
direct methods may be possible (Sheldrick etal., 1993). At ultra-high resolution, a further 
level of detail becomes apparent in the density map, corresponding to the deformation 
density from the spherical atom approximation, but charge density studies on 
macromolecules will not be feasible in the near future. 
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Swanson proposed that Deff be defined by a separation distance related to the distance 
between the maximum of an average image peak and its first inflection point. This was 
justified because, as B increases, the peak shape changes and the first minimum 
becomes shallower and moves further from the central maximum at a faster rate than the 
first inflection point. The average image peak was generated from the Fourier transform 
of the resolution dependent average structure factor, calculated by averaging data in 
resolution bins. The first inflection point occurs at the first zero of the second derivative of 
the density function. For the example structures given, the effective resolution is found to 
be in the range 1.1 -1 .2 dmin. 
The Shape of Electron Density 
The resolvability of atoms was assessed by direct inspection of density maps. This is 
justified since it is the resolvability of atoms in the actual density map which affects the 
course of refinement. While it is true that thermal motion results in the broadening and 
merging of peaks, this effect can be at least partially compensated for, as described 
above, by using sharpened maps. 
The visibility of atoms in the density for maps at different resolutions and with different 
degrees of sharpening was investigated by examining the shape of the density between 
neighbouring atomic centres. All pairs of fully occupied atoms, not including solvent, 
separated by distances of 1.9 A or less were selected. The electron density at the two 
atomic centres, and at nine equally spaced points along the line connecting them, was 
calculated. The symmetrically placed pairs of points which were equidistant from the 
midpoint were averaged. The resulting values for the density between each pair of atoms 
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2.0 A 
1.5 A 
0.92 A 
0.1 0.2 0.3 0.4 0.5 
Fractional interatomic distance 
Figure 2. Average shape of the density between neighbouring atoms. 
Maps of rubredoxin using data of different sharpness and resolution were investigated. 
The normalised density values are plotted against fractional distance from the atomic 
centre, for E-maps (dashed line) and F-maps (continuous line) for maps with 
0.92, 1.5 and 2.0 Angstrom high resolution data cutoffs applied. 
normalised 
P 
\ E-map 
vF -map X 
E-map - F-map 
1 1.2 1.4 1.6 1.8 2 
resolution (A) 
Figure 3. 
A comparison of the resolvability of atoms on E maps and F maps at different resolutions for 
rubredoxin. 
If Pgjj,^ = averaged, normalised density at the atom centre and 
p^.^pg.^^=density at the midpoint, calculated as explained for Figure 2, then 
^difference " P atom P midpoint 
difference 
is plotted against resolution cutoff, for E maps(small dashes), F maps(large dashes) and 
Pdifferenci^ "^^P) " Pdifference^^^^^^P) (continuous line). 
were normalised to give unity at the atomic centre. These values give a representation of 
the average shape of the density between neighbouring atoms, Figure 2. 
If patom is the averaged, normalised density at the atom centre, pmidpoim is the density at 
the midpoint between two atoms and pditference is the difference between patom and pmidpoim . 
then the atoms can be said to be 100% resolved if 
patom = 1 and Pmidpoint = 0 therefore Pditference = 1 • 
The plot of pdifference against resolution cutoff. Figure 3, shows that the atoms on the E-
map are around 40% better defined at atomic resolution, i.e 
Pdifference (E-map) = 1 and Pdifference (E-map) - Pdlfference(F-map) = 0.4 
The resolvability of atoms in maps of all degrees of sharpness declines as the high angle 
data are cut. However, the extra interpretability of E-maps over F-maps increases. At 2.0 
A the resolvability of atoms is 8% in E-maps, 4% in F-maps, which is a 100% advantage 
for the E-maps. An advantage is retained until around 2.25 A to 2.5 A. 
The shape of the electron density between atoms is principally determined by the 
resolution of the data. At atomic resolution, there is a pronounced minimum at the 
midpoint, Figure 2. This minimum is lower in the E-map. The depth of the minimum 
decreases, for all maps, as the resolution is cut. At around 2.5 A the shape of the density 
is completely altered and there is a maximum at the midpoint, Figure 4. Between 2 A and 
2.5 A it may be possible to resolve atoms on the E-map, as the minimum is still present, 
although it is not in the F-map. 
The shape of the density on the F-map is influenced by the thermal parameters of the 
structure. For a structure with higher B factors, the atoms are less resolved. A map in 
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Figure 5a. The resolvability of solvent atoms. 
E-map (dashed line) and F-map (continuous line) density between solvent 
sites is plotted for rubredoxin at 0.92 and with data cut to 2.5 Angstrom. 
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which resolution had been artificially cut can be distinguished from one for which data are 
present up to the diffraction limit. Thus there is a substantial difference between the 
shape of the density in the F-map for protein G at 2.0 A, and that for eglin at 2.0 A, Figure 
4, due to the difference in average B factors for the structures. Table 1. Since, ideally, 
thermal effects should be removed during the calculation of E-values, there is a greater 
similarity between the shape of the density in the E-maps. Errors are not compensated 
for so the shape of the E-map densities will not be identical. 
The density around solvent atoms was also analysed. Figure 5. The separation between 
solvent sites is greater than that between adjacent atoms in the protein, so solvent 
molecules are still distinct at a lower resolution. The change in shape of the density with 
resolution cutoff was much more gradual for solvent. This demonstrates that the high 
resolution data contain little information about the solvent. 
Electron Density Histograms 
If a grid is drawn over the map and a histogram of the (FQ, etc) electron density at the 
gridpoints is plotted, this distribution will contain information about the nature of the 
structure and the correctness of the phases (Cochran, 1952; Podjarny & Yonath, 1977; 
Main, 1990; Lunin, 1993). The map consists of atomic electron density, which at high 
resolution is seen as a collection of approximately Gaussian peaks, overlying a random 
noise contribution. Noise arises from errors in the model, the presence of high and low 
resolution cutoffs in the data as well as errors in the data. The density histogram of the 
noise is a Gaussian, centred at zero. The atomic electron density histogram has the 
shape of a Gaussian rotated through 90°. The range of this function is 0 < p < pmax- The 
overall density histogram adopts a characteristic, skewed shape, resulting from the 
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convolution of two component distributions, with a short tail in the negative density region 
and a long one for positive density (Main, 1990). 
It has been postulated that the best set of phases will result in the most skewed density 
histogram (Cochran, 1952). This relates to the fact that improving the phases causes a 
reduction in noise, removing small and negative values of p and shortening the p < 0 tail 
of the histogram. The skewness of the density histogram reflects the level of noise in the 
map. If maps are generated using the same phases, but from structure factors with 
different degrees of sharpening, this discriminator should still apply and the most 
interpretable map should therefore be that for which the density histogram possesses 
maximum skewness. 
The variation of skewness of the density distribution with map sharpness, for maps of 
type ( F o ' Eo '^'*^,ac), was evaluated. Figure 6. The value of x at which skewness is a 
maximum is defined as x^ax , thus the ( F o * ^ ^ ^^(i-xmax; ^^^p possesses the density 
distribution of maximum skewness. The plot of Xmax against resolution cutoff is shown in 
Figure 7, for all four data sets. According to this plot, at 1 A resolution, the highly 
sharpened (F°^ E ° ° ) synthesis would be expected to contain the most interpretable 
features. As the resolution is decreased, the optimal degree of sharpening is reduced. 
This can be explained by the fact that as more of the high resolution data are removed 
termination errors increase the noise. Thus a greater 'P contribution to the structure 
factors is necessary to dampen the noise, and the F /E balance swings towards F. 
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Figure 6. 
Skewness of the density distribution was calculated for maps of the form (Fo ^ Eo ^^''^') with 
X 0->1, for rubredoxin. Plots of skewness against x for maps with a specific high resolution 
cutoff are shown, for cutoffs at 0.92,1.0, 1.1, 1.2, 1.6, and 2.0 Angstrom. The value of x at which 
skewness is maximum, defined as x ^ ^ , is marked b y X for each plot. 
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Figure 7. 
The plot of Xj^g^against resolution cutoff is shown for rubredoxin(large dashes), protein G 
(continuous line), transthyretin(medium dashes), and eglin C(small dashes). 
x^g^ is the value of x at which the skewness of (Fo '^ Eo ) maps is maximum. 
In other words, the (Fo^"^^o map possesses the density distribution of maximum 
skewness 
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Refinement using Sharpened Maps 
Use of maps of varying degrees of sharpness during real-space improvement steps of 
refinement has been investigated. A structure obtained from the anisotropic refinement of 
rubredoxin from Desulfovibrio vulgaris at 0.9 A and five other models derived from this 
first model were subject to refinement. 
Refinement 
Restrained least-squares refinement of atomic positions and thermal parameters was 
performed. The two models referred below to as I and II were refined using SHELXL-93 
(Sheldrick, 1993), the remaining examples using PROLSQ. The Automated Refinement 
Procedure (ARP, Lamzin & Wilson, 1993) was employed for modification of the structures 
in real space. The refinements were repeated with variation in the sharpness of the 
(3Fo-2Fc,cxc) map input to ARP: unsharpened (F), fully sharpened (E) and half-sharpened 
^po.sgo.s ^ structure factors were used in turn. An account of general refinement 
protocol is given in the introduction to Chapter 4. 
The following models were refined; 
/: An anisotropic model, comprising residues 1-52, with 82 water molecules and R and 
Rfree values of 8.3% and 11.2%. The SHELXL-93 diffuse solvent correction, based on 
Babinet's principle (Langridge et a/., 1960), had been applied during the previous 
cycles of refinement. The resolution range of the data was 20 A to 0.92 A. 5% of the 
reflections had been removed from the working dataset for calculation of Rfree-
//: Solvent atoms with B factor > 30 A^  were removed from /, leaving 32 waters. R and 
Rfree values were 10.4% and 12.2% respectively. 
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///: A random positional error with rms 0.3 A was introduced into model / and, in 
addition, the co-ordinates were shifted by 0.5 A along the a axis. This mimics 
inaccuracies which could be present in a model obtained by molecular replacement. 
R and Rfree were 44.8% and 45.9%. 
IV: Molecular replacement was carried out using AMORE (Navaza, 1994). The search 
model used was the 1.4 A structure of rubredoxin from Desulfovibrio gigas (Frey et 
a/., 1987), which has an rms displacement of 0.65 A from /, for CA atoms. There are 
14 sequence differences between the two structures. Side chain shortening 
mutations only were carried out, where this was appropriate. 7 residues in the 
molecular replacement model were mutated to Ala and 2 to Ser, leaving 9 sequence 
differences between the starting model and /. R and Rfree were 39.2% and 41.0%. 
V: A loop region in /, comprising residues Pro 20 to Val 24, was removed. R and Rfree 
were 20.9% and 24.3%. 
For / & //, five cycles of SHELXL-93 anisotropic refinement were run, followed by a cycle 
of ARP. This was iterated ten times. ARP was used for modification of solvent only. The 
distance limits for addition of new atoms were set to 2.2-3.3 A and the merging distance 
to 0.6 A, Refinement was run with and without application of the SHELXL-93 diffuse 
solvent correction and with and without real space refinement. The number of atoms to 
be added and removed in each cycle was set to 0 or 5 for / and 10 or 15, for //. 
For ///, IV &. V, PROLSQ refinement was performed until further cycles gave no further 
drop in R factor. Following each cycle, ARP was run. Real space refinement was carried 
out on all atoms, but only those designated as solvent were cut and added. Atoms were 
added at distances of 1.0-3.3 A from existing ones, and merged if they came within 0.6 
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A. These limits were set to allow for the fact that some of the 'solvent' may represent 
protein atoms. The change in R factor was useful in determining the convergence point 
of a refinement, while the refinement parameters were being tuned. However, a 
comparison of R factor does not give a good assessment of how well the refinement 
process corrects the deliberate errors introduced, since R factors refer to the whole 
model. 
Results of Refinement 
In the final stages of refinement, the well defined part of the model remains virtually 
unchanged, while improvements are made in the fitting in the disordered regions and 
solvent. Such was the case for the refinements of / and //. Since scattering from the 
regions which were modified by these refinements does not contribute greatly to the high 
resolution data, the effect of sharpening was not dramatic. 
Final R and Rfree values. Figures 8a and b are almost uniformly lowest for refinements 
performed using H maps. Use of H maps is advantageous, although the effect is small. 
Use of fully sharpened maps was ineffective, causing the maximum number of atoms to 
be removed and added on each cycle, arguing that the noise level in these maps was too 
high, while semi-sharpened maps were more useful than plain F-maps. Real space 
refinement assisted in the equilibration of the solvent building during the reconstruction of 
the solvent network of model //. This can be explained by the observation that diffuse 
atoms tend to drift towards the edges of the density, a problem corrected for by real 
space fitting. 
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Figure 8a. Results of test refinements of rubredoxin. 
Final R and Rfree from the refinement of model I is plotted against 
sharpness of maps used in the refinement; E, H, and F maps. 
R factor (%) 
8.8 
Rfree (%) 
H F 
type of maps used during refinement 
H F 
type of maps used during refinement 
Refinement conditions: 
RS(continuous line), R{large dashes), S(small dashes) and neither(dash-dot). 
R = real space refinement performed, S = diffuse solvent correction applied. 
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Figure 8b. Results of test refinements of rubredoxin. 
Final R and Rfree from the refinement of model II is plotted against 
sharpness of maps used in the refinement; E, H, and F maps. 
R factor (%) 
9 
Rfree (%) 
H F 
type of maps used during refinement 
12.25 
11.75 
11.25 
10.75 
H F 
type of maps used during refinement 
Refinement conditions: 
RS(continuous line), R(large dashes), S(small dashes) and neither(dash-dot). 
R = real space refinement performed, S = diffuse solvent correction applied. 
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Figure Sc. Final R, Rfree and rmsd of CA atoms from those in the target model, I 
are plotted for refinement of models III, IV, and V using E, H, and F maps, 
model lll(continuous line), model IV(large dashes) and model V(small dashes) 
R factor (%) 
17.5 
Rfree (%) 
H F 
type of maps used during refinement 
18.5 
^^•^E H F 
type of maps used during refinement 
rmsd of CA atoms from Target model 
9( 
H F 
type of maps used during refinement 
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The effect of the application of the SHELXL-93 diffuse solvent correction was much more 
noticeable, since this correction is specific to the low resolution data. When the solvent 
correction was implemented during the building of a very incomplete solvent network, the 
addition of solvent was slowed down. When the virtually complete model / was refined, 
with the solvent correction operative, the resulting model had fewer solvent molecules 
and a lower value of Rfree, Figure 8b. This can be ascribed to the removal of peaks which 
were present due to incorrect scaling of low resolution terms. 
Models ///, IV and V roughly approximate to structures at earlier stages in refinement, 
with significant errors in the well defined part of the density. The degree to which 
refinement has corrected the inaccuracies which were introduced can be assessed by 
observing change in the rms displacement of the main chain atoms from those of model 
/, Figure 8c. IV, the molecular replacement model, possesses 3 regions in which the 
position of the chain is seriously in error and requires interactive graphical rebuilding. 
When these regions are not used in the calculation of rms displacement of CA atoms 
from those /, the values obtained closely mirror those found for model ///. Rfree values 
reflect the success in correcting the mistake in the main chain, while R values are 
insensitive. In all three cases, refinement using E-maps produced the best final model. 
The results from using H-maps were similar to those obtained with E-maps, while the F-
map based models were considerably worse. 
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Figure 9. rubredoxin: a/ 3Fo - 2Fc b/ 3Eo - 2Ec map 
Glu 17 
W A f i i 
WAT 35 
WAT 29 
Glu 12 
Conclusions 
This investigation was concerned with the resolvability of atoms in maps of different 
sharpness. Plots of the mean density between adjacent atoms show that fully 
sharpened maps contain the best resolved peaks in well resolved parts of the structure, 
due to the removal of peak broadening thermal effects. Concurrent with the increasing 
sharpness of peaks in the protein region, there is an increase in the background noise 
level, and a consequent reduction in peak size in less well defined regions, as is 
illustrated by the density maps of rubredoxin in Figure 9. 
The interplay of these factors is resolution dependent. If maximum skewness in the 
density histogram corresponds to minimum noise in the map, the optimal level of 
sharpness increases with resolution: around (E°^F°'^ ) at atomic resolution and between 
(E° V®) and (E° V * ) at 2 A resolution. 
The results of refinements performed on rubredoxin demonstrate the effectiveness of 
sharpening in the early stages, while showing that this approach is less advantageous 
towards the end of a refinement. For the atomic resolution rubredoxin structure, the 
optimal degree of sharpening appears to lie between fully (E) and half-sharpened 
^go.spo.sj priaps. For an almost fully refined model, the use of half-sharpened maps is 
most effective, while the worse the model, the sharper the maps should be. These 
results agree with the trend shown in minimum map noise levels by the density 
histogram study, Figure 7. 
Use of sharpening during automated improvement of the model in real space directly 
enhances the accuracy with which atoms can be placed within well resolved density. 
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This can be seen as the primary effect of sharpening. Where significant errors are 
present in well-defined regions, improvement in the model is accelerated and enhanced. 
A secondary effect of sharpening stems from the reduction in noise in the density map 
which results from this improvement in the model. Weaker peaks emerge above the 
background noise level, allowing effective modelling of more peripheral parts of the 
model, such as mobile side chains and the solvent network. In the closing stages of 
refinement, as most of the atoms are already well positioned, potential improvements 
due to map sharpening are small. 
The level of sharpness which produces the most informative map is strongly resolution 
dependent. While sharpening is most effective for atomic resolution data, it should be 
advantageous for any refinement at a resolution higher than 2.5 A, a range which 
encompasses more than half the structures at present in the Protein Databank (Lamzin 
etal., 1995). 
200 
References, Chapter 5A 
Betzel, C , Dauter, Z., Genov, N., Lamzin, V., Navaza, J., Schnebli, H.P., Visanji, M. & 
Wilson, K.S. (1993) Structure of the proteinase inhibitor eglin C with hydrolysed reactive 
centre at 2.0 A resolution. FEBS Lett. 317, 185-188. 
Blessing, R.H. & Langs, D.A. (1988) A pr/on estimation of scale and overall anisotropic 
temperature factors from the Patterson origin peak. Acta Crystallogr. A44, 729-735. 
Blessing, R.H. & Langs, D.A. (1996) Statistical expectation value of the Debye-Waller 
factor and E{hkt) values for macromolecular crystals. Acta Crystallogr. D52, 257-266. 
Cochran, W. (1952) A relation between the signs of structure factors, ^cfa Crystallogr. 5, 
65-67. 
Damas, A.M., Ribeiro, S., Lamzin, V.L., Porto, J.A. & Saraiva, M.J. (1996) The crystal 
structure of Val-122-lle variant transthyretin - a cardiomyopathic mutant. Acta Crystallogr. 
D. in press. 
Dauter, Z., Sieker, LC. & Wilson, K.S. (1992) Refinement of Rubredoxin from 
Desulfovibrio vulgaris at 1 A with and without restraints. Acta Crystallogr. B48, 42. 
Dauter, Z., Lamzin, V.L. & Wilson, K.S. (1995) Proteins at atomic resolution. Curr. Opin. 
Struct. Biol. 5, 784-790. 
Derrick, J.P. & Wigley, D.B. (1994) The third IgG-binding domain from streptococcal 
protein G. An analysis by X-ray crystallography of the structure alone and in a complex 
with Fab. J. Mol. Biol. 243, 906-918. 
Frey, M. Sieker, L.C., Payan, F., Haser, R., Bruschi, M., Pepe, G. & Le Gall, J. (1987) 
Rubredoxin from Desulfovibrio gigas. A molecular model of the oxidised form at 1.4 A. J. 
Mol. Biol.-197, 525. 
James, R.W., (1948) False detail in three-dimensional Fourier representations of crystal 
structures. Acta Crystallogr. 1, 132-134. 
Karle, J. and Hauptmann, H. (1953) Application of statistical methods to the naphtalene 
structure. Acta Crystallogr. 6 473-476. 
Karle, J. and Hauptmann, H. (1956) A theory of phase determination for the four types of 
non-centrosymmetric space grous 1P222, 2P22, 3P2i2, 3P^. Acta Crystallogr. 9, 635-
651. 
Lamzin, V.S., Sevcik, J., Dauter, Z. & Wilson, K.S. (1995) Implications of atomic 
resolution. Making the most of your model. Proceedings of the CCP4 Study Weekend, 6-
7 January, SERC Daresbury Laboratory, Daresbury, Warrington, England, 33-40. 
Langridge, R., Marvin, D.A., Seeds, W.E., Wilson, H.R., Hooper, C.W., Wilkins, M.H.F. & 
Hamilton, L.D. (1960) The molecular configuration of Deoxyribonucleic Acid. II. Molecular 
models and their Fourier transforms. J. Mol. BioL 2, 38-64. 
201 
Lunin, V.Y. (1993) Electron-density histograms and the phase problem. Acta Crystallogr. 
D49, 90-99. 
Main, P. (1990) A formula for electron density histograms for equal-atom structures. Acta 
Crystallogr. A46, 507-509. 
Podjarny, A.D. & Yonath, A. (1977) Use of matrix direct methods for low-resolution phase 
extension for tRNA. Acta Crystallogr. ASS, 655-661. 
Sheldrick, G.M., Dauter, Z., Wilson, K.S., Hope, H. & Sieker, L.C. (1993) The application 
of direct methods and Patterson interpretation to high-resolution protein data. Acta 
Crystallogr. D49,18-23. 
Stenkamp, R.E. & Jensen, L.H. (1984) Resolution revisited: limit of detail in electron 
density maps. Acta Crystallogr. A40, 251-254. 
Swanson, S.M., (1988) Effective resolution of macromolecular X-ray diffraction data. Acta 
Crystallogr. A44, 437-442. 
Tronrud, D.E. (1996) The TNT Refinement Package. In Methods in Enzymology {Carier, 
C. & Sweet, B. eds.) in press. 
Wilson, A.J.C. (1942) Determination of absolute from relative X-ray data intensities. 
A/afure 150,151-152 
see also general crystallographic references, end of Chapter 5 
202 
Chapter 5B 
Treatment of solvent in protein crystal structures 
List of abbreviations used in the description of solvent structure, Chapter SB 
~\/^ crystal volume per unit molecular weight (Matthews, 1968) ( D ' ^ ) 
VASSY volume of asymmetric unit ( ) 
pAssY average density of asymmetric unit (g cm"^) 
Vprot. Vf,prot volume of protein in asymmetric unit (A^), fractional volume of protein 
Mprot mass of protein in asymmetric unit 
Pp,o, average density of protein (g cm'^) 
Vsc % volume of solvent by relative cell and protein volumes, from equation (3). 
Psoivent average density of solvent (g cm'^) 
Nsoi.modeiied number of solvent sites modelled in asymmetric unit 
Nsoi.totai total number of solvent sites, calculated from Vsc, with the approximation psoivent = 1 
Vsoi.ordered % volume of Ordered solvent, from proportion totahmodelled solvent, equation (9) 
Vsoi,diffuse % volume of diffuse solvent, from proportion totahmodelled solvent, equation (9) 
Vss % volume of ordered solvent, from analysis of gridpoint-atom separation, Figure 5 
Vra % volume remote from protein, from analysis of gridpoint-atom separation, Figure 5 
Vds % volume of diffuse solvent, from analysis of gridpoint-atom separation, Figure 5 
ksoi contrast parameter for the modelling of diffuse solvent, defined as Spsoi(r) / SppmieinCr). 
Bsoi average B factor for diffuse solvent (A^ ) 
d resolution (A) 
s resolution expressed as sin9 / X, (A'^ ) 
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Introduction 
What is solvent structure? 
The essential difference between small molecule crystals and those of macromolecules 
(although a sharp boundary does not exist, a continuum of examples exists between 
large and small) is that a large part of the volume of the latter is taken up by solvent. 
Realistic modelling of this solvent is a matter of concern because of the fundamental 
nature of a crystallographic model. Model phases are generated by combining the 
scattering contributions from all the constituents of the unit cell. Consequently, the quality 
of the whole model affects the detail which can be seen in each part and careful 
modelling of the solvent is necessary to achieve the most informative model of, for 
example, the active site. 
A measure of packing density is given by Vm, the crystal volume per unit molecular weight 
(1) (Matthews, 1 9 6 8 ) . 
Vn,= VASSY/Mpro, (1) 
For protein crystals Vni values lie in the range 1 .65 to 3 . 3 5 A^Da'\ most frequently 
between 2.1 and 2 . 4 k^Da\ The distribution has a sharp cutoff at the lower end, 
reflecting the fact that the limits of close packing have been reached, while at the upper 
end there is a long tail, since there is no definite limit to how loosely packed a structure 
could feasibly be. Vm is related to the fractional solvent content of the crystal (2) . 
Vf.prot = Vprot / V ^ g s Y = (Mprot / pprot) (PASSY ^ ^ASSY) = (VASSY PASSY) (Vm Pprot M^SY) 
Vf,p,ot=1 /Vmpprot (2) 
If Vm is expressed in A^Da'^  and pprot approximated to 1 .35 g cm'^, then the solvent 
content of the crystal can be expressed by (3) (Matthews, 1 9 6 8 ) . 
Vsc = 1 0 0 ( 1 - ( 1 . 2 3 / V m ) ) % (3) 
2 0 4 
The fraction of volume occupied by solvent for a typical protein crystal is between 25% 
and 65%, with an average of 43%. Although the volume occupied by solvent in a protein 
crystal varies greatly, the structure adopted by the solvent does not. This justifies the 
development of a general model for the solvent network and a protocol for solvent 
treatment which should be valid in most cases. 
Ideas about the solvent structure around a protein have been developed from 
complementary viewpoints; X-ray diffraction crystallography, NMR spectroscopy and 
theoretical modelling (Karplus & Faerman, 1994; Levitt & Park, 1993). In crystal structures 
discrete solvent sites are visible, mainly in the boundary region, between protein and 
diffuse solvent. The number of such sites which are conserved between different 
crystallographic forms, with the exception of waters buried within the protein, is a subject 
of contention between NMR spectrocopists and crystallographers. 
NMR studies show that, in solution, all except the buried waters are in rapid motion, with 
exchange rates > 1x1 o'° s''. Theoretical calculations support this view and suggest that 
the same is true within the crystal. It may be constructive to consider the solvent sites 
observed in a crystal structure as the positions of minima in the free energy potential for 
solvent molecules, influenced as much by crystal field forces as chemical interactions 
with neighbouring side chains. 
The H-bonding network around the surface of the protein incorporates a shell of solvent, 
which can be modelled as a set of discrete atoms on fully occupied sites. If the resolution 
of the data permits, partially occupied sites, linked to disordered systems of side chains, 
may also be included in the model. The remaining solvent is not attached to specific 
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minima. This diffuse solvent contributes to the scattering at low resolution, due to the 
contrast in electron density between diffuse and ordered regions of the unit cell. There is 
no sharp boundary between these regions, the density varying smoothly between the 
centre of the protein molecule and the diffuse solvent zone. Thus, the occupancies of 
some of molecules in the first solvent shell appear to be less than unity and some 
discrete solvent peaks may be located further from the molecule, in the essentially diffuse 
solvent region. 
Treatment of diffuse solvent 
If the region of a model crystal structure actually filled with diffuse solvent is considered to 
be a vacuum, there will be systematic errors in the calculated intensities at low resolution, 
because the contrast in density between protein and diffuse solvent is much smaller than 
that between protein and an empty void. The scattering of water exhibits periodicity at 
around 3 A, but little above 4 A (Blessing & Langs, 1988). Therefore, at low resolution, its 
scattering can be considered to be that of a gas of uniform electron density. The volume 
occupied by the water is equal to the unit cell volume minus the sum of partial atomic 
volumes of all atoms in the protein model. The partial atomic volume of an atom is similar 
whether it is surrounded by water or buried in the protein. Babinet's principle states that 
the scattering, due to water in the space around the molecule, has the same amplitude 
but opposite phase to the scattering from the molecular volume if it were filled with water 
(4). If neither scattering pattern has much detail, which is the case at low resolution, and 
the contrast between the density of water and protein is small, the assumption (5) can be 
made. 
Fso,(s) = " ^sol in protein volume (s) (4) 
^sol in protein volume(s) = Fprotein(S), SO F3rotein(s) = - Fsol(s) (5) 
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The contrast between protein and water requires the introduction of a scaling factor, ksoi, 
defined as <psoi(r)> / <pprotein(r)>. A resolution dependent factor, exp{-Bso\ s^), is required to 
restrict the relation to low angle data. The total scattering from the crystal may be 
expressed as ( 6 ) , which leads to the approximation ( 7 ) . Thus, the introduction of a scaling 
factor (1-ksoi exp(-Bsoi s^)) for Fc ' s corrects for the diffuse solvent scattering. Bsoi and ksoi 
may be determined during the scaling of Fc ' s to Fo 's by the minimisation of function ( 8 ) 
(Langridge etal., 1 9 6 0 ; Driessen etal., 1 9 8 9 ; Tronrud, 1 9 9 6 ) . 
Fc(s) = Fprotein(s) + Fsoi(s) ( 6 ) 
Fc(s) = (1 - ksoi eXpi-Bsoi S )^) Fproteln(s) ( 7 ) 
/ = Z (Fo(s) - k exp(-Bs')( 1 - ksoi e x p ( - B s o i s')) Fp^,ein(s))' ( 8 ) 
Aims 
The nature of a diffuse solvent correction of the type described above and the effects of 
its application during the refinement of a small protein structure have been investigated. 
For a good assessment to be made of whether the solvent treatment is effective and 
justified, it is first necessary to have an understanding about the nature of the solvent 
structure in the crystal. 
Experimental 
Application of a diffuse solvent correction 
Plotting resolution dependence of the diffuse solvent scaling factor, (1 - ksoiexp(Bsoi s^)), 
Figure 1 , shows that the presence of diffuse solvent should be accounted for during the 
refinement of any structure for which there are data at a resolution lower than 5 A. An 
alternative is the complete removal of these low resolution data, but this sacrifices 
structural information and results in extremely noisy density maps, due to truncation 
errors. 
2 0 7 
Figure 1. 
The diffuse solvent scaling factor (1 - ksoiexp(Bsoi s^)) is plotted against resolution, 1/d (A'^ ) This 
scaling does not effect data of resolution higher than 2.5 A (l/d > 0.4 A ) , while strongly influencing 
low resolution terms, below 5 A (1/d < 0.2 A), 
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B=400 / 
B=100 
0.2 0.4 0.6 0.8 1 
1/d Angstrom 
Figure 1 . 
The di f fuse solvent scal ing factor Y=(1-kgQ^xp(Bg^|S % is plotted against resolut ion, 1/d. 
Th is scal ing does not effect data of resolut ion > 2.5 Angst rom (1/d > 0.4), whi le strongly 
inf luencing low resolut ion terms, below 5 Angst rom (1/d < 0.2). 
Values for ksoi and Bsoi must be estimated during refinement, as described above, ksoi is 
the contrast parameter; using an incorrect value is equivalent to setting the wrong 
average density of diffuse solvent, which results In under or over-scaling of Fc's. Bsoi 
determines the manner in which solvent Is modelled at the solvent protein interface. 
Figure 2a illustrates the protein/solvent Interface schematically. The effects of setting Bsoi 
to reasonable, small and large values are shown. The correct value gives a smoothly 
changing density across the boundary. If Bsoi is too small, there will be a 'hole' in the 
density, If it Is too large, there will be a high density 'ridge' at the protein/solvent interface. 
The resulting ripples in the density may make it impossible to distinguish real features of 
the model from artificial peaks. In reciprocal space, a badly estimated value of Bsoi gives 
rise to an inadequate fit between calculated and observed structure factors at low 
resolution. 
If discrete solvent sites are not modelled, the estimated value of Bsoi will be small. As 
solvent is added, Bsoi increases. When no discrete solvent has been modelled, there is a 
sharp boundary between protein and diffuse solvent regions. Solvent sites are added at 
the interface. Increasing the width of the threshold region. Thus, a more gradually varying 
function is necessary to model smooth change in density and the value of Bsoi increases, 
as Illustrated schematically In Figure 2b. 
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Figure 2a. Schematic representation of the protein/solvent interface, 
illustrating both well and poorly nrodelled electron density 
protein boundary region diffuse solvent region 
P protein 
Bsoi too 
small 
Bsoi too large 
P solvent 
distance from centre of protein 
Figure 2b. 
Schematic Representation of changes in boundary region during construction of a solvent network 
Bsoi increasing 
protein 
diffuse 
solvent 
(1) 
No solvent modelled 
protein 
diffuse solvent 
solvent shell 
(2) 
Single shell of solvent 
modelled around protein 
diffuse solvent density 
protein 
diffuse second solvent 
solvent solvent shell 
shell 
\ 
(3) 
Second solvent shell modelled 
Analysis of the nature of solvent in the crystal structures of two small proteins 
The data-to-parameter ratio for a protein crystal structure necessitates the application of 
numerous restraints on main chain and side chain geometry. This is not required for 
solvent atoms. Distance constraints may be applied, restricting them to a range of 
distances from the next atom, so they neither become isolated, nor approach closer than 
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a feasible H-bondIng distance, this latter condition being unjustified for overlapping 
solvent networks. During anisotropic refinement with SHELXL-93 (Sheldrick, 1993) 
solvent may be restrained to be approximately isotropic, to prevent the volume of the 
thermal ellipsoid refining to a negative value, which can easily occur, since an ellipsoid is 
an Inadequate model for the density of a typical solvent site. Solvent is otherwise refined 
without restraints and, as a consequence, the solvent co-ordinate error distribution is an 
unbiased Gaussian. Thus, analysis of the solvent can give an independent assessment 
of model quality. 
Model protein structures 
Two structures were used as examples in this Investigation of solvent character; protein 
G from Streptococcus (Derrick & Wigley, 1994, Chapter 4A) and rubredoxin from 
Desulfovibrio vulgaris {Dauter etal., 1992, Chapter 4B), Table 1. Both these models have 
been subject to anisotropic refinement using SHELXL-93. The models used in this 
analysis were subsequently refined using all of the data, but at this stage, 5% of the 
reflections had been kept separate, for the calculation of Rfree- The occupancy of all 
solvent sites was 100%. 
Table 1. Structural details 
rubredoxln protein G 
Space group P2i P 2 i 2 i 2 i 
Resolution (A) 20 - 0.92 10 .0 -1 .1 
B factor from Wilson plot (A )^ 15 20 
mean B factor, protein (A )^ 9.1 12.5 
mean B factor, solvent (A )^ 32.1 35.3 
Vm (A'Da^) 1.74 2.23 
Vsc (%) 29 45 
R(%) 8.3 9.8 
Rfree (%) 11.2 12.7 
Nsol.modelled 82 119 
Nsol.total 94 222 
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Application of a diffuse solvent correction during refinement 
A suitable approach to the treatment of diffuse solvent during the refinement of protein G 
was required. Several schemes were tested and their results compared. The refinement 
process is summarised in Table 2. Poor scaling caused by data collection problems 
(Chapter 4A) resulted in large errors in the low resolution data. Consequently, a low 
resolution cutoff of 10 A was applied. The lack of the lowest angle reflections is not ideal 
for the modelling of solvent and may result in inaccuracies in calculation and refinement 
of the diffuse solvent parameters. Large errors and absences in low resolution data are 
also a source of noise, making the modelling of solvent and disordered side chains in 
diffuse density more difficult. 
Table 2. Refinement of protein G 
Stage 
1 isotropic refinement, PROLSQ(Konnert & Hendrickson, 1980) 
+ real space refinement, construction of solvent network, ARP 
2 anisotropic refinement, SHELXL-93, ARP 
3 introduction of 7 double conformations, occupancies of 8 sidechains refined 
4 sharpened (3Fo-2Fc) maps input to ARP; F°-^E° ^ 
diffuse solvent scaling no diffuse solvent scaling 
after Stage model R.(%) Rfree.(%) total water model R.(%) Rfree.(%) total water 
2 2A 10.1 12.9 119 2R 10.1 12.9 120 
3 3A 9.6 12.5 125 3R 9.8 12.6 120 
4 4A 9.5 12.5 132 4R 9.7 12.8 120 
Anisotropic refinement was performed, using SHELXL-93,' with the application of the 
diffuse solvent correction. The diffuse solvent correction in SHELXL-93 refines the value 
of ksoi, but Bsoi must be assigned a value which is not refined. In SHELXL-96 (Sheldrick & 
Schneider, 1996) both ksoi, and Bsoi are refined, but this was a development subsequent 
to this study, ksoi refined to a physically meaningless value, possibly due to truncation 
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errors. The solvent correction was retained, since it appeared to help compensate for 
these errors, giving the refinement more stability. 
During the refinement, the Fo 's and Fc 's output from SHELXL-93 were scaled, before 
being used for density map synthesis, providing the Input for ARP (Lamzin & Wilson, 
1993), which was employed for modification of the structures In real space. Two parallel 
refinements were performed, the first using the CCP4 program, RSTATS. The second 
refinement utilised an alternative scaling program, Implemented In ARP. This calculates a 
diffuse solvent correction, as described above, refining values of ksoi and Bsoi (Tronrud, 
1996). The refinements were, In all other ways. Identical. 
The solvent structures of four models, listed in Table 3, were compared. The separation 
of solvent sites was calculated between pairs of models: 3A & 3R, 4R & 3R, 4A & 3A, 
Figures 3a & b. Sites more than 0.5 A distant from the nearest site in the other model 
were considered to be different. The positions of these sites in the density were 
inspected, using FRODO (Jones,1978), with the results shown In Table 4. 
Table 3. Models used for comparison of solvent structure treatment 
model result of refinement with result of refinement with more careful 
sharpened maps input to ARP diffuse solvent correction applied 
3A no no 
3R no yes 
4A yes no 
4R yes yes 
Table 4. An assessment of the new solvent sites 
comparison of / to new sites average B (A )^ well positioned badly positioned 
3A/3R 20 65.5 7 10 
4A/3A 14 79.3 " " 5 6 
4R/3R 6 63.5 0 4 
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Figure 3. 
H is tograms of the separat ion of solvent sites for pairs of protein G models, 
wi th nomenc la ture as def ined in Table 3. 
(a) Separat ion of solvent in 3A f rom 3R, the effect of ref inement with dif fuse 
solvent correct ion app l ied. 
% 
sites 
1 0 0 95.0 
87.8 
8 0 
6 0 
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2 0 
0 .5 1 1.5 2 2 . 5 3 
separation (Angstrom) 
Figure 3. 
H is tograms of the separat ion of solvent sites for pairs of protein G models, 
w i th nomenc la tu re as de f ined in Table 3. 
(b) Separat ion of solvent in 4R f rom 3R(grey) and 4A f rom 3A(white) ; the effect of 
ref inement wi th and wi thout the appl icat ion of a dif fuse solvent correct ion. 
1\S 
Fo/Fc 
Figure 4. 
A n assessment of the match of calculated and observed structure factors. Fo and Fc for protein G 
mode ls at sequent ia l s tages in ref inement, with nomenclature as def ined in Table 5, were sorted into 
resolut ion b ins. The fit of Fo and Fc at dif ferent stages in ref inement was compared . 
2 2 
(a) Fo/Fc against sin Q/X 
mode l l ( iarge dashes) , model l l (small dashes) , model l l l (dash-dot) , model IV(cont inuous line). 
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R (%) 
Figure 4. 
A n assessmen t of the match of calculated and observed structure factors. Fo and Fc for protein G 
models at sequent ia l s tages in ref inement, with nomenclature as def ined in Table 5, were sorted into 
resolut ion b ins. The fit of Fo and Fc at dif ferent stages in ref inement was compared , 
(b) R aga ins t s in ^ 9 / A, ^ 
mode l l ( large dashes) , model l l (small dashes) , model l l l (dash-dot) , model IV(continuous line). 
117 
20000 
17500 
15000 
12500 
10000 
7500 
5000 
2500 
. 1 rv/"^\ 
« 
' (IV) 
0.2 0.4 0.6 0.8 
S2 
Figure 4 . 
A n assessment of the match of calculated and observed structure factors. Fo and Fc for protein G 
models at sequent ia l s tages in ref inement, with nomenclature as def ined in Tab le 5, were sorted into 
resolut ion b ins. The fit of Fo and Fc at different stages in ref inement was compared . 
2 2 2 
(c) N A against s in 0 / X 
model l( large dashes) , model l l (small dashes) , model l l l (dash-dot) , model IV(cont inuous l ine). 
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Figure 4. 
T h e d i f ference in f i t t ing a t low resolut ion result ing f rom the appl icat ion of the 
di f fuse solvent correct ion is too smal l to show up on the scale of (a), (b), and (c) 
(d) N aga ins t s in "^QIX ^ 
mode l IV(cont inuous line) and model V(dashes) . 
Zl9 
Application of the diffuse solvent correction lead to a decrease in the R factor of 0.19% 
and in Rfree, 0.35%. The use of this correction allowed weakly diffracting solvent to be 
modelled, with some success. Once the diffuse solvent correction had been applied, use 
of sharpened maps expedited the placing of further solvent sites in weak density. Without 
this correction, use of sharpened maps did not contribute to improvement of the model. 
Low resolution fit of the model 
Omission or incorrect modelling of solvent results in bad agreement between model 
structure factors and observed data at low resolution. The match of calculated and 
observed structure factors was assessed at sequential stages in the refinement of protein 
G, as listed in Table 5, as the treatment of solvent became progressively more 
sophisticated. Figures 4 a, £», c & cfplot the fit of Fc to Fo for these models. 
Table 5. Models used in assessment of fitting of the low resolution data 
model description 
I 'unrefined' model from isotropic model 1 igd (Derrick & Wigley, 1994) all solvent 
removed, random positional error of rms 0.3 A applied to co-ordinates. 
II isotropic model refined from I using PROLSQ. Solvent network modelled using ARP. 
III anisotropic model refined without diffuse solvent correction, using SHELXL-93 and 
ARP. 
IV anisotropic model refined with the SHELXL-93 diffuse solvent correction applied, ksoi 
refined, Bsoi, fixed. 
V anisotropic model refined with the ARP diffuse solvent correction applied; ksoi and Bsoi 
both refined. 
The plot of resolution dependence of (Fo/Fc) , Figure 4a, shows an improvement of the fit 
at low resolution for // when compared with /, due to the addition of discrete solvent 
during the Isotropic refinement. Fc is much reduced, but still too large, after the isotropic 
refinement. The anisotropic model, without diffuse solvent correction, shows no 
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improvement at low resolution, with respect to //. However the models which have been 
refined with a diffuse solvent correction appear to be over-corrected, with Fc < F o , in the 
low resolution range, for both IV& V. 
The R factor, Figure 4b, of the lowest resolution data is the same for the three refined 
models, //, /// & IV although, obviously, there is a progressive reduction of R at high 
resolution. The plot of NA^, Figures 4c & d, is most sensitive to differences in the quality 
of the models at low resolution. An improvement Is seen for each level of sophistication in 
the solvent modelling, although the relative size of the improvements gets progressively 
smaller. 
From the plot of (Fo/Fc) against resolution. It appears that both types of diffuse solvent 
correction are over enthusiastic. Changes in the solvent modelling do not strongly 
Influence the low resolution R factor and NA^ Is a much more sensitive indicator of 
improvements. 
Distributions of solvent properties 
The ordering of solvent In the rubredoxin and protein G structures described In Table 1 
was compared. The rubredoxin model Investigated contained 82 water molecules. If the 
volume unoccupied by protein were filled with pure water, the total solvent content of the 
unit cell would be 94 molecules. Therefore, virtually the entire solvent network may be 
modelled as a system of discrete sites and the amount of diffuse solvent must be 
minimal. The protein G solvent structure Is more typical for a protein crystal. 119 water 
molecules were present in the model used in this comparison, while there Is space for 
222. Thus, almost half of the solvent Is diffuse. This difference Is reflected by the Vm 
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values for the structures. Vm for protein G , 2 . 2 3 A^Da \ lies in the middle of the range of 
the Vm distribution for protein structures, which is discussed above, while the rubredoxin 
value, 1 .74 A^Da \ is at its lower limit. 
The manner in which the crystal volume is divided into protein, ordered and diffuse 
solvent regions can be investigated by placing a grid inside the unit cell and ascertaining 
the distance of each grid point from the protein and from modelled solvent sites. 
Distributions of these distances were compared. Figures 5a, b & c. The histograms 
demonstrate the way in which the unit cell volume is apportioned between protein, 
hydrogen bonding shell around the protein and intermolecular space remote from the 
protein. 
All the histograms. Figures 5a, b& c, have maxima in the 1.5 - 2 .0 A range, relating to a 
separation of 3 -4 A between atoms, which is the range of the van der Waal's radii for C, 
O and N atoms, while the area under the tail of the distribution, with d > 2 k, gives 
information about characteristics of the solvent. 
2 2 2 
(%) 
2 3 
^vdw 
4 5 6 7 
separation (Angstrom) 
Figure 5. 
An assessment of the division of tfie cell volume into protein, ordered and diffuse solvent regions, for 
rubredoxin and protein G models, Table 1. A grid was constructed inside the unit cell with divisions 
of around 0.5 Angstrom along each cell axis. A set of 128000 points was used. The rms separation 
between atom and closest gridpoint was around 0.25 Angstrom. Separations were computed for; 
gridpoint to closest atom 
gridpoint to closest protein atom 
histograms were plotted of these lists of separations. The area under the histogram 
for separations d1 ->d2 = unit cell volume separated by d1 ->d2 from all/protein atoms. 
volume remote from the protein = volume of diffuse solvent region V(ds) 
volume remote from all atoms = V(ra) 
volume of the ordered solvent region, V(ss) = V(ds) - V(ra) 
(a) Separation of gridpoints from closest atom, for rubredoxin (continuous line) and protein G (dashes). 
Area under the plot with d > 2.5 Angstrom = V(ra) 
l t 3 
(%) 
separation (Angstrom) 
Figure 5b. 
Separation of gridpoints from closest atom(continuous line) and protein atom(dashes), 
for rubredoxin. Area under continuous line plot with d > 2.5 Angstrom = V(ra), 
area between curves = V(ss) 
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(%) 
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separation (Angstrom) 
Figure 5c. 
Separation of gridpoints from closest atom(continuous line) and protein atom(dashes), 
for protein G. Area under continuous line plot with d > 2.5 Angstrom = V(ra), 
area between curves = V(ss) 
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The results of this analysis of the solvent structure are summarised in Table 6. From the 
gridpoint analysis, the percentage of the cell volume occupied by the shell of ordered 
solvent, V s s , is very similar for the two structures, 19.6% and 20.3%, for rubredoxin and 
protein G respectively. The percentage of ordered water in the cell can also be evaluated 
from V s c and the total solvent content calculated from relative cell and protein volumes 
(9). Vsoi, ordered Is 25 % and 24 % for rubredoxin and protein G. This gives a strong 
indication that the solvent shell around a protein has a standard conformation which is 
not greatly influenced by the nature of the protein or the packing density in the crystal, 
although the shell volume is obviously a function of the molecular surface area, which is 
relatively larger for a smaller protein. 
Vsol , ordered — V s c Nsol.modelled / Nsol.total (%) (9) 
From the gridpoint analysis, the percentage of the cell volume lying remote from the 
protein, V d s , is 16.1% for rubredoxin and 31.4% for protein G, or, if Vds is evaluated using 
gridpoint separation > 3 A, 0.6% and 11.2% respectively. Using the alternative method 
(9), Vsol, diffuse is 4% for rubredoxin and 21% for protein G. Thus, the protein G structure 
contains a large volume filled by diffuse solvent, while the rubredoxin structure has 
essentially no diffuse solvent region. 
Table 6. Results of the analysis of solvent structure 
rubredoxin protein G 
from relative protein and cell volumes (Table 1): 
Vsc (%) 29 45 
Nsol.modelled 82 119 
NsoMotal 94 222 
from gridpoint analysis (Figure 5) 
Vss (%) 19.6 20.3 
Vds with d > 2.5 A (%) 16.1 31.4 
Vds with d > 3 A (%) 0.6 11.2 
from Vsc , Nsol,modelled & Nsol.total 
Vsol, ordered (%) 25 24 
Vsol. diffuse (%) 4 21 
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A layered solvent structure, with solvent sites clustered at specific separation ranges from 
the protein, each cluster possessing a characteristic B factor range, will give rise to a 
series of peaks in the distribution of the function [B * (separation from protein)], Figure 6. 
For protein G, this distribution has two major peaks, at 100 and 150 A^, while the 
rubredoxin distribution has only one peak, at 100 A^. This suggests that a first solvent 
shell Is present in both cases. Giving rise to the 100 A^ peak, it is situated in the hydrogen 
bonding region, at around 2.2 - 3.3 A from the protein surface, with a characteristic B 
factor range, 25 - 35 A^. The second peak, present only in the protein G structure, could 
be caused by a second shell of water 3.3-4.0 A from the protein surface with B factors in 
the region 35-50 k?. 
The separation distance 3.3-4.0 A is rather small for a second solvent shell and a value 
of 4.5 A would be better. However solvent does indeed adopt a shell structure around the 
protein molecule in both crystals and rubredoxin is exceptional in having insufficient 
space between the molecules to incorporate more than a single shell. 
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Figure 6. 
The distribution of d(sp) * B(s) for rubredoxin(continuous line) and protein G(dashes), where d(sp) 
is the separation of a solvent site from its closest protein atom and B(s), the solvent site B factor. 
The existence of consecutive solvent shells, each possessing a characteristic B factor range, 
will give rise to a series of peaks in this distribution. Peaks are observed at separations 
s.| and s 2for the protein G distribution, and s only for rubredoxin. 
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